feature photo

Publications

Need help locating a publication? Try the search tools here ➜

You can search by year or by author/keyword. Narrow your search results by using both, select a year then enter a partial name or key word and click the search button.

Use the New Search button to try another search.

Search by year, by keyword, or both:

Year:   keyword:    

All Years:

Author Title Journal Year   Volume Issue Pages PubMed ID PubMed Central ID Study

Ann Melvin, Lisa Aaron, Grace Montepiedra, William Meyer, Hans Spiegel, William Borkowsky, Mark Abzug, Brookie Best, Marilyn Crain, Peggy Borum, Bobbie Graham, Patty Anthony, Katie Shin, George Siberry for the P1063 study team

Safety and efficacy of atorvastatin in HIV-infected children and youth with hyperlipidemia.

Pediaric Infectious Disease Journal

2017

36

1

53-60

27749649

P1063

MJ Levin, JC Lindsey, SS Kaplan, W Schimana, J Lawrence, M McNeal, M Bwakura-Dangarembizi, A Ogwu, E Mpabalwani, B Heckman, P Sato, GK Siberry, M Nelson, D Hille, GA Weinberg, A Weinberg for the IMPAACT P1072 team

Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa

Lancet

2017

 

 

 

27662551

P1072

MJ Levin, JC Lindsey, SS Kaplan, W Schimana, J Lawrence, M McNeal, M Bwakura-Dangarembizi, A Ogwu, E Mpabalwani, B Heckman, P Sato, GK Siberry, M Nelson, D Hille, GA Weinberg, A Weinberg for the IMPAACT P1072 team

Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa

Clinical Infectious Diseases

2017

 

 

 

27662551

P1072

MJ Levin, JC Lindsey, SS Kaplan, W Schimana, J Lawrence, M McNeal, M Bwakura-Dangarembizi, A Ogwu, E Mpabalwani, B Heckman, P Sato, GK Siberry, M Nelson, D Hille, GA Weinberg, A Weinberg for the IMPAACT P1072 team

Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa

AIDS

2017

2

31(1)

49-59

27662551

P1072

Nikki Mulligan, Stein Schalkwijk, Brookie Best, Angela Colbers, Jiajia Wang, Edmund Capparelli, Jose Molto, Alice Stek, Graham Taylor, Elizabeth Smith, Carmen Hidalgo Tenorio, Nahida Chakhtoura, Marjo Van Kasteren, Courtney Fletcher, Mark Mirochnick, David Burger, on behalf of the PANNA network, IMPAACT 1026s study team

Etravirine Pharmacokinetics In HIV-Infected Pregnant Women

Clinical Infectious Diseases

2016

 

 

 

27540363

PMC4972814

P1026S

M G Fowler, M Qin, S A Fiscus, J S Currier, P M Flynn, T Chipato, J McIntyre, D Gnanashanmugam, G K Siberry, A S Coletti, T E Taha, K L Klingman, R E Martinson, M Owor, A Violari, D Moodley, G B Theron, R Bhosale, R Bobat, B H Chi, R Strehlau, P Mlay, A J Loftis, R Browning, T Fenton, L Purdue, M Basar, D E Shapiro, L M Mofenson for the IMPAACT 1077BF/1077FF PROMISE study team

Benefits and risks of Antiretroviral Therapy for Perinatal HIV Prevention

New England Journal of Medicine

2016

375

18

1726-1737

27806243

PMC5214343

1077BF, 1077FF

Elizabeth G. Livingston , Yanling Huo , Kunjal Patel , Ruth E. Tuomala , Gwendolyn B. Scott , Alice Stek for the P1025 Team

Complications and route of delivery in a large cohort study of HIV-1-infected women - IMPAACT P1025

American Journal of Obstetrics and Gynecology

2016

 

 

 

27082506

PMC4981552

DACS 643i-P1025

Elizabeth G. Livingston , Yanling Huo , Kunjal Patel , Ruth E. Tuomala , Gwendolyn B. Scott , Alice Stek for the P1025 Team

Complications and route of delivery in a large cohort study of HIV-1-infected women - IMPAACT P1025

Journal of Acquired Immune Deficiency Syndromes

2016

1

73(1)

74-82

27082506

PMC4981552

DACS 643i-P1025

Joan Price, Stephanie Wheeler, Lynda Stranix-Chibanda, Sybil Hosek, D. Heather Watts, George Siberry, Jeffrey Stringer, Benjamin Chi

Cost-effectiveness of Pre-Exposure HIV Prophylaxis During Pregnancy and Breast feeding in Sub-Saharan Africa

Journal of Acquired Immune Deficiency Syndromes

2016

1

72 Suppl 2

s145-53

27355502

PMC5043081

IMPAACT 2009

A Gupta, G Montepiedra, A Gupte, J Jubulis, B Zeldow, B Detrick, A Violari, SA Madhi, R Bobat, MF Cotton, C Mitchell, SA Spector for the IMPAACT NWCS113 and P1041 Study Team

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants is Strongly Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

Lancet

2016

 

 

 

26872154

PMC4752266

NWCS 113, P1041

A Gupta, G Montepiedra, A Gupte, J Jubulis, B Zeldow, B Detrick, A Violari, SA Madhi, R Bobat, MF Cotton, C Mitchell, SA Spector for the IMPAACT NWCS113 and P1041 Study Team

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants is Strongly Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

PLoS One

2016

11

2

e0148649

26872154

PMC4752266

NWCS 113, P1041

A Gupta, G Montepiedra, A Gupte, J Jubulis, B Zeldow, B Detrick, A Violari, SA Madhi, R Bobat, MF Cotton, C Mitchell, SA Spector for the IMPAACT NWCS113 and P1041 Study Team

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants is Strongly Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

Lancet

2016

 

 

 

26872154

PMC4752266

NWCS 113, P1041

A Gupta, G Montepiedra, A Gupte, J Jubulis, B Zeldow, B Detrick, A Violari, SA Madhi, R Bobat, MF Cotton, C Mitchell, SA Spector for the IMPAACT NWCS113 and P1041 Study Team

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants is Strongly Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

PLoS One

2016

11

2

e0148649

26872154

PMC4752266

NWCS 113, P1041

Charlotte Hobbs, Erin Gabriel , Portia Kamthunzi, Gerald Tegha, Elizabeth Wills Petzold, Linda Barlow-Mosha, Ben Chi, Yonghua Li, Tiina Ilmet, Brian Kirmse, Jillian Neal, Sunil Parikh, Nagamah Deygoo, Patrick Jean Philippe, Lynne Mofenson, Roy Prescott, Philippa Musoke, Paul Palumbo, Patrick Duffy, William Borkowsky for the P1068s team

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

Lancet

2016

 

 

 

27936233

P1068S

Charlotte Hobbs, Erin Gabriel , Portia Kamthunzi, Gerald Tegha, Elizabeth Wills Petzold, Linda Barlow-Mosha, Ben Chi, Yonghua Li, Tiina Ilmet, Brian Kirmse, Jillian Neal, Sunil Parikh, Nagamah Deygoo, Patrick Jean Philippe, Lynne Mofenson, Roy Prescott, Philippa Musoke, Paul Palumbo, Patrick Duffy, William Borkowsky for the P1068s team

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

PLoS One

2016

11

12

e0165140

27936233

P1068S

Linda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, Moherndran Archary, Mark Cotton, Sylvia Dittmer, Lee Fairlie, Enid Kabugho, Portia Kamthunzi, Arti Kinikar, Tapiwa Mbengeranwa, Levina Msuya, Pauline Sambo, Kunjal Patel, Emily Barr, Patrick Jean-Phillipe, Avy Violari, Lynne Mofenson, Paul Palumbo, Benjamin H Chi

Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 study

2016

 

 

 

27439527

PMC5036919

P1060

Linda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, Moherndran Archary, Mark Cotton, Sylvia Dittmer, Lee Fairlie, Enid Kabugho, Portia Kamthunzi, Arti Kinikar, Tapiwa Mbengeranwa, Levina Msuya, Pauline Sambo, Kunjal Patel, Emily Barr, Patrick Jean-Phillipe, Avy Violari, Lynne Mofenson, Paul Palumbo, Benjamin H Chi

Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 study

The Journal of the American Medical Association

2016

 

 

 

27439527

PMC5036919

P1060

Linda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, Moherndran Archary, Mark Cotton, Sylvia Dittmer, Lee Fairlie, Enid Kabugho, Portia Kamthunzi, Arti Kinikar, Tapiwa Mbengeranwa, Levina Msuya, Pauline Sambo, Kunjal Patel, Emily Barr, Patrick Jean-Phillipe, Avy Violari, Lynne Mofenson, Paul Palumbo, Benjamin H Chi

Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 study

Clinical Infectious Diseases

2016

15

63(8)

1113-21

27439527

PMC5036919

P1060

Anna Tran, Brookie M. Best, Alice Stek, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Mark Mirochnick, for the IMPAACT P1026s Protocol Team

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

Journal of Infectious Diseases

2016

 

 

 

26918544

PMC4911231

P1026S

Anna Tran, Brookie M. Best, Alice Stek, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Mark Mirochnick, for the IMPAACT P1026s Protocol Team

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

Journal of Acquired Immune Deficiency Syndromes

2016

1

72(3)

289-96

26918544

PMC4911231

P1026S

Anna Tran, Brookie M. Best, Alice Stek, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Mark Mirochnick, for the IMPAACT P1026s Protocol Team

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

Journal of Infectious Diseases

2016

 

 

 

26918544

PMC4911231

P1026S

Anna Tran, Brookie M. Best, Alice Stek, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Mark Mirochnick, for the IMPAACT P1026s Protocol Team

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

Journal of Acquired Immune Deficiency Syndromes

2016

1

72(3)

289-96

26918544

PMC4911231

P1026S

Tim Cressey, Rohan Hazra, Andrew Wiznia, Marc Foca, Patrick Jean-Philipe, Bobbie Graham, Jennifer King, Paula Britto, Vincent Carey, Edward Acosta, Ram Yogev for the IMPAACT P1058A team

Pharmacokinetics of unboosted atazanavir once-daily in HIV-Infected Children, Adolescents and young Adults

AIDS

2016

 

 

 

27583590

PMC5106325

P1058A

Tim Cressey, Rohan Hazra, Andrew Wiznia, Marc Foca, Patrick Jean-Philipe, Bobbie Graham, Jennifer King, Paula Britto, Vincent Carey, Edward Acosta, Ram Yogev for the IMPAACT P1058A team

Pharmacokinetics of unboosted atazanavir once-daily in HIV-Infected Children, Adolescents and young Adults

Pediatric Infectious Disease Journal

2016

35

12

1333-1335

27583590

PMC5106325

P1058A

Marc Foca, Ram Yogev, Andrew Wiznia, Rohan Hazra, Patrick Jean-Philippe, Bobbie Graham, Paula Britto, Vincent J Carey, Jennifer King, Edward P Acosta, Tim R Cressey

Rilpivirine Pharmacokinetics With and Without Darunavir/Ritonavir Once Daily in Adolescents and Young Adults

Pediatric Infectious Disease Journal

2016

35

9

e271-4

27187753

PMC5245132

P1058

S Gantt, E Leister, DL Jacobsen, I Boucioran, ML Huang, KR Jerome, G Jourdain, N Ngo-Giang-Huong, S Burchett, L Frenkel

Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.

Journal of Medical Virology

2016

88

6

1051-8

26519647

PMC4818099

ACTG 316, iDACS 655-P1025

Maritz ER, Montepiedra G, Liu L, Mitchell CD, Madhi SA, Bobat R, Violari A, Ogwu A, Hesseling AC, Cotton MF

Source case identification in HIV- exposed infants relative to Tuberculosis diagnosis in an Isoniazid prevention study

International Journal of Tuberculosis and Lung Disease

2016

20

8

1060-4

27393540

PMC5066391

DACS 646

Maritz ER, Montepiedra G, Liu L, Mitchell CD, Madhi SA, Bobat R, Violari A, Ogwu A, Hesseling AC, Cotton MF

Source case identification in HIV- exposed infants relative to Tuberculosis diagnosis in an Isoniazid prevention study

International Journal of Tuberculosis and Lung Disease

2016

20

8

1060-4

27393540

PMC5066391

DACS 646

Christy Beneri, Lisa Aaron, Soyeon Kim, Patrick Jean-Philippe, Avy Violari, Mark F. Cotton, Charles Mitchell, Sharon Nachman and the rest of the P1041 team

Understanding NIH Clinical Case Definitions for Pediatric Intrathoracic TB by Applying Them to a Clinical Trial

International Journal of Tuberculosis and Lung Disease

2016

20

1

93-100

26688534

DACS 658, P1041

FT Aweeka, C Hu, L Huang, BM Best, A Stek, P Lizak, SK Burchett, JS Read, H Watts, M Mirochnick, EV Capparelli, IMPAACT P1026s Protocol Team

Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.

HIV Medicine

2015

16

3

176-183

25407158

PMC4320673

P1026S

Grant R. Campbell, Rachel S. Bruckman, Stephen A. Spector

Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1

Journal of Biological Chemistry

2015

290

8

5028-5040

25540204

PMC4335239

 

Priyanka Uprety, Ellen G. Chadwick, Kaitlin Rainwater-Lovett, Carrie Ziemniak, Katherine Luzuriaga, Edmund V. Capparelli, Gayane Yenokyan, Deborah Persaud

Cell-Associated HIV-1 DNA and RNA Decay Dynamics during Early Combination Antiretroviral Therapy in HIV-1-Infected Infants

Clinical Infectious Diseases

2015

15

61(12)

1862-70

26270687

PMC4657533

P1030

Gayatri Mirani, Paige Williams, Miriam Chernoff, Mark Abzug, Myron Levin, George Seage, James Oleske, Murli Purswani, Rohan Hazra, Shirley Traite, Bonnie Zimmer, Russell Van Dyke for the IMPAACT P1074 team

Changing Trends in Complications and Mortality among US Youth and Young Adults with HIV Infection in the Era of Combination Antiretroviral Therapy

Clinical Infectious Diseases

2015

61

12

1850-1861

 

DJ Curtis, P Muresan, S Nachman, T Fenton, KM Richardson, T Dominguez, PM Flynn, SA Spector, CK Cunningham, A Bloom, A Weinberg

Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth

PLoS One

2015

3

 

e0118567

25785995

PMC4364897

NWCS 114, P1088

Kristina Adachi, Jeffrey D Klasner, Jiahong Xu, Bonnie Ank, Claire C. Bristow, Mariza G Morgado, D. Heather Watts, Fred Weir, David Persing, Lynne M. Mofenson, Valdilea G. Veloso, Jose Henrique Pilotto, Esau Joao, Glenda Gray, Gerhard Theron, Breno Santos, Rosana Fonseca, Regis Kreitchmann, Jorge Pinto, Marisa Mussi-Pinhata, Mariana Ceriotto, Daisy Maria Machado, Yvonne J Bryson, Beatriz Grinsztejn, Francisco I Bastos, George Siberry, Karin Neilsen-Saines for the NICHD HPTN 040 Study Team

Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes

Pediaric Infectious Disease Journal

2015

 

 

 

26372927

PMC4571193

 

Kristina Adachi, Jeffrey D Klasner, Jiahong Xu, Bonnie Ank, Claire C. Bristow, Mariza G Morgado, D. Heather Watts, Fred Weir, David Persing, Lynne M. Mofenson, Valdilea G. Veloso, Jose Henrique Pilotto, Esau Joao, Glenda Gray, Gerhard Theron, Breno Santos, Rosana Fonseca, Regis Kreitchmann, Jorge Pinto, Marisa Mussi-Pinhata, Mariana Ceriotto, Daisy Maria Machado, Yvonne J Bryson, Beatriz Grinsztejn, Francisco I Bastos, George Siberry, Karin Neilsen-Saines for the NICHD HPTN 040 Study Team

Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes

Sexually Transmitted Diseases

2015

42

10

554-65

26372927

PMC4571193

 

 

Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Infant HIV Transmission

Sexually Transmitted Diseases

2015

42

10

544-565

26372927

PMC4571193

 

AL Ciaranello, K Doherty, M Penazzato, JC Lindsey, L Harrison, K Kelly, RP Walensky, S Essajee, E Losina, L Muhe, K Wools-Kaloustian, S Ayaya, MC Weinstein, P Palumbo, KA Freedberg

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than three years of age

AIDS

2015

29

10

1247-1259

25870982

DACS 656, P1060

Weinberg A, Muresan P, Richardson KM, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ, P1086 team

Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine.

PLoS One

2015

10

4

e0122431

25874544

PMC4395240

P1086

CS Crowell, Y Huo, K Tassiopoulos, KM Malee, R Yogev, R Hazra, RM Rutstein, SL Nichols, RA Smith, PL Williams, J Oleske, WJ Muller, PACTG 219C Study Team, PHACS

Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children

AIDS

2015

29

3

295-304

25686678

PMC4332557

ACTG 219C

CS Crowell, Y Huo, K Tassiopoulos, KM Malee, R Yogev, R Hazra, RM Rutstein, SL Nichols, RA Smith, PL Williams, J Oleske, WJ Muller, PACTG 219C Study Team, PHACS

Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children

AIDS

2015

29

3

295-304

25686678

PMC4332557

ACTG 219C

Suad Kapetanovic, Lisa Aaron, Grace Montepiedra, Patricia Anthony, Kasalyn Thuvamontolrat, Savita Pahwa, Sandra Burchett, Adriana Weinberg, Andrea Kovacs for the Pediatric AIDS Clinical Trials Group

Effect of Cytomegalovirus Co-infection on Normalization of Selected T-cell Subsets in Children with Perinatally Acquired HIV Infection Treated with Combination Antiretroviral Therapy

PLoS One

2015

10

3

e0120474

25794163

PMC4368806

ACTG 366

Adriana Weinberg , Petronella Muresan, Kelly Richardson, Terence Fenton, Teresa Dominguez, Anthony Bloom, D Heather Watts, Mark J Abzug, Sharon A Nachman, Myron J Levin for the P1086 study team

Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women

AIDS Research and Human Retroviruses

2015

31

11

1170-7

26322930

PMC4651022

P1086

Adriana Weinberg , Petronella Muresan, Kelly Richardson, Terence Fenton, Teresa Dominguez, Anthony Bloom, D Heather Watts, Mark J Abzug, Sharon A Nachman, Myron J Levin for the P1086 study team

Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women

AIDS Research and Human Retroviruses

2015

31

11

1170-7

26322930

PMC4651022

P1086

L Harrison, A Melvin, S Fiscus, Y Saidi, E Nastouli, L Harper, A Compagnucci, A Babiker, R McKinney, D Gibb, G Tudor-Williams, PENPACT-1 (PENTA 9/PACTG 390) Study Team

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds

Journal of Acquired Immune Deficiency Syndromes

2015

70

1

42-53

26322666

PMC4556171

ACTG 390

Linda Harrison, Ann Melvin , Susan Fiscus , Yacine Saidi , Eleni Nastouli , Lynda Harper , Alexandra Compagnucci , Abdel Babiker , Ross McKinney , Diana Gibb , Gareth Tudor-Williams , the PENPACT-1 (PENTA 9/PACTG 390) Study Team

HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds

Journal of Acquired Immune Deficiency Syndromes

2015

70

1

42-53

26322666

PMC4556171

ACTG 390

Mary-Ann Davies, Kunjal Pate, M Koller, B Chi, K Wools-Kaloustian, V Leroy, K Chokephaibulkit, C Chimbetete, D Avila, R Hazra, S Ayaya, F Dicko, HK Trong, M Egger

Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries.

Journal of Acquired Immune Deficiency Syndromes

2015

68

1

62-72

25501345

PMC4351302

ACTG 219C

Genevieve Fouda, Coleen Cunningham, E McFarland, B Borkowsky, P Muresan, J Pollara, L Y Song, B Liebl, K Whitaker, X Shen, N Vandergrift, RG Overman, N Yates, A Moody, C Fry, J Kim, N Michael, P Pitisuttithum, J Kaewkungwal, S Nitayaphan, S Rerks-Ngarm, H-X Liao,, B Haynes, D Montefiori, G Ferrari, G Tomaras, S Permar

Infant HIV Type 1 gp120 vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G responses and only Rare Envelope-Specific Immunoglobulin A Responses

Journal of Infectious Diseases

2015

211

4

508-517

25170104

PMC4318918

NWCS 121

RM Rutsein, P Samson, T Fenton, CV Fletcher, JJ Kiser, Mofenson LM, E Smith, B Graham, M Mathew, G Aldrovani, PACTG 1020A Study Team

Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.

Pediatric Infectious Disease Journal

2015

34

2

162-167

25232777

PMC4355059

P1020A

Angela Colbers, Brookie Best, Stein Schalkwijk, Jiajia Wang, Alice Stek, Carmen Hidalgo Tenorio, David Hawkins, Graham Taylor, Regis Kreitchmann, Sandra Burchett, Annette Haberl, Kabeya Kabamba, Marjo van Kasteren, Elizabeth Smith, Edmund Capparelli, David Burger, Mark Mirochnick on behalf of the PANNA network and the IMPAACT 1026s study team

Maraviroc Pharmacokinetics in HIV-1 Infected pregnant Women

Clinical Infectious Diseases

2015

61

10

1582-1589

26202768

PMC4614410

P1026S

Angela Colbers, Brookie Best, Stein Schalkwijk, Jiajia Wang, Alice Stek, Carmen Hidalgo Tenorio, David Hawkins, Graham Taylor, Regis Kreitchmann, Sandra Burchett, Annette Haberl, Kabeya Kabamba, Marjo van Kasteren, Elizabeth Smith, Edmund Capparelli, David Burger, Mark Mirochnick on behalf of the PANNA network and the IMPAACT 1026s study team

Maraviroc Pharmacokinetics in HIV-1 Infected pregnant Women

Clinical Infectious Diseases

2015

61

10

1582-1589

26202768

PMC4614410

P1026S

S Nachman, C Alvero, EP Acosta, H Teppler, B Homony, B Graham, T Fenton, X Xu, ML Rizk, SA Spector, LM Frenkel, C Worrell, E Handelsman, A Wiznia

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age

2015

4

4

76-83

26582887

PMC4681385

P1066

Alice Stek, Brookie M. Best, Jiajia Wang, Edmund V. Capparelli, Steven Rossi, Sandra K Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Tim R. Cressey, Lynne M. Mofenson, Elizabeth Smith, David Shapiro, Mark Mirochnick, IMPAACT P1026s Protocol Team

Pharmacokinetics of Once versus Twice Daily Darunavir In Pregnant HIV-Infected Women

Journal of Acquired Immune Deficiency Syndromes

2015

70

1

33-41

25950206

PMC4579345

P1026S

Sharon Nachman, Carmelita Alvero, Edward P. Acosta, Hedy Teppler, Brenda Homony, Bobbie Graham, Terence Fenton, Xia Xu, Matthew L. Rizk, Stephen A. Spector, Lisa Frenkel, Carol Worrell, Edward Handelsman, Andrew Wiznia, the IMPAACT P1066 study team

Pharmacokinetics, and 48 Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus type-1 (HIV) infected Children 4 weeks to 2 years of age

2015

 

 

 

26582887

P1066

Sharon Nachman, Carmelita Alvero, Edward P. Acosta, Hedy Teppler, Brenda Homony, Bobbie Graham, Terence Fenton, Xia Xu, Matthew L. Rizk, Stephen A. Spector, Lisa Frenkel, Carol Worrell, Edward Handelsman, Andrew Wiznia, the IMPAACT P1066 study team

Pharmacokinetics, and 48 Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus type-1 (HIV) infected Children 4 weeks to 2 years of age

2015

 

 

 

26582887

P1066

Rizk ML, Du L,  Bennetto-Hood C, Wenning L, Teppler H, Homony B, Graham B, Fry C, Nachman S, Wiznia A, Worrell C, Smith B, Acosta EP

Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV- Infected Children 4 weeks to 18 Years of Age.

Journal of Clinical Pharmacology

2015

55

7

748-756

2573401

P1066

Deborah Kacanek, Konstantia Angelidou, Paige L. Williams, Miriam Chernoff, Kenneth D. Gadow, Sharon Nachman for IMPAACT P1055 Study Team

Psychiatric condition symptoms and antiretroviral non-adherence in US youth with perinatal HIV infection: A longitudinal study

AIDS

2015

29

10

1227-1237

26035322

P1055

Kacanek D, Angelidou K, Williams PL, Chernoff M, Gadow KD, Nachman S, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1055 Study Team

Psychiatric Symptoms and Antiretroviral Non-adherence in US Youth with Perinatal HIV: A Longitudinal Study

AIDS

2015

29

10

1227-1237

26035322

in-process

P1055

SC Olson, N Nqo-Giang-Huong, I Beck, W Deng, P Britto, DE Shapiro, RE Bumgarner, JI Mullins, RB Van Dyke, G Jourdain, LM Frenkel

Resistance detected by pyrosequencing following zidovudine-monotherapy for prevention of HIV-1 mother-to-child-transmission

AIDS

2015

29

12

1467-1471

26244386

PMC4618483

P1032

Rolando M. Viani, Carmelita Alvero, Terry Fenton, Edward P. Acosta, Rohan Hazra, Ellen O’Gara, Debra Steimers, Sherene Min, Andrew Wiznia on behalf of the P1093 study team.

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093

Pediatric Infectious Disease Journal

2015

34

11

1207-1213

26244832

PMC4604048

P1093

SH Vermund

Screening for Sexually Transmitted Infections in Antenatal Care is Especially Important Among HIV-infected Women

Sexually Transmitted Diseases

2015

42

10

566-568

26372928

 

C Bennetto-Hood, G Tabolt, P Savina, EP Acosta

A Sensitive HPLC-MS/MS Method for the Determination of Dolutegravir in Human Plasma

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

2014

 

 

225-232

24361860

PMC4229012

P1093

FT Aweeka, C Hu, L Huang, BM Best, A Stek, P Lizak, SK Burchett, JS Read, H Watts, M Mirochnick, EV Capparelli, IMPAACT P1026s Protocol Team

Alteration in Cytochrome P450 3A4 Activity as Measured by a Urine Cortisol Assay in HIV-1-Infected Pregnant Women and Relationship to Antiretroviral Pharmacokinetics

HIV Medicine

2014

16

3

176-183

25407158

PMC4320673

P1026S

NH Tobin, GM Aldrovandi

Are infants unique in their ability to be "functionally cured" of HIV-1

Current HIV/AIDS Reports

2014

11

1

1-10

24390641

 

Qin M, Brummel S, Singh KK, Fenton T, Apector SA

Associations of Host Genetic Variants on CD4+ Lymphocyte Count and Plasma HIV-1 RNA in Antiretroviral Naïve Children.

Pediaric Infectious Disease Journal

2014

33

9

946-952

2797997

PMC4216611

 

GK Siberry, H Li, D Jacobson, PACTG 219/219c

Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children

AIDS

2014

28

3

247-250

22471877

PMC3292745

01071988, 1077BF, 1077HS, 1099s, 123, 265, ACTG 219C

A Garg, SA Spector

HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.

Journal of Infectious Diseases

2014

209

3

441-451

23999600

PMC3883171

 

R Kantor, D Bettendorf, RJ Bosch, M Mann, D Katzenstein, S Cu-Uvin, R D'Aquila, L Frenkel, S Fiscus, R Coombs, ACTG A5077 Study Team

HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-blood Compartments from HIV-1-Infected Men and Women Enrolled in AIDS Clinical Trials Group Study A5077.

PLoS One

2014

9

4

e93537

24699474

PMC3974754

 

Tim R Cressey, Saik Urien, Edmund B. Capparelli, Brookie M. Best, Sudanee Buranabajasatean, Aram Limtrakul, Weerapong Suwankornsakul, Somsak Pattarakulwanich, Jean-Marc Treluyer, Gonzague Jourdain, Alice Stek, Marc Lallemant, Mark Mirochnick

Impact of Body Weight and Missed Doses on Lopinavir concentrations with Standard and Increased Lopinavir/Ritonavir Doses during Late Pregnancy.

Journal of Antimicrobial Chemotherapy

2014

70

1

217-224

25261418

PMC4267507

DACS 652, P1026S

KB Larson, K Wang, C Delille, I Otofokun, EP Acosta

Pharmacokinetic Enhancers in HIV Therapeutics

Clinical Pharmacokinetics

2014

53

10

865-872

25164142

 

KB Larson, K Wang, C Delille, I Otofokun, EP Acosta

Pharmacokinetic Enhancers in HIV Therapeutics

Clinical Pharmacokinetics

2014

53

10

865-872

25164142

 

Charles D Mitchell, Miriam C. Chernoff, George R. Seage III, Murli R Purswani, Hans M.L. Spiegel, Gaston Zilleruelo, Carolyn Abibol, Barbara Heckman, Christopher B Ponce, James M Oleske

Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection

Pediatric Nephrology

2014

30

1

153-165

25149850

PMC4301405

DACS 617i

H Watts, A Stek, B Best, J Wang, E Capparelli, T Cressey

Raltegravir Pharmacokinetics during Pregnancy

Journal of Acquired Immune Deficiency Syndromes

2014

67

4

375-381

25162818

PMC4213295

P1026S

Diana F. Clarke, Edward P. Acosta, Matthew Rizk, Yvonne Bryson, Stephen A. Spector, Lynne Mofenson, Hedy Teppler, Carolee Welebob, Deborah Persaud, Mae P. Cababasay, Jiajia Wang, Mark Mirochnick, the P1097 Team

Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing

Journal of Acquired Immune Deficiency Syndromes

2014

67

3

310-315

25162819

PMC4197108

P1097

G Baheti, JR King, EP Acosta, CV Fletcher

Age-Related Differences in Plasma and Intracellular Tenofovir Concentrations in HIV-1 Infected children, adolescents and adults.

AIDS

2013

27

2

223-225

23032419

PMC3586236

P1058A

MJ Abzug, LY Song, MJ Levin, SA Nachman, W Borkowsky, SI Pelton, IMPAACT P1024 and P1061 Protocol Teams

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination inHIV-infected children on highly active antiretroviral therapy

Vaccine

2013

31

42

4782-90

23954381

PMC3825555

P1024, P1061s

 

Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children

PLoS One

2013

8

11

e81213

24312277

PMC3861509

1077HS

KJ Nakamura, C Cerini, ER Sobrera, L Heath, M Sinkala, C Kankasa, DM Thea, JI Mullins, L Kuhn, GM Aldrovandi

Coverage of Primary Mother-to-Child HIV Transmission Isolates by Second Generation Broadly Neutralizing Antibodies

AIDS

2013

27

3

337-46

23296195

PMC3863550

 

 

Development of a Novel Codon-Specific PCR for the detection of CXCR4-Utilizing HIV-1 Subtype B.

AIDS Research and Human Retroviruses

2013

29

5

814-25

23343425

PMC3636599

 

 

Discordant associations between SLCO1B1 521T¿C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146

Therapeutic Drug Monitoring

2013

35

2

209-216

23503447

PMC3603284

 

 

Ethical tradeoffs in trial design: Case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings

Developmental Pharmacology and Therapeutics

2013

13

2

95-104

23725055

PMC3716837

 

 

Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa

Journal of Acquired Immune Deficiency Syndromes

2013

63

1

1-8

23221981

PMC3625520

HPTN 027

 

Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central

Journal of Acquired Immune Deficiency Syndromes

2013

62

2

197-203

23138837

PMC3658306

ACTG 152, ACTG 300

KK Singh, Y Wang, KP Gray, M Farhad, S Brummel, T Fenton, R Trout, SA Spector

Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central Nervous System Impairment in Children

Journal of Acquired Immune Deficiency Syndromes

2013

62

2

197-203

23138837

PMC3658306

 

KK Singh, Y Wang, KP Gray, M Farhad, S Brummel, T Fenton, R Trout, SA Spector

Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central Nervous System Impairment in Children

Journal of Acquired Immune Deficiency Syndromes

2013

62

2

197-203

23138837

PMC3658306

 

 

Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FC¿ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth

Clinical and Vaccine Immunology

2013

20

6

900-6

23595505

PMC3675972

P1065

 

HIV Disease Progression in the First Year after Delivery among African Women followed in the HPTN 046 Clinical Trial

Journal of Acquired Immune Deficiency Syndromes

2013

64

3

299-306

23846568

PMC3800257

HPTN 046

RF Pass, S Nachman, PM Flynn, P Muresan, T Fenton, CK Cunningham, W Borkowsky, JB McAuley, SA Spector, E Petzold, W Levy, GK Siberry, E Handelsman, LJ Utech, A Weinberg

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth

2013

2

4

352-360

24363932

PMC3869470

P1089

NH Tobin, GM Aldrovandi

Immunology of pediatric HIV infection

European Journal of Immunology

2013

254

1

143-169

23772619

PMC3737605

 

 

Infant Growth Outcomes After Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy

Journal of Acquired Immune Deficiency Syndromes

2013

64

4

374-81

24169122

PMC3818710

P1025

 

Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa

International Journal of Tuberculosis and Lung Disease

2013

17

1

32-38

23232002

PMC3556820

P1041

 

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 Psychiatric Comorbidity Study

Journal of Acquired Immune Deficiency Syndromes

2013

63

3

401-9

23714737

PMC3683105

P1055

 

Pharmacokinetics and Safety of Tenofovir in HIV-infected Women during Labor and their Infants During the First Week of Life

Journal of Acquired Immune Deficiency Syndromes

2013

 

 

 

23979002

NIHMSID #524792

HPTN 057

 

Pharmacokinetics of an Increased Atazanavir Dose with and without Tenofovir During the Third Trimester of Pregnancy

Journal of Acquired Immune Deficiency Syndromes

2013

63

1

59-66

23392467

PMC3625451

P1026S

Paige L. Williams, Mark J. Abzug, Denise L. Jacobson, Jiajia Wang, Russell B. Van Dyke, Rohan Hazra, Kunjal Patel, Linda A. DiMeglio, Elizabeth J. McFarland, M Silio, W Borkowsky, GR Seage 3rd, JM Oleske, ME Geffner, IMPAACT P219 & 219c

Pubertal Onset in children with perinatal HIV-infected in the Era of Combination Antiretroviral Treatment

AIDS

2013

27

12

1959-1970

24145244

PMC4143250

ACTG 219C

 

Pubertal Onset in HIV-infected Children in the Era of Combination Antiretroviral Treatment

AIDS

2013

27

12

1959-1970

24145244

ACTG 219C

 

Raltegravir In Vitro Effect on Bilirubin Binding

Pediaric Infectious Disease Journal

2013

32

9

978-980

23470680

PMC3856729

P1097

 

Reduced indinavir exposure during pregnancy

Journal of Clinical Pharmacology

2013

76

3

475-83

23305215

PMC3769674

P1026S

 

Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women

Clinical Infectious Diseases

2013

56

10

1488-97

23378284

PMC3634309

P1086

 

Safety and Infectivity of Two Doses of Live -Attenuated Recombinant Cold-Passaged Human Parainfluenza Type 3 Virus Vaccine rHPIV3cp45 in HPIV3 Seronegative Young Children

Vaccine

2013

31

48

5706-12

24103895

P1096

 

Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay

Journal of Virological Methods

2013

129

1-2

39-43

23660583

PMC3708483

 

 

Social Ecological Predictors of Longitudinal Pediatric HIV Treatment Adherence

Journal of Pediatric Psychology

2013

38

6

664-74

23629146

PMC3701127

P1042S

 

Vitamin D Attenuates Nucleoside Reverse Transcriptase Inhibitor Induced Human Skeletal Muscle Mitochondrial DNA Depletion

AIDS

2013

27

9

1397-401

23435299

PMC3762245

 

A Moodley, M Qin, KK Singh, SA Spector

Vitamin D-related host genetic variants alter HIV disease progression in children.

Pediatric Infectious Disease Journal

2013

32

11

1230-1236

23736144

PMC3811908

 

 

Humoral, mucosal and cell-mediated immunity against vaccine and non-vaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children

Journal of Infectious Diseases

2012

206

8

1309-1313

22859825

PMC3529604

P1047

 

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.

Clinical Infectious Diseases

2012

54

2

285-93

22144539

PMC3245730

P1032

 

A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4 T-cell recovery despite sustained virologic suppression: ACTG A5256

Journal of Infectious Diseases

2012

206

4

534-42

22740718

PMC3491731

 

 

Antiretroviral Treatment for Young, HIV-infected Children: A Randomized Trial Comparing Nevirapine- versus Lopinavir/ritonavir-based Therapy

New England Journal of Medicine

2012

366

25

2380-9

22716976

PMC3443859

P1060

 

Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing

Clinical Pharmacology & Therapeutics

2012

91

2

243-249

22190064

PMC3356582

P1030

Robert J. McLinden, Ph.D.

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

AIDS

2012

26

1

1-9

21971356

 

 

Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy

HIV Medicine

2012

13

6

372-8

22257000

PMC3500098

 

 

Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1.

2012

8

10

1523-5

22892387

PMC3679232

 

 

Barriers to Medication Adherence in HIV-Infected Children and Youth Based on Self- and Caregiver Report

Pediatrics

2012

129

5

1244-51

22508915

PMC3340587

P1042S

 

Chronic Kidney Disease Associated with Perinatal HIV infection in Children and Adolescents.

Pediatrics

2012

27

6

981-9

22366874

PMC3715373

ACTG 219C, DACS 617i

Sharon L. Nichols, Ph.D., Grace Montepiedra, Ph.D., Patricia Sirois, Ph.D., John J. Farley, M.D., M.P.H., Kathleen Malee, Ph.D., Betsy Kammerer, Ph.D., Patricia A. Garvie, Ph.D., Sylvie Naar-King, M.D., Ph.D.

Cognitive, Academic and Behavioral Correlates of Medication Adherence in Children and Adolescents with Perinatally Acquired HIV-1 Infection

Journal of Developmental Pediatrics

2012

33

4

298-308

22366661

PMC3538821

P1042S

 

Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.

Journal of Clinical Microbiology

2012

50

8

2737-47

22692747

PMC3421531

 

 

Distribution of Hematological and Chemistry Values among Infants in Malawi and Uganda

2012

32

4

213-27

23164296

PMC3571100

 

 

Drug Resistance and Coreceptor Usage in HIV-1 Subtype C Infected Children Initiating or Failing Highly Active Antiretroviral Therapy in South Africa

AIDS Research and Human Retroviruses

2012

28

4

324-32

21819257

PMC3316120

 

 

Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active antiretroviral therapy less than six months of age

AIDS

2012

26

12

1483-90

22555165

PMC3495308

P1030

 

Efavirenz Pharmacokinetics during the Third Trimester of Pregnancy and Postpartum

AIDS

2012

59

3

245-252

22083071

PMC3288559

P1026S

 

Effect of pregnancy on emtricitabine pharmacokinetics.

HIV Medicine

2012

13

4

226-35

22129166

PMC3342997

P1026S

 

Efficacy and Safety of an Extended Nevirapine Regimen in Breastfeeding Infants of HIV-1-Infected Women for Prevention of Postnatal HIV Transmission: Results of the Randomized, Double-Blind, Placebo-Controlled HPTN 046 Trial

Lancet Infectious Diseases

2012

379

9812

221-228

22196945

PMC3539769

HPTN 046

 

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel

Journal of Infectious Diseases

2012

205

Sup2

s199-208

22448023

PMC3334506

 

 

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel

Journal of Infectious Diseases

2012

205

Sup2

S209-15

22476719

PMC3334504

 

Christina Blanchard-Horan, Ph.D., M.A., C.C.R.P., Vicki Stocker, R.N., M.S., Laura E. Moran, M.P.H., Elaine Ferguson, R.Ph., M.S., Karin L. Klingman, M.D., Deborah McMahon, M.D., Jane Hitti, M.D., M.P.H.

Examining the challenges and solutions to the implementation of trials in resource-limited settings: limited resource trials

Applied Clinical Trials

2012

21

1

34-42

22798719

PMC3392753

 

 

Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe

AIDS

2012

26

3

325-33

22112598

PMC3356697

DACS 645

 

From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part I–Extrapolation of a Covariate Model From Morphine to Zidovudine

Clinical Pharmacology & Therapeutics

2012

 

 

e9

PMC3603431

DACS 644

 

High Prevalence Of Drug Resistance Amongst HIV-Exposed And Infected Children With Culture-Confirmed Tuberculosis On A Tuberculosis Prevention Trial

International Journal of Tuberculosis and Lung Disease

2012

 

 

 

22236919

PMC3265022

P1041

 

HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.

Archives of Pediatrics and Adolescent Medicine

2012

166

6

528-35

22312169

PMC3407294

P1055

 

Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a

AIDS

2012

205

9

1443-7

22454462

PMC3324397

 

 

Immune Correlates of Herpes Zoster in HIV-Infected Children and Youth

Journal of Virology

2012

86

5

2878-81

22171274

PMC3302278

NWCS 092

 

Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus

Pediatrics

2012

161

4

676-81

22622049

PMC3434315

P1065

 

Immunogenicity, Immunologic Memory, and Safety Following Measles Re-Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Journal of Infectious Diseases

2012

206

4

512-22

22693229

PMC3491735

P1024, P1061s

 

Impaired peripheral blood T follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine.

Blood

2012

120

5

985-93

22692510

PMC3412336

 

 

Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.

Pediaric Infectious Disease Journal

2012

31

6

583-91

22333700

PMC3648848

 

 

Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings

Pediatrics

2012

129

6

e1525-e1532

22585772

PMC3362906

P1054

 

Isoniazid pharmacokinetics and dosing in South African infants

Therapeutic Drug Monitoring

2012

34

4

446-451

22695364

PMC3397663

P1041

 

Laboratory abnormalities among HIV-exposed, uninfected infants: IMPAACT Protocol P1025

Journal Of Dentistry For Children

2012

5

22

 

PMC3656554

P1025

 

Longitudinal Study of Incidence and Predictors of Mental Health Concerns in Youth Perinatally-Infected with HIV and Controls

Journal Of Developmental and Behavioral Pediatrics

2012

33

6

456-68

22772819

P1055

 

Monitoring of HIV-1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells during Suppressive Antiretroviral Therapy does not Predict Virologic Failure

AIDS Research and Human Retroviruses

2012

28

8

780-88

22081867

PMC3399556

 

 

Nevirapine Exposure with WHO Pediatric Weight Band Dosing – Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience

Antimicrobial Agents and Chemotherapy

2012

56

10

5374-80

22869579

PMC3457371

DACS 606

 

Prevalence of Congenital Anomalies in Infants with in Utero Exposure to Antiretrovirals

Pediaric Infectious Disease Journal

2012

31

2

160-174

21983213

PMC3261302

P1025

 

Production of interferon a by human immunodeficiency virus type 1 in human plasmacytoid dendritic cells is dependent on induction of autophagy.

Journal of Infectious Diseases

2012

205

8

1258-67

22396599

PMC3308911

 

 

Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy.

Clinical and Vaccine Immunology

2012

19

5

752-6

22441393

PMC3346323

 

 

Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in HIV-1 Perinatally Infected Children and Youth

Journal of Infectious Diseases

2012

206

3

421-30

22615311

PMC3490699

P1088

 

Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children

Pediaric Infectious Disease Journal

2012

31

1

47-52

21987006

PMC3252429

P1065

 

Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants

Journal of Acquired Immune Deficiency Syndromes

2012

60

5

462-5

22614899

PMC3404155

 

 

T-Cell Activation and Neurodevelopmental Outcomes in Perinatally HIV-Infected Children

AIDS

2012

26

8

959-69

22382148

PMC3437925

ACTG 366

 

The Impact of HAART on Cardiac Dysfunction among Children and Adolescents Perinatally Infected with HIV-1.

AIDS

2012

26

16

2027-37

22781228

PMC3513344

ACTG 219C

 

The Pharmacogenetics of NAT2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving Isoniazid

Clinical Pharmacology & Therapeutics

2012

52

4

511-9

21558457

PMC3182303

P1041

 

The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals.

Journal of Infectious Diseases

2012

205

1

87-96

22180621

PMC3242744

 

 

The Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV Infected Children

2012

5

1

17-31

23772317

PMC23650490

DACS 616i

 

Three Postpartum Antiretroviral Regimens to Prevent HIV Infection

New England Journal of Medicine

2012

366

25

2368-79

22716975

PMC3590113

P1043

 

Toll-Like Receptor 8 Ligands Activate a Vitamin D Mediated Autophagic Response that Inhibits Human Immunodeficiency Virus Type 1

PLoS One

2012

8

11

e1003017

23166493

PMC3499571

 

 

Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children.

Pediaric Infectious Disease Journal

2012

31

11

e222-8

22785048

PMC3473149

 

 

Use of dried blood spots for the determination of genetic variation of interleukin-10, killer immunoglobulin-like receptor and HLA class I genes.

2012

79

2

114-22

22107032

PMC3253194

 

 

Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults

AIDS

2012

59

3

325-328

22083069

PMC3288740

P1045

Athe Tsibris, M.D., Kay E. Leopold, Roger Paredes, Eoin Coakley, M.D., Zhaohui Su, Ph.D., Wayne Greaves, M.D., Roy (Trip) Gulick, M.D., M.P.H., Daniel R. Kuritzkes, M.D.

Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures

Journal of Virology

2012

86

12

6416-26

22491471

PMC3393533

 

 

Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy

PLoS One

2012

8

5

e1002689

22589721

PMC3349755

 

 

Steady-State Pharmacokinetics of Tenofovir Based Regimens in HIV-Infected Pediatric Patients

Antimicrobial Agents and Chemotherapy

2011

55

9

4290-4

21670182

PMC3165337

P1058

Kevin R. Robertson, Ph.D.

A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

Journal of Neurovirology

2011

17

5

438-47

21786076

PMC3362044

 

 

A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study

HIV Clinical Trials

2011

12

4

201-14

22044856

PMC3328407

 

Ronald J. Bosch, Ph.D.

A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.

Journal of Interferon and Cytokine Research

2011

31

6

481-3

21291323

PMC3104401

 

 

Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.

AIDS

2011

24

4

557-61

21487249

PMC3261770

 

 

Association of HIV diversity and survival in HIV-infected Ugandan infants

PLoS One

2011

6

4

 

21533179

PMC3077388

 

Susan Ellen Cohn, M.D., M.P.H., Hongyu Jiang, Ph.D., J. Allen McCutchan, M.D., M.Sc., Susan L. Koletar, M.D., Robert L. Murphy, M.D., Kevin R. Robertson, Ph.D., Annabelle de St. Maurice, Judith Silverstein Currier, M.D., M.Sc., Paige L. Williams, Ph.D.

Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362

AIDS Care

2011

23

6

775-85

21293986

PMC3095689

 

 

Association of recent HIV infection and in-utero HIV-1 transmission.

AIDS

2011

25

11

1357-64

21572305

PMC3263827

 

 

Atazanavir and Atazanavir/Ritonavir Pharmacokinetics in HIV-Infected Infants, Children, and Adolescents

AIDS

2011

25

12

1489-1496

21610486

PMC3177533

P1020A

 

Atazanavir Pharmacokinetics With and Without Tenofovir during Pregnancy

Journal of Acquired Immune Deficiency Syndromes

2011

56

5

412-419

21283017

PMC3125419

P1026S

Elizabeth Connick, M.D., Ronald J. Bosch, Ph.D., Evgenia Aga, M.Sc., Rick Schlichtemeier, B.S., Lisa M. Demeter, M.D., Paul Volberding, M.D.

Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection

Journal of Acquired Immune Deficiency Syndromes

2011

58

1

1-8

21637110

PMC3159837

 

 

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG

Journal of Infectious Diseases

2011

203

12

1791-801

21606537

PMC3100514

 

 

Clinical Management and Follow-up of Hypercholesterolemia Among Perinatally HIV-Infected Children Enrolled in the PACTG 219C Study

Journal of Acquired Immune Deficiency Syndromes

2011

57

5

413-420

21602698

PMC3159838

ACTG 219C, DACS 628i

Giovanni Schifitto, M.D.

Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

Journal of Neurovirology

2011

17

1

17-25

21181521

PMC3229167

 

 

Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study

Journal of Acquired Immune Deficiency Syndromes

2011

58

3

253-60

21857357

PMC3196673

 

 

Correlation of HIV-specific immunity, viral control, and diversification following planned multiple exposures to autologous HIV in a pediatric population

Clinical and Vaccine Immunology

2011

18

10

1628-3

21813662

PMC3187040

 

 

Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants

2011

 

 

 

21843318

PMC3189118

 

Kit Simpson, M.P.H., Ph.D., Rukmini Rajagopalan, M.B.A., R.N., D.Ph., Birgitta Dietz, Kevin W. Garren, Ph.D., Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D.

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Cost Effectiveness and Resource Allocation

2011

9

1

5

21548986

PMC3117802

 

 

Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir.

AIDS

2011

25

18

2227-34

21918423

PMC3314338

P1059

Todd Hulgan, M.D., M.P.H., Richard H. Haubrich, M.D., Sharon A. Riddler, M.D., M.P.H., Pablo Tebas, M.D., Marylyn D. Ritchie, Ph.D., Grace McComsey, M.D., David W. Haas, M.D., Jeffrey A. Canter, M.D., M.P.H.

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS clinical trials group study A5142

AIDS

2011

25

1

37-47

20871389

PMC2995830

 

Jessica H. Brehm, B.S., Christina M. Lalama, M.S., Michael Hughes, Ph.D., Richard H. Haubrich, M.D., Sharon A. Riddler, M.D., M.P.H., Nicolas Sluis-Cremer, Ph.D., John W. Mellors, M.D.

Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase

Journal of Acquired Immune Deficiency Syndromes

2011

56

4

344-8

21350368

PMC3086845

 

Andrea L. Ciaranello, M.D., Shahin Lockman, M.D., M.Sc., Kenneth A. Freedberg, M.D., M.Sc., Michael Hughes, Ph.D., Jennifer Chu, B.S., Judith Silverstein Currier, M.D., M.Sc., Robin Wood, M.D., Charles Holmes, M.D., M.P.H., Sandy Pillay, M.B., CHB, Francesca Conradie, M.D., DTM&H, James Alasdair McIntyre, M.D., Elena Losina, Rochelle Paula Walensky, M.D., M.P.H.

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial

AIDS

2011

25

4

479-92

21293199

PMC3068908

 

 

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

Lancet

2011

S1473-3099

10

70313-3

21288774

PMC3111069

ACTG 390

 

Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens

Journal of Acquired Immune Deficiency Syndromes

2011

56

4

325-332

21350366

PMC3079288

ATN 024

 

HLA Alleles are Associated with Altered Risk for Disease Progression and Central Nervous System Impairment of HIV-Infected Children

Journal of Acquired Immune Deficiency Syndromes

2011

57

1

32-39

21283014

PMC3107908

 

 

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

AIDS

2011

25

18

2269-2278

21941167

 

 

Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.

Journal of Allergy and Clinical Immunology

2011

128

6

 

21752440

PMC3229646

 

 

Long-term Outcomes for HIV-Infected Infants <6 Months of Age at Initiation of Lopinavir/Ritonavir Combination Antiretroviral Therapy

AIDS

2011

25

5

643-9

21297419

PMC3068474

P1030

Heather D. Watts, M.D., Sharon Huang, M.S., Mary Culnane, C.R.N.P., M.S., Kathleen A. Kaiser, A.A.S., Angela Scheuerle, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Kenneth Stanley, Ph.D., Marie Louise Newell, M.D., Laurent Mandelbrot, M.D., Jean-Francois Delfraissy, M.D., Coleen K. Cunningham, M.D.

Low rate of birth defects among infants born to HIV-infected women on antiretrovirals

Journal of Perinatal Medicine

2011

39

2

163-170

21142844

PMC3068472

ACTG 316

Susan Swindells, M.B.B.S., Hongyu Jiang, Ph.D., Lisa Mukherjee, M.S., Mark A. Winters, M.S., Ronald J. Bosch, Ph.D., David Katzenstein, M.D.

Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.

HIV Clinical Trials

2011

12

2

79-88

21498151

 

Kathleen Malee, Ph.D., Paige L. Williams, Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D, John J. Farley, M.D., M.P.H., Betsy Kammerer, Ph.D.

Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.

AIDS Patient Care and STDs

2011

25

3

191-200

21323533

PMC3101948

ACTG 219C, DACS 607

 

Medication Adherence in Youth with HIV Infection: Associations with Behavioral Impairment

AIDS Patient Care and STDs

2011

25

3

191-200

21323533

PMC3101948

ACTG 219C, DACS 607

 

Multiple independent lineages of HIV-1 persist in breast milk and plasma

AIDS

2011

25

2

143-152

21173592

PMC3032216

 

 

Nelfinavir and Lamivudine Pharmacokinetics During the First Two Weeks of Life

Pediaric Infectious Disease Journal

2011

30

9

769-72

21666540

PMC3158246

P1043

Heather Ribaudo, Ph.D., Constance A. Benson, M.D., Yu (Evelyn) Zheng, M.S., Susan L. Koletar, M.D., Ann C. Collier, M.D., Judith J. Lok, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Ronald J. Bosch, Ph.D., Barbara Bastow, R.N., B.S.N., Jeffrey T. Schouten, M.D.,J.D.

No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT

Clinical Infectious Diseases

2011

52

7

929-40

21427402

PMC3062545

 

 

Pharmacokinetics and Safety of a New Pediatric Fixed-Dose-Combination of Zidovudine/Lamivudine/Nevirapine Compared to the Original Liquid Formulations in HIV-infected Children

Journal of Acquired Immune Deficiency Syndromes

2011

2011

16

2040-2058

22155910

PMC3348490

P1069

 

Pharmacokinetics and Safety of Single Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1 Infected Pregnant Women and their Infants

Antimicrobial Agents and Chemotherapy

2011

55

12

5914-22

2189691

PMC3232794

ACTG 394

 

Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.

HIV Clinical Trials

2011

12

1

9-23

21388937

PMC3227722

 

 

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

New England Journal of Medicine

2011

365

1

21-31

21732834

PMC3164539

P1041

Patricia A. Garvie, Ph.D., Patricia M. Flynn, M.D., M.S., Marvin Eric Belzer, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Bobbie L. Graham, B.S., Michael N. Neely, M.D., George D. McSherry, M.D., Stephen A. Spector, M.D., Aditya Gaur, M.D.

Psychological Factors, Beliefs About Medication, and Adherence of Youth with HIV-1 in a Multisite Directly Observed Therapy (DOT) Pilot Study

Journal of Adolescent Health

2011

48

6

637-640

21575827

PMC3096841

P1036B

 

Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa

International Journal of Gynecology & Obstetrics

2011

113

1

44-9

21251654

PMC3087603

P1031A

 

Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa

International Journal of Gynecology & Obstetrics

2011

113

1

44-9

21251654

PMC3087603

P1031A

 

Safety and Immunogenicity of Early Measles Vaccination in Children Born to HIV Infected Mothers: Results of Pediatric AIDS Clinical Trials Group (PACTG)

Journal of Infectious Diseases

2011

2011

204

S179-S189

21666159

PMC3143449

ACTG 225

 

Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.

Journal of Acquired Immune Deficiency Syndromes

2011

58

3

241-247

21765365

PMC3196829

P1022

Heather Jaspan, M.D., F.A.A.P., Ph.D., L. Myer, A. J. Flisher, Keren Middelkoop, D. Mark, Catherine Mathews, Linda-Gail Bekker, MB ChB, D.C.H., Ph.D.

Sexual health, HIV risk, and retention in an adolescent HIV vaccine trial preparatory cohort

Journal of Adolescent Health

2011

49

1

42-46

21700155

PMC3124666

 

Susan Brogly, Ph.D., Salvatore Dimauro, Russell B. Van Dyke, M.D., Paige L. Williams, Ph.D., Ali Naini, Daniel E. Libutti, Julia Choi, Michelle Chung, Mariana Gerschenson, Ph.D.

Short Communication: Transplacental Nucleoside Analogue Exposure and Mitochondrial Parameters in HIV-Uninfected Children

AIDS

2011

27

7

777-83

21142587

PMC3159117

NWCS 091

Benjamin P. Linas, M.D., Bingxia Wang, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Elena Losina, Ronald J. Bosch, Ph.D., Bruce R. Schackman, Ph.D., Jian Rong, Ph.D., Paul Edward Sax, M.D., Rochelle Paula Walensky, M.D., M.P.H., Jeffrey T. Schouten, M.D.,J.D., Kenneth A. Freedberg, M.D., M.Sc.

The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort

Journal of Viral Hepatitis

2011

18

7

506-12

20546501

PMC3347883

 

 

Upregulation of IL-21 Receptor on B cells and IL-21 secretion distinguishes H1N/09 vaccine responders from non-responders among HIV infected persons on combination antiretroviral therapy.

Journal of Immunology

2011

186

11

 

21531891

PMC3170914

 

 

Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.

Journal of Clinical Microbiology

2011

49

12

 

21956987

PMC3232965

 

 

4E10-Resistant HIV-1 Isolated from 4 subjects with Rare Membrane-Proximal External Region Polymorphisms

PLoS One

2010

5

3

e9786

20352106

PMC2843716

 

 

A Chewable Pediatric Fixed-dose Combination Tablet of Stavudine, Lamivudine, and Nevirapine: Pharmacokinetics and Safety Compared With the Individual Liquid Formulations in Human Immunodeficiency Virus-infected Children in Thailand

Pediatric Infectious Disease Journal

2010

29

10

940-944

20453709

PMC2981099

P1056

 

A modified method for determination of lumefantrine in human plasma by HPLC-UV and combination of protein precipitation and solid-phase extraction: application to a pharmacokinetic study.

Journal of Analytical Chemistry Insights

2010

5

 

15-23

20448843

PMC2865164

 

Marisa T. Tungsiripat, M.D., Doug Kitch, M.S., Marshall Jay Glesby, M.D., Ph.D., Samir K. Gupta, M.D., John W. Mellors, M.D., Laura E. Moran, M.P.H., Lynne Jones, B.S., Beverly L. Alston-Smith, M.D., James F. Rooney, M.D., Judith A. Aberg, M.D.

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206

AIDS

2010

24

11

1781-4

20495438

PMC2913151

 

Mina John, David Heckerman, Larry Park, Ian James, Jonathan Carlson, Abha Chopra, Silvana Gaudieri, David Nolan, Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D., Simon Mallal

Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs

Journal of Immunology

2010

184

8

4368-77

20231689

PMC3011274

 

 

Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV infected in utero

AIDS

2010

24

3

381-386

19996936

PMC3063063

 

Jeffrey A. Canter, M.D., M.P.H., Gregory K. Robbins, M.D., M.P.H., Doug Selph, David B. Clifford, M.D., Asha R. Kallianpur, Robert Shafer, M.D., Shawn Levy, Deborah G. Murdock, M.D., Marylyn D. Ritchie, Ph.D., David W. Haas, M.D., Todd Hulgan, M.D., M.P.H.

African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.

Journal of Infectious Diseases

2010

201

11

1703-7

20402593

PMC2862090

 

Robert T. Schooley, M.D., John Spritzler, Sc.D., Hongying Wang, M.S., Michael M. Lederman, M.D., Diane V. Havlir, M.D., Daniel R. Kuritzkes, M.D., Richard B. Pollard, M.D., Cathy Battaglia, M.P.H., C.C.R.P., Michael N. Robertson, M.D., Devan V. Mehrotra, Danilo R. Casimiro, Ph.D., Kara Cox, Barbara Schock, M.S.

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein

Journal of Infectious Diseases

2010

202

5

705-16

20662716

PMC2916952

 

 

Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda

AIDS Research and Human Retroviruses

2010

26

5

563-568

20455758

PMC2875950

 

 

Analysis of HIV diversity using a high-resolution melting assay

AIDS Research and Human Retroviruses

2010

26

8

913-8

20666583

PMC2920076

 

 

Analysis of HIV tropism in Ugandan infants

Current HIV Research

2010

8

7

498-503

21073438

PMC3075545

 

Denise Campbell, J. P. Lai, Nancy Tustin, M.L.T., (ASCP), Eric Riedel, B.S., Richard Tustin, III, Jeff Taylor, J. Edward Murray, Steven D. Douglas, M.D.

Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein

Clinical and Vaccine Immunology

2010

17

7

1148-1154

20463101

PMC2897254

 

Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Robert Walker, M.D., Maria Allende, M.D., Terence Fenton, Ed.D., Patricia Patterson, M.D., Sharon Appelbaum Nachman, M.D., George Kemble, Ph.D., Tingting Yi, Patricia Alexandra Defechereux, Ph.D., Diane W. Wara, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Myron Levin, M.D.

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

Journal of Acquired Immune Deficiency Syndromes

2010

55

2

189-96

20581690

PMC3290334

P1057

Nancy Isham, M(ASCP), Mahmoud A. Ghannoum, M.Sc., Ph.D.

Antifungal activity of miconazole against recent Candida strains

Mycoses

2010

53

5

434-7

19531099

 

Shahin Lockman, M.D., M.Sc., Michael Hughes, Ph.D., James Alasdair McIntyre, M.D., Yu (Evelyn) Zheng, M.S., Tsungai Chipato, MB ChB, Francesca Conradie, M.D., DTM&H, Fred Sawe, M.D., MB ChB, MMED, Aida Tesfamaraim Asmelash, M.D., M.P.H., Mina Christine Hosseinipour, M.D., Lerato Mohapi, M.D., Elizabeth Stringer, M.D., Abraham Mosigisi Siika, MB ChB, MMED, Diana Atwine, MMED, James Gita Hakim, M.D., Douglas Shaffer, M.D., M.H.S., Cecelia Kanyama, M.B.B.S., Kara Wools-Kaloustian, M.D., Robert A. Salata, M.D., Evelyn Hogg, B.A., Beverly L. Alston-Smith, M.D., Ann Walawander, M.A., Eva L. Smith, Pharm.D., Susan H. Eshleman, M.D., PH.D., James F. Rooney, M.D., Sibtain Rahim, M.D., Lauren E. Petrella, John W. Mellors, M.D., Robert T. Schooley, M.D., Judith Silverstein Currier, M.D., M.Sc.

Antiretroviral therapies in women after single-dose nevirapine exposure

New England Journal of Medicine

2010

363

16

1499-509

20942666

PMC2994321

 

 

Antiretroviral treatment for children with peripartum nevirapine exposure

New England Journal of Medicine

2010

363

13

1510-150

20942667

PMC3021781

P1060

 

Antiretroviral treatment for children with peripartum nevirapine exposure

New England Journal of Medicine

2010

363

16

1510-1520

20942667

PMC3021781

P1060

 

Association between Detection of HIV-1 DNA Resistance Mutations by a Sensitive Assay at Initiation of Antiretroviral Therapy and Virologic Failure

Clinical Infectious Diseases

2010

50

10

1397–1404

20377404

PMC2856716

 

Todd T. Brown, M.D., Katherine Tassiopoulos, Sc.D., M.P.H., Ronald J. Bosch, Ph.D., Cecilia M. Shikuma, M.D., Grace McComsey, M.D.

Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy

Diabetes Care

2010

33

10

2244-9

20664016

PMC2945167

 

Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Caroline J. Chantry, M.D., Michael Hughes, Ph.D., Carmelita Alvero, William A. Meyer, III, Ph.D., Janice Hodge, R.N., B.S., Peggy R. Borum, Ph.D., John ( Jack ) Moye, Jr., M.D., Stephen A. Spector, M.D.

Associations of Proinflammatory Cytokine Levels With Lipid Profiles, Growth, and Body Composition in HIV-Infected Children Initiating or Changing Antiretroviral Therapy

Pediatric Infectious Disease Journal

2010

29

12

1118-1122

20631646

PMC2991416

P1010

Susan Brogly, Ph.D., Mark J. Abzug, M.D., Heather D. Watts, M.D., Coleen K. Cunningham, M.D., Paige L. Williams, Ph.D., James M. Oleske, M.D., Daniel H. Conway, M.D., Rhoda S. Sperling, M.D., Hans ML Spiegel, M.D., Ph.D., Russell B. Van Dyke, M.D.

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Pediaric Infectious Disease Journal

2010

29

8

721-727

20539252

PMC2948952

ACTG 219C

 

Clinical evaluation of a dried blood spot assay for atazanavir

Antimicrobial Agents and Chemotherapy

2010

54

10

4124-8

20660680

PMC2944558

 

Kenneth D. Gadow, Ph.D., Miriam Chernoff, Ph.D., Paige L. Williams, Ph.D., Pim Brouwers, Ph.D., Jerry D. Heston, M.D., Edward V. Morse, Ph.D., Janice Hodge, R.N., B.S., Vinnie Dipoalo, Nagamah Sandra Deygoo, Sharon Appelbaum Nachman, M.D.

Co-Occuring Psychiatric Symptoms in Children Perinatally Infected With HIV and Peer Comparison Sample.

Journal Of Developmental and Behavioral Pediatrics

2010

31

2

116-128

20110828

PMC2868331

P1055

Bernard J.C. Macatangay, M.D., Lu (Summer) Zheng, Ph.D., Charles Rinaldo, Jr., Ph.D., Alan Landay, Ph.D., Richard B. Pollard, M.D., Savita G. Pahwa, M.D., Michael M. Lederman, M.D., R. Pat Bucy, M.D., Ph.D.

Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS clinical trials group trial A5181

Clinical and Vaccine Immunology

2010

17

9

1452-9

20631337

PMC2944467

 

Charles Flexner, M.D., Camlin Tierney, Ph.D., Robert Gross, M.D., M.S.C.E., Adriana Andrade, M.D., M.P.H., Christina M. Lalama, M.S., Susan H. Eshleman, M.D., PH.D., Judith A. Aberg, M.D., Ian M. Sanne, M.D., FCP (medicine), DTM&H, Teresa Parsons, Ph.D., Angela D.M. Kashuba, Pharm.D., Susan L Rosenkranz, Ph.D., Anne Kmack, B.S., Elaine Ferguson, R.Ph., M.S., Marjorie Dehlinger, D.N.Sc., Donna Mildvan, M.D.

Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial

Clinical Infectious Diseases

2010

50

7

1041-52

20192725

PMC2833234

 

Cynthia (Cindy) Firnhaber, M.D., Laura Smeaton, M.S., Nasinuku TJ Saukila, M.B.B.S., Timothy P. Flanigan, M.D., Raman Raghunathrao Gangakhedkar, M.B.B.S., D.C.H., M.P.H., Jacob M. Kumwenda, Alberto Martin La Rosa, M.D., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Victor DeGruttola, Sc.D., James Gita Hakim, M.D., Thomas B. Campbell, M.D.

Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas

International Journal of Infectious Diseases

2010

14

12

e1088-92

20961784

PMC3021118

 

Irene Lubega, Mary Glenn Fowler, M.D., M.P.H., Ali M. Elbireer, M.B.A., Danstan Bagenda, George E. Kafulafula, MMED, F.A.C.O.G., M.B.B.S., Jeanne Ko, Linda Mipando, Mike Mubiru, Newton Kumwenda, M.P.H., Ph.D., Taha El Tahir Taha, M.B.B.S., Ph.D., M.P.H., Brooks Jackson, M.D., M.B.A., Laura A. Guay, M.D.

Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.

Journal of Acquired Immune Deficiency Syndromes

2010

55

1

58-64

20588184

PMC3033212

 

Ronald J. Bosch, Ph.D., Richard B. Pollard, M.D., Alan Landay, Ph.D., Evgenia Aga, M.Sc., Lawrence Fox, M.D., Ph.D., Ronald T. Mitsuyasu, M.D.

Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG protocol A5051, a rollover trial of ACTG protocol A328)

AIDS Research & Therapy (online journal)

2010

7

30

30

20687947

PMC2924251

 

Lori Kamemoto, M.D., M.P.H., Susan Ellen Cohn, M.D., M.P.H., Mary A. Vogler, M.D., Kristine Patterson, M.D., Lori Kamemoto, M.D., M.P.H., Jeong-Gun Park, Ph.D., Heather D. Watts, M.D., Francesca Aweeka, Pharm.D., Karin L. Klingman, M.D., Apsara Nair, M.S., Song Yu, M.S., Susan Ellen Cohn, M.D., M.P.H.

Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188

Journal of Acquired Immune Deficiency Syndromes

2010

55

4

473-82

20842042

 

 

Cross-contamination during processing of dried blood spots used for rapid diagnosis of HIV-1 infection of infants is rare and avoidable.

Journal of Virological Methods

2010

163

2

489-91

19878694

PMC2815236

 

Akihiko Saitoh, M.D., Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Elizabeth Sarles, Kumud K. Singh, Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D.

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1 infected children receiving HAART.

Journal of Acquired Immune Deficiency Syndromes

2010

54

3

285-289

19890215

PMC3119357

ACTG 366, ACTG 377

 

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

2010

54

3

285-9

19890215

PMC3119357

ACTG 366, ACTG 367

Michael T. Brady, M.D., James M. Oleske, M.D., Paige L. Williams, Ph.D., Carol Elgie, B.S., Lynne M. Mofenson, M.D., F.A.A.P., Wayne M. Dankner, M.D., Russell B. Van Dyke, M.D.

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.

Journal of Acquired Immune Deficiency Syndromes

2010

53

1

86-94

20035164

PMC2801894

ACTG 219C

 

Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.

Journal of Clinical Microbiology

2010

48

5

1555-6

20181911

PMC2863880

 

 

Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins

Journal of Biological Chemistry

2010

285

24

18319-25

20378550

PMC2881757

 

Aditya Gaur, M.D., Marvin Eric Belzer, M.D., Paula Britto, M.S., Patricia A. Garvie, Ph.D., ChengCheng Hu, Ph.D., Bobbie L. Graham, B.S., Michael N. Neely, M.D., George D. McSherry, M.D., Stephen A. Spector, M.D., Patricia M. Flynn, M.D., M.S.

Directly Observed Therapy (DOT) for Non-adherent HIV Infected Youth - Lessons Learned, Challenges Ahead

AIDS Research and Human Retroviruses

2010

26

9

947-53

20707731

PMC2957634

P1036B

 

Early antiretroviral therapy for patients with acute AIDS-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164

HIV Clinical Trials

2010

11

5

248-59

21126955

PMC3183461

 

David W. Haas, M.D., Heather Ribaudo, Ph.D., Heather Ribaudo, Ph.D., Huan Liu, M.S., Matthias Schwab, Elke Schaeffeler, Michel Eichelbaum, Alison A. Motsinger, Marylyn D. Ritchie, Ph.D., Ulrich M. Zanger, Edward P. Acosta, Pharm.D., Gene D. Morse, Pharm.D., Roy (Trip) Gulick, M.D., M.P.H., Gregory K. Robbins, M.D., M.P.H., David B. Clifford, M.D., David W. Haas, M.D.

Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS clinical trials group study

Journal of Infectious Diseases

2010

202

5

717-22

20662624

PMC2919241

 

 

Efficacy and safety of 1-month postpartum zidovudine and didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.

Clinical Infectious Diseases

2010

50

6

898-908

20158398

PMC2922986

 

 

Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration

AIDS

2010

24

4

557-61

20057308

PMC3065236

 

 

Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region

Tropical Medicine and International Health

2010

15

9

1011-20

20636301

PMC3024440

 

Athe Tsibris, M.D.

Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate

Journal of Acquired Immune Deficiency Syndromes

2010

55

4

420-7

20856130

PMC3070184

 

Yoninah S. Cramer, M.S., Susan L Rosenkranz, Ph.D., Stephen D Hall, Ph.D., Lynda Anne Szczech, M.D., M.S.C.E., Valerianna K. Amorosa, M.D., Samir K. Gupta, M.D.

Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177

Journal of Acquired Immune Deficiency Syndromes

2010

54

4

e7-9

20611034

PMC2912759

 

Kenneth E. Sherman, M.D., Ph.D., Susan D. Rouster, B.S., S. Stanford, Jason T. Blackard, Ph.D., Norah Shire, M.P.H., Margaret James Koziel, M.D., Marion G. Peters, M.D., Raymond T. Chung, M.D.

Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens

Journal of Infectious Diseases

2010

201

5

712-9

20105080

PMC2827649

 

 

HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells

Journal of Biomedical Science

2010

285

3

1681-1691

19917610

PMC2804326

 

 

HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays

Journal of Clinical Virology

2010

47

1

18-22

19896416

PMC2818273

 

Sonia Napravnik, M.P.H., Ph.D., Ada Cachafeiro, Paul Stewart, Ph.D., Joseph J. Eron, Jr., M.D., Susan A. Fiscus, Ph.D.

HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays

Journal of Clinical Virology

2010

47

1

18-22

19896416

PMC2818273

 

Carlum Shiu, Coleen K. Cunningham, M.D., Thomas C. Greenough, M.D., Petronella Muresan, M.S., Victor Sanchez Merino, Vincent J. Carey, Ph.D., Brooks Jackson, M.D., M.B.A., Carrie Ziemniak, Lawrence Fox, M.D., Ph.D., Marvin Eric Belzer, M.D., Stuart C. Ray, Katherine Luzuriaga, M.D., Deborah Persaud, M.D.

Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive HAART

Journal of Virology

2010

83

19

9731-42

19605490

PMC2748010

P1059

Carlum Shiu, Coleen K. Cunningham, M.D., Thomas C. Greenough, M.D., Petronella Muresan, M.S., Victor Sanchez Merino, Vincent J. Carey, Ph.D., Brooks Jackson, M.D., M.B.A., Carrie Ziemniak, Lawrence Fox, M.D., Ph.D., Marvin Eric Belzer, M.D., Stuart C. Ray, Katherine Luzuriaga, M.D., Deborah Persaud, M.D.

Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral

Journal of Virology

2010

83

19

9731-42

P1059

 

Immune Exhaustion Occurs Concomitantly With Immune Activation and Decrease in Regulatory T Cells in Viremic Chronically HIV-1-Infected Patients

Journal of Acquired Immune Deficiency Syndromes

2010

54

5

447-54

20463584

PMC3095513

 

Edgar (Turner) Overton, M.D., Minhee Kang, M.S., Ph.D., Marion G. Peters, M.D., Triin Umbleja, M.Sc., Beverly L. Alston-Smith, M.D., Barbara Bastow, R.N., B.S.N., Debra DeMarco, B.S.N., A.C.R.N., Margaret James Koziel, M.D., Lori Mong-Kryspin, B.S., M.T., Heather L. Sprenger, M.S., Ji Young Yu, M.P.H., Judith A. Aberg, M.D.

Immune response to Hepatitis B vaccine in HIV-positive subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG Study 5220

Vaccine

2010

28

34

5597-604

20600512

PMC2943846

 

Nishaki Mehta, Coleen K. Cunningham, M.D., Patricia M. Flynn, M.D., M.S., Joyce Pepe, Stephen Obaro, M.B.B.S., Ph.D., Bill G. Kapogiannis, M.D., James Bethel, Ph.D., Katherine Luzuriaga, M.D.

Impaired Generation of Hepatitis B Virus-specific Memory B Cells in HIV Infected Individuals Following Vaccination

Vaccine

2010

28

21

3672-8

20356567

PMC2862082

ATN 048

Nicholas T. Funderburg, Ph.D., Elizabeth Mayne, Scott F. Sieg, Ph.D., Robert Asaad, M.D., Wei Jiang, M.D., M.S., Magdalena Kalinowska, Angel A. Luciano, Wendy Stevens, M.D., Benigno Rodriguez, M.D., Jason M. Brenchley, Daniel C Douek, M.D., Ph.D., Michael M. Lederman, M.D.

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation

Blood

2010

115

2

161-7

PMC2808148

 

David W. Ouyang, M.D., Susan Brogly, Ph.D., David E. Shapiro, Ph.D., Ronald C. Hershow, M.D., Anne French, Rob Leighty, Ph.D., Betsy Thompson

Lack of Increased Hepatotoxicity in HIV-infected Pregnant Women Receiving Nevirapine Compared to Other Antiretrovirals

AIDS

2010

24

1

109-14

19926957

PMC3388940

DACS 622, P1025

Judith J. Lok, Ph.D., Ronald J. Bosch, Ph.D., Constance A. Benson, M.D., Ann C. Collier, M.D., Gregory K. Robbins, M.D., M.P.H., Robert Shafer, M.D.

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

AIDS

2010

24

12

1867-76

20467286

PMC3018341

 

Francesca Aweeka, Pharm.D., Alice M. Stek, M.D., Brookie M. Best, Pharm.D., ChengCheng Hu, Ph.D., Diane Holland, M.Phil., Ashwaq E. Hermes, Pharm.D., Sandra K. Burchett, M.D., M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D.

Lopinavir protein binding in HIV-1-infected pregnant women.

HIV Medicine

2010

11

4

232-8

20002783

PMC2874627

P1026S

Brookie M. Best, Pharm.D., Mark Mirochnick, M.D., Alice M. Stek, M.D., ChengCheng Hu, Ph.D., Hong Li, Sandra K. Burchett, M.D., M.S., Steven Rossi, Ph.D., Elizabeth (Betsy) Smith, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Edmund Capparelli, Pharm.D.

Lopinavir tablet pharmacokinetics with an increased dose during pregnancy

Journal of Acquired Immune Deficiency Syndromes

2010

54

4

381-8

20632458

PMC3265163

P1026S

Elias (Lou) K. Halvas, Ph.D., A. Wiegand, Valerie F. Boltz, Mary Kearney, Dwight V. Nissley, Michael Wantman, Scott M. Hammer, M.D., Sarah Palmer, Ph.D., Florin Vaida, Ph.D., John Coffin, M.D., John W. Mellors, M.D.

Low frequency NNRTI-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients

Journal of Infectious Diseases

2010

201

5

672-80

20102272

PMC2835354

 

Homer L. Twigg, III, M.D., Carol T Schnizlein Bick, Ph.D., Michael D. Weiden, M.D., Fred T. Valentine, M.D., L. Joseph Wheat, M.D., Richard B. Day, B.S., Helen C. Rominger-Grubbs, R.N., M.S.N, F.N.P., C.C.R.C., Lu (Summer) Zheng, Ph.D., Ronald G. Collman, M.D., Robert W. Coombs, M.D., Ph.D., R. Pat Bucy, M.D., Ph.D., Naser L. Rezk, Ph.D., Angela D.M. Kashuba, Pharm.D.

Measurement of antiretroviral drugs in the lungs of HIV-infected patients

HIV Therapy

2010

4

2

247-51

20436781

PMC2861507

 

Homer L. Twigg, III, M.D., Carol T Schnizlein Bick, Ph.D., Michael D. Weiden, M.D., Lu (Summer) Zheng, Ph.D., L. Joseph Wheat, M.D., Richard B. Day, B.S., Helen C. Rominger-Grubbs, R.N., M.S.N, F.N.P., C.C.R.C., Ronald G. Collman, M.D., Lawrence Fox, M.D., Ph.D., Barbara Brizz, M.H.S.Ed., B.S.N., Joan Dragavon, M.L.M., Robert W. Coombs, M.D., Ph.D., R. Pat Bucy, M.D., Ph.D., Fred T. Valentine, M.D.

Measurement of antiretroviral drugs in the lungs of HIV-infected patients

HIV Therapy

2010

4

2

247-51

20437681

PMC2861507

 

Timothy Schacker, M.D., Ronald J. Bosch, Ph.D., Kara Bennett, M.S., Richard B. Pollard, M.D., Gregory K. Robbins, M.D., M.P.H., Ann C. Collier, M.D., Roy (Trip) Gulick, M.D., M.P.H., John Spritzler, Sc.D., Donna Mildvan, M.D.

Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV

Journal of Acquired Immune Deficiency Syndromes

2010

54

1

59-62

20182359

PMC2955357

 

Elizabeth Livingston, M.D., Yanling Huo, M.S., Kunjal Patel, D.Sc., M.P.H., Susan Brogly, Ph.D.

Mode of Delivery and Infant Respiratory Morbidity Among Infants Born to HIV-1-Infected Women: IMPAACT Protocol P1025

Obstetrics and Gynecology

2010

116

2

335-43

20664394

PMC2964131

P1025

Kevin R. Robertson, Ph.D.

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.

Neurology

2010

74

16

1260-6

20237308

PMC2860482

 

Paige L. Williams, Ph.D., Miguel Marino, Kathleen Malee, Ph.D., Susan Brogly, Ph.D., Michael Hughes, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P.

Neurodevelopment and In Utero Antiretroviral Exposure of HIV-Exposed Uninfected Infants

Pediatrics

2010

125

2

e250-60

20083530

PMC2951128

ACTG 219C

Rajesh Gandhi, M.D., Ronald J. Bosch, Ph.D., Evgenia Aga, M.Sc., Mary Albrecht, M.D., Lisa M. Demeter, M.D., Carrie Dykes, Ph.D., Barbara Bastow, R.N., B.S.N., Michael F. Para, M.D., J. P. Lai, Robert F. Siliciano, M.D., Ph.D., Janet M. Siliciano, Ph.D., Joseph J. Eron, Jr., M.D.

No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.

Journal of Infectious Diseases

2010

201

2

293-6

20001856

PMC2887684

 

 

Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays

Journal of Immunological Methods

2010

363

1

42-50

20888337

PMC3068047

 

Keith Crawford, Ph.D., R.Ph., C. Li, A. Keung, Zhaohui Su, Ph.D., Michael Hughes, Ph.D., Wayne Greaves, M.D., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H., Charles Flexner, M.D.

Pharmacokinetic/Pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211)

Journal of Acquired Immune Deficiency Syndromes

2010

53

5

598-605

PMC2862681

 

 

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda

Antimicrobial Agents and Chemotherapy

2010

54

1

52-9

19841149

PMC2798532

 

Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, Nachman S, IMPAACT P1065 Protocol Team

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.

Pediatric Infectious Disease Journal

2010

29

5

391-6

20431379

PMC2868314

P1065

Ying Qing Chen, A. Young, E. Brown, Charles Chasela, Susan A. Fiscus, Ph.D., Irving Hoffman, M.P.H., P.A., Megan E. Valentine, P.A.-C., Lynda Emel, Taha El Tahir Taha, M.B.B.S., Ph.D., M.P.H., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H

Population Attributable Fractions for Late Postnatal Mother-to-Child Transmission of HIV-1 in Sub-Saharan Africa

Journal of Acquired Immune Deficiency Syndromes

2010

54

3

311-6

20224418

PMC3086731

 

Marilyn Jean Crain, M.P.H., M.D., Miriam Chernoff, Ph.D., James M. Oleske, M.D., Susan Brogly, Ph.D., Kathleen Malee, Ph.D., Peggy R. Borum, Ph.D., William A. Meyer, III, Ph.D., Wendy G Mitchell, M.D., John ( Jack ) Moye, Jr., M.D., Heather Ford-Chatterton, B.S.N., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H.

Possible Mitochondrial Dysfunction and Its Association with Antiretroviral Therapy Use in Children Perinatally Infected with HIV

Journal of Infectious Diseases

2010

202

2

291-301

20533872

PMC2913975

ACTG 219C, DACS 616i

Nilla Viani, Susan Brogly, Ph.D., Marc Foca, M.D., Jaime G. Deville, M.D., Mark Mirochnick, M.D., Gwendolyn B. Scott, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Lynne M. Mofenson, M.D., F.A.A.P., Rolando M. Viani, M.D., M.T.P., Sandra K. Burchett, M.D., M.S., Ellen Rae Cooper, M.P.H., M.D., Renee Browning, R.N., M.S.N, David E. Shapiro, Ph.D.

Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.

Journal of Acquired Immune Deficiency Syndromes

2010

53

1

154-7

20035168

PMC3241607

DACS 626i, P1025

Roger Paredes, Christina M. Lalama, M.S., Heather Ribaudo, Ph.D., Bruce R. Schackman, Ph.D., Cecilia M. Shikuma, M.D., Francoise Giguel, William A. Meyer, III, Ph.D., Victoria A. Johnson, M.D., Susan A. Fiscus, Ph.D., Richard T. D'Aquila, M.D., Roy (Trip) Gulick, M.D., M.P.H., Daniel R. Kuritzkes, M.D.

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.

Journal of Infectious Diseases

2010

201

5

662-71

20102271

PMC2825289

 

Caroline J. Chantry, M.D., Michael Hughes, Ph.D., Carmelita Alvero, Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Janice Hodge, R.N., B.S., Peggy R. Borum, Ph.D., John ( Jack ) Moye, Jr., M.D.

Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.

HIV Medicine

2010

11

9

573-83

20345880

PMC3075205

P1010

 

Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay

PLoS One

2010

5

10

e13259

20949006

PMC2952593

 

Kunjal Patel, D.Sc., M.P.H., David E. Shapiro, Ph.D., Susan Brogly, Ph.D., Elizabeth Livingston, M.D., Alice M. Stek, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Ruth E. Tuomala, M.D.

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy

Journal of Infectious Diseases

2010

201

7

1035-44

20196654

PMC2946359

P1025

Leslie Serchuck, M.D., Paige L. Williams, Ph.D., Sharon Appelbaum Nachman, M.D., Kenneth D. Gadow, Ph.D., Miriam Chernoff, Ph.D., Lynnae Schwartz

Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households.

AIDS Care

2010

22

5

 

20401767

PMC3156589

P1055

Carrie Dykes, Ph.D., Lisa Mukherjee, M.S., Ronald J. Bosch, Ph.D., Elizabeth Connick, M.D., Paul Volberding, M.D., Lisa M. Demeter, M.D.

Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371

Journal of Acquired Immune Deficiency Syndromes

2010

55

1

132-4

20733405

PMC2928582

 

Robin DiFrancesco, M.T., (ASCP), M.B.A., Robin DiFrancesco, M.T., (ASCP), M.B.A., Susan L Rosenkranz, Ph.D., Lisa Mukherjee, M.S., Lisa M. Demeter, M.D., Hongyu Jiang, Ph.D., Robert DiCenzo, Pharm.D., Carrie Dykes, Ph.D., Prakash Sista, Ph.D., Alex R. Rinehart, Ph.D., Mary Albrecht, M.D., Gene D. Morse, Pharm.D.

Quality assessment for therapeutic drug monitoring in AIDS clinical trials group (ACTG 5146): a multicenter clinical trial

Therapeutic Drug Monitoring

2010

32

4

458-66

20592644

PMC2936454

 

 

Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV

Neurobehavioral HIV Medicine

2010

2010

2

39-48

20865061

PMC2943434

ACTG 219C

 

Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission

PLoS One

2010

5

4

e10213

20422033

PMC2857876

 

Philip Grant, M.D., Lauren Komarow, M.S., Janet Andersen, Sc.D., Irini Sereti, M.D., Savita G. Pahwa, M.D., Michael M. Lederman, M.D., Joseph J. Eron, Jr., M.D., Ian M. Sanne, M.D., FCP (medicine), DTM&H, William G. Powderly, M.D., Evelyn Hogg, B.A., Carol Suckow, B.S.N., Andrew R. Zolopa, M.D.

Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.

Public Library of Science One

2010

5

7

e11416

20617176

PMC2895658

 

Myron Levin, M.D., Anna-Barbara Moscicki, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Emily Demske, B.A., William A. Meyer, III, Ph.D., Barbara Nowak, B.A., Carlos A. Sattler, M.D., Alfred J. Saah, M.D., M.P.H., David Radley, M.S., Mark T. Esser, Adriana Weinberg, M.D.

Safety and Immunogenicity of a Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Vaccine in HIV-Infected Children 7 TO 12 Years Old

Journal of Acquired Immune Deficiency Syndromes

2010

55

2

197-204

20574412

PMC3033215

P1047

Eric S Rosenberg, M.D., Barney S. Graham, M.D., Ph.D., Ellen Chan, M.Sc., Ronald J. Bosch, Ph.D., Vicki Stocker, R.N., M.S., Janine Maenza, M.D., Martin Markowitz, M.D., Susan J. Little, M.D., Gary Nabel, M.D., Ph.D., Terry L. Flynn, Daniel R. Kuritzkes, M.D., Dan H. Barouch, M.D., Ph.D.

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection

Public Library of Science One

2010

5

5

e10555

20479938

PMC2866663

 

 

Substance Use and its Association with Psychiatric Symptoms in Perinatally HIV-infected and HIV-Affected Adolescents.

AIDS and Behavior

2010

14

5

1072-82

20725774

PMC2949058

P1055

Jeffrey T. Schouten, M.D.,J.D., Amy Krambrink, M.S., Heather Ribaudo, Ph.D., Anne Kmack, B.S., Nancy Webb, M.S., Cecilia M. Shikuma, M.D., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H.

Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095

Clinical Infectious Diseases

2010

50

5

787-91

20121419

NIHMS239272

 

Kenneth E. Sherman, M.D., Ph.D., Janet Andersen, Sc.D., Adeel A. Butt, M.D., M.S., Triin Umbleja, M.Sc., Beverly L. Alston-Smith, M.D., Margaret James Koziel, M.D., Marion G. Peters, M.D., Mark S. Sulkowski, M.D., Z. D. Goodman, Raymond T. Chung, M.D.

Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)

Journal of Acquired Immune Deficiency Syndromes

2010

55

5

597-605

20921898

PMC3017670

 

Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Robert Walker, M.D., Maria Allende, M.D., Terence Fenton, Ed.D., Sharon Appelbaum Nachman, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Julie A. Patterson, B.S., Myron Levin, M.D.

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines

AIDS Research and Human Retroviruses

2010

26

1

51-9

20059397

PMC2858897

P1057

Rajesh Gandhi, M.D., Lu (Summer) Zheng, Ph.D., Ronald J. Bosch, Ph.D., Ellen Chan, M.Sc., David M. Margolis, M.D., Sarah W. Read, M.D., Beatrice A. Kallungal, B.S., Sarah Palmer, Ph.D., Kathleen A. Medvik, B.S., M.T. (A.S.C.P.), Michael M. Lederman, M.D., Nadia Alatrakchi, M.D., Ph.D., Jeffrey M. Jacobson, M.D., A. Wiegand, Mary Kearney, John Coffin, M.D., John W. Mellors, M.D., Joseph J. Eron, Jr., M.D.

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Public Library of Science: Medicine

2010

7

8

pii: e1000321

20711481

PMC2919424

 

Timothy J. Wilkin, M.D., M.P.H., Zhaohui Su, Ph.D., Amy Krambrink, M.S., Jianmin Long, Ph.D., Wayne Greaves, M.D., Robert Gross, M.D., M.S.C.E., Michael Hughes, Ph.D.

Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.

Journal of Acquired Immune Deficiency Syndromes

2010

54

5

470-6

20672447

PMC2917795

 

Denise Jacobson, Jane C. Lindsey, Sc.D., Catherine M. Gordon, M.D., M.Sc., John ( Jack ) Moye, Jr., M.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D., Grace M. Aldrovandi, MD

Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045

AIDS

2010

24

5

687-96

20168204

PMC3154736

P1045

Carl J. Fichtenbaum, M.D., Tzu-min Yeh, Scott Evans, Ph.D., Judith A. Aberg, M.D.

Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087

Journal of Clinical Lipidology

2010

4

4

279-87

20824151

PMC2932453

 

Kimberly Y. Smith, M.D., M.P.H., Lu (Summer) Zheng, Ph.D., Ronald J. Bosch, Ph.D., David M. Margolis, M.D., Allan R. Tenorio, M.D., Laura A. Napolitano, M.D., Michael Switow Saag, M.D., Elizabeth Connick, M.D., Jody Lawrence, M.D., Barry H. Gross, M.D., Issac R. Francis, M.D., Hernan Valdez, M.D., Rui Wang, M.S., Norma Muurahainen, M.D., Ph.D., Vicki Stocker, R.N., M.S., Richard B. Pollard, M.D.

Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174

AIDS Research and Human Retroviruses

2010

26

4

425-432

PMC2864047

 

Tzu-min Yeh, Scott Evans, Ph.D., Roy (Trip) Gulick, M.D., M.P.H., David B. Clifford, M.D.

Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211.

HIV Clinical Trials

2010

11

1

51-8

20400411

PMC2958041

 

Todd A. Alonzo, Christos T. Nakas, Constantin Yiannoutsos, Ph.D., Sherri Bucher

A comparison of tests for restricted orderings in the three-class case

Statistics In Medicine

2009

28

7

1144-58

 

Parris Jordan, Art Poon, Joseph J. Eron, Jr., M.D., Kathleen E. Squires, M.D., Caroline Ignacio, Douglas D. Richman, M.D., Davey M. Smith, M.D.

A novel codon insert in protease of clade B HIV type 1.

AIDS Research and Human Retroviruses

2009

25

5

547-50

19397401

PMC2749665

 

Anne A. Gershon, M.D., Myron Levin, M.D., Aaron Weinberg, Lin-Ye Song, Ph.D., Philip LaRussa, M.D., Julie A. Patterson, B.S., S. Steinberg

A Phase I-II Study of Live Attenuated Varicella-Zoster Virus Vaccine to Boost Immunity in HIV-Infected Children with Previous Varicella

Pediatric Infectious Disease Journal

2009

28

7

653-655

19561431

PMC2868313

ACTG 391

Davey M. Smith, M.D., Susanne May, Samantha Tweeten, Lydia N. Drumright, Ph.D., M.P.H., Mary Pacold, Sergei L. Kosakovsky Pond, Ph.D., Rick L. Pesano, M.D., Ph.D., Yolanda Lie, Douglas D. Richman, M.D., Simon D. W. Frost, D.Phil., Christopher H. Woelk, Susan J. Little, M.D.

A public health model for the molecular surveillance of HIV transmission in San Diego, California

AIDS

2009

23

2

225-232

PMC2644048

 

Rajesh Gandhi, M.D., David O'Neill, M.D., Ronald J. Bosch, Ph.D., Ellen Chan, M.Sc., R. Pat Bucy, M.D., Ph.D., J. Shopis, Lynn Baglyos, M.S.N, Elizabeth Adams, M.D., Lawrence Fox, M.D., Ph.D., Lynette Purdue, Pharm.D., Ann Marshak, Teri Flynn, R.N., A.N.P., M.S.N, Reena Masih, M.A., Barbara Schock, M.S., Donna Mildvan, M.D., Sarah J. Schlesinger, M.D., Mary A Marovich, M.D., DTM&H, Nina Bhardwaj, M.D., Ph.D., Jeffrey M. Jacobson, M.D.

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.

Vaccine

2009

27

43

6088-94

19450647

PMC2820102

 

Lisa M. Demeter, M.D., Hongyu Jiang, Ph.D., Lisa Mukherjee, M.S., Gene D. Morse, Pharm.D., Robin DiFrancesco, M.T., (ASCP), M.B.A., Robert DiCenzo, Pharm.D., Carrie Dykes, Ph.D., Prakash Sista, Ph.D., Lee Bacheler, Ph.D., Karin L. Klingman, M.D., Alex R. Rinehart, Ph.D., Mary Albrecht, M.D.

A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients

AIDS

2009

23

3

357-68

PMC2798571

 

Mark F. Cotton, MMED, Ph.D., MB ChB, Soyeon Kim, Ph.D., Helena Rabie, MMED, M.D., Heinrich Cjristoff Weber, MB ChB, Joan Coetzee, C.P.N., Sharon Appelbaum Nachman, M.D.

A window into a public program for prevention of mother to child transmission of HIV: evidence from screening for a prospective clinical trial.

2009

10

4

16-19

20607114

PMC2896226

P1041

Shane Cross, Pharm.D., John H. Rodman, Pharm.D., Jane C. Lindsey, Sc.D., Brian Robbins, Ph.D., Charles Rose, Geoffrey Yuen, Pharm.D., Lawrence D'Angelo, M.D., M.P.H.

Abacavir and metabolite pharmacokinetics in HIV-1-infected children and adolescents.

Journal of Acquired Immune Deficiency Syndromes

2009

51

1

54-9

19282779

PMC2836884

P1018

John W. Sleasman, M.D., Brian Robbins, Ph.D., Shane Cross, Pharm.D., Jane C. Lindsey, Sc.D., Barbara E. Heckman, B.S., H.G. Sprenger, M.D., Nancy Tustin, M.L.T., (ASCP), Charles Rose, Gary E. Pakes, Pharm.D., Edmund Capparelli, Pharm.D., P Poston, E Neal, M Nikanjam

Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.

Clinical Pharmacology & Therapeutics

2009

85

4

394-401

19118380

PMC2767189

P1052

Paul Edward Sax, M.D., Camlin Tierney, Ph.D., Ann C. Collier, M.D., Margaret A. Fischl, M.D., Katie Mollan, M.S., Lynne Peeples, M.S., Catherine Godfrey, M.D., Nasreen Jahed, M.P.H., Laurie S. Myers, M.S., M.T. (A.S.C.P.), David Katzenstein, M.D., Awny Farajallah, M.D., James F. Rooney, M.D., Belinda Ha, Ph.D., William Chris Woodward, D.O., Susan L. Koletar, M.D., Victoria A. Johnson, M.D., P. Jan Geiseler, M.D., Eric S Daar, M.D.

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

New England Journal of Medicine

2009

361

23

2230-40

19952143

PMC2800041

 

Andrea L. Ciaranello, M.D., Rochelle Paula Walensky, M.D., M.P.H., Paul Edward Sax, M.D., Yuchiao Chang, Kenneth A. Freedberg, M.D., M.Sc., Joel S. Weissman

Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents

HIV Clinical Trials

2009

10

1

13-24

PMC2763544

 

Victor G. Valcour, M.D., Tzu-min Yeh, Russell Bartt, M.D., David B. Clifford, M.D., Mariana Gerschenson, Ph.D., Scott Evans, Ph.D., Bruce A. Cohen, M.D., G. J. Ebenezer, M.B.B.S., Peter Hauer, M.D., Linda L. Millar, B.S., Mary Gould, R.N., B.A., Paul T. Tran, R.Ph., Cecilia M. Shikuma, M.D., Scott Souza, Pharm.D., Justin C. McArthur, M.B.B.S., M.P.H.

Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection

HIV Medicine

2009

10

2

103-110

PMC2653263

 

Sylvie Naar-King, M.D., Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., John J. Farley, M.D., M.P.H., Patricia A. Garvie, Ph.D., Betsy Kammerer, Ph.D., Kathleen Malee, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D

Allocation of family responsibility for illness management in pediatric HIV.

Journal of Pediatrics

2009

34

2

187-94

18586756

PMC2722122

P1042S

Kumud K. Singh, A. Lieser, Ping Ruan, Ph.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D.

An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children.

Journal of Clinical Immunology

2009

122

1

173-80

18602571

PMC2748310

 

Allison Agwu, M.D., Jane C. Lindsey, Sc.D., Kimberly Ferguson, Hao Zhang, M.D., Stephen A. Spector, M.D., Bret J. Rudy, M.D., Stuart C. Ray, Steven D. Douglas, M.D., Patricia M. Flynn, M.D., M.S., Deborah Persaud, M.D.

Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy antiretroviral Therapy.

AIDS Patient Care and STDs

2009

22

7

545-52

ACTG 381

Paul Volberding, M.D., Lisa M. Demeter, M.D., Ronald J. Bosch, Ph.D., Evgenia Aga, M.Sc., Carla Pettinelli, M.D., Ph.D., Martin S. Hirsch, M.D., Mary A. Vogler, M.D., Ana I. Martinez, R.Ph., Susan J. Little, M.D., Elizabeth Connick, M.D.

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment

AIDS

2009

23

15

1987-95

PMC2888600

 

Noriaki Hosoya, Zhaohui Su, Ph.D., Timothy J. Wilkin, M.D., M.P.H., Roy (Trip) Gulick, M.D., M.P.H., Charles Flexner, M.D., Michael Hughes, Ph.D., Paul Skolnik, M.D., Francoise Giguel, Wayne Greaves, M.D., Eoin Coakley, M.D., Daniel R. Kuritzkes, M.D.

Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.

Journal of Clinical Microbiology

2009

47

8

2604-6

19494074

PMC2725648

 

Judith A. Aberg, M.D.

Cardiovascular complications in HIV management: past, present, and future (Review)

Journal of Acquired Immune Deficiency Syndromes

2009

50

1

54-64

19295335

PMC2746916

 

Donald Campbell, Ph.D., Nancy Tustin, M.L.T., (ASCP), Eric Riedel, B.S., Richard Tustin, III, Jonathan Taylor, Ph.D., Steven D. Douglas, M.D., J. Edward Murray

Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes

Clinical and Vaccine Immunology

2009

16

11

1648-53

19726615

PMC2772387

 

Allan R. Tenorio, M.D., Hongyu Jiang, Ph.D., Yu (Evelyn) Zheng, M.S., Barbara Bastow, R.N., B.S.N., Daniel R. Kuritzkes, M.D., John Alexander Bartlett, M.D., Steven G. Deeks, M.D., Alan Landay, Ph.D., Sharon A. Riddler, M.D., M.P.H.

Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115

AIDS Research and Human Retroviruses

2009

25

2

135-9

PMC2755543

 

 

Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period

AIDS and Public Policy Journal

2009

22

17

2341-6

 

Patricia A. Garvie, Ph.D., Joanne Lawford, Ph.D., Patricia M. Flynn, M.D., M.S., Aditya Gaur, M.D., Marvin Eric Belzer, M.D., George D. McSherry, M.D., Lawrence B. Friedman, M.D., ChengCheng Hu, Ph.D.

Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability.

Journal of Adolescent Health

2009

44

2

124-32

19167660

PMC2659610

P1036A

Andrew R. Zolopa, M.D., Janet Andersen, Sc.D., Lauren Komarow, M.S., Ian M. Sanne, M.D., FCP (medicine), DTM&H, Alejandro Sanchez, M.D., Evelyn Hogg, B.A., Carol Suckow, B.S.N., William G. Powderly, M.D.

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

Public Library of Science One

2009

4

5

e5575

19440326

PMC2680972

 

Ellen Gould Chadwick, M.D., Jorge Pinto, M.D., D.Sc., Ram Yogev, M.D., Carmelita Alvero, Michael Hughes, Ph.D., Paul Palumbo, M.D., Brian Robbins, Ph.D., Rohan Hazra, M.D., Leslie Serchuck, M.D., Barbara E. Heckman, B.S., Lynette Purdue, Pharm.D., Renee Browning, R.N., M.S.N, Katherine Luzuriaga, M.D., John H. Rodman, Pharm.D., Edmund Capparelli, Pharm.D.

Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age: Pharmacokinetics and 24-Week Safety and Efficacy.

Pediatric Infectious Disease Journal

2009

28

3

215-219

P1030

Ellen Gould Chadwick, M.D., Jorge Pinto, M.D., D.Sc., Ram Yogev, M.D., Carmelita Alvero, Michael Hughes, Ph.D., Paul Palumbo, M.D., Brian Robbins, Ph.D., Rohan Hazra, M.D., Leslie Serchuck, M.D., Barbara E. Heckman, B.S., Lynette Purdue, Pharm.D., Renee Browning, R.N., M.S.N, Edmund Capparelli, Pharm.D.

Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.

Pediatric Infectious Disease Journal

2009

28

3

215-19

19209098

NIHMS113014

P1030

Jane C. Lindsey, Sc.D., Ronald J. Bosch, Ph.D., Bret J. Rudy, M.D., Patricia M. Flynn, M.D., M.S.

Early patterns of adherence in adolescents initiating highly active antiretroviral therapy predict long-term adherence, virologic, and immunologic control.

AIDS Patient Care and STDs

2009

23

10

799-801

19803676

PMC2832651

ACTG 381

Tim Roy Cressey, B.Sc., Ph.D., Russell B. Van Dyke, M.D., Gonzague A. Jourdain, M.D., Thanyawee Puthanakit, M.D., M.H.S., Anuvat Roongpisuthipong, M.D., Jullapong Achalapong, M.D., Prapap Yuthavisuthi, M.D., Sinart Prommas, M.D., Nantasak Chotivanich, M.D., Robert T. Maupin, Jr., M.D., Elizabeth (Betsy) Smith, M.D., David E. Shapiro, Ph.D., Mark Mirochnick, M.D.

Early Postpartum Pharmacokinetics (PK) of Lopinavir (LPV) Initiated Intrapartum in Thai Women: a substudy of the International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) Group P1032 study

Antimicrobial Agents and Chemotherapy

2009

53

5

2189-2191

19237646

PMC2681511

P1032

Carol Onyango, M.D., Danstan Bagenda, Anthony Mwatha, S. Omer, Philippa Musoke, MB ChB, Francis Mmiro, Sheryl L. Zwerski, M.S.N, Brenda Asiimwe-Kateera, Maria Musisi, Mary Glenn Fowler, M.D., M.P.H., Laura A. Guay, M.D., Brooks Jackson, M.D., M.B.A.

Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda

Journal of Acquired Immune Deficiency Syndromes

2009

 

 

EPub Ahead of Print

19779355

PMC2888913

 

Mari M. Kitahata, M.D., M.P.H., Stephen J. Gange, Alison A. Abraham, Barry Merriman, Michael Switow Saag, M.D., Amy C. Justice, M.D.,Ph.D., Robert S. Hogg, Steven G. Deeks, M.D., Joseph J. Eron, Jr., M.D., John Brooks, Sean B. Rourke, M. John Gill, Ronald J. Bosch, Ph.D., Jeffrey N. Martin, Marina B. Klein, M.D., C.M., M.Sc., Lisa P. Jacobson, Benigno Rodriguez, M.D., Timothy R. Sterling, M.D., M.P.H., Gregory D. Kirk, Sonia Napravnik, M.P.H., Ph.D., Anita Rachlis, M.D., Liviana M. Calzavara, Michael Horberg, Michael J. Silverberg, Kelly A. Gebo, James J. Goedert, M.D., Constance A. Benson, M.D., Ann C. Collier, M.D., Stephen E. Van Rompaey, Heidi M. Crane, Rosemary G. McKaig, M.P.H., Ph.D., Bryan Lau, Aimee M. Freeman, Richard D. Moore

Effect of early versus deferred antiretroviral therapy for HIV on survival

New England Journal of Medicine

2009

360

18

1815-26

PMC2854555

 

Rebecca J. Basham, B.S., D. Richardson, Cara Sutcliffe, M.S., David W. Haas, M.D.

Effect of HIV-1 infection on human DNA yield from saliva.

HIV Clinical Trials

2009

10

4

282-5

19723616

PMC2761620

 

 

Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia

International Journal of Gynecology & Obstetrics

2009

107

3

202-7

19716560

PMC2783250

 

David B. Clifford, M.D., Marlene Smurzynski, Ph.D., M.S.P.H., Lesley Suejean Park, B.A., Tzu-min Yeh, Yu Zhao, Laura L. Blair, B.S., MT, (ASCP), Max Arens, Ph.D., Scott Evans, Ph.D.

Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients

Neurology

2009

73

4

309-14

19636051

PMC2715213

 

 

Evidence for limited compartmentalization of HIV-1 between lung and blood

Public Library of Science One

2009

4

9

e6949

PMC2736399

 

Jack T. Stapleton, M.D., Kathryn M. Chaloner, Ph.D., Jiameng Zhang, Ph.D., Donna Klinzman, B.A., I. E. Souza, Jinhua Xiang, Alan Landay, Ph.D., John L. Fahey, M.D., Richard B. Pollard, M.D., Ronald T. Mitsuyasu, M.D.

GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy

AIDS

2009

23

5

605-610

PMC2739595

 

David W. Haas, M.D., Susan L. Koletar, M.D., Laura J. Laughlin, R.N., Michelle A. Kendall, M.S., Carol Suckow, B.S.N., John G. Gerber, M.D., Andrew R. Zolopa, M.D., Richard J. Bertz, Ph.D., Michael J. Child, B.S., Lara A. Hosey, M.A., C.C.R.P., Beverly L. Alston-Smith, M.D., Edward P. Acosta, Pharm.D.

Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.

Journal of Acquired Immune Deficiency Syndromes

2009

50

3

290-3

19194314

PMC2653210

 

Zabrine J. Brumme, Mina John, Jonathan Carlson, Chanson J. Brumme, Dennison Chan, Mark Brockman, Luke Swenson, Iris Tao, Sharon Szeto, Pamela Rosato, Jennifer Sela, Carl Kadie, Nicole Frahm, Christian Brander, David W. Haas, M.D., Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D., Bruce D. Walker, M.D., P. Richard Harrigan, David Heckerman, Simon Mallal

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

Public Library of Science One

2009

4

8

E6687

PMC2723923

 

Mark A. Jacobson, M.D., Dirk P. Dittmer, Ph.D., Elizabeth Sinclair, Ph.D., Jeffrey N. Martin, Steven G. Deeks, M.D., Peter W. Hunt, M.D., Edward S. Mocarski, Caroline Shiboski, D.D.S., M.P.H., Ph.D.

Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients

Public Library of Science One

2009

4

4

e5277

PMC2667217

 

Dejiang Zhou, Stephen A. Spector, M.D.

Human immunodeficiency virus type-1 infection inhibits autophagy.

AIDS

2009

22

6

695-9

18356598

PMC2764485

 

Irini Sereti, M.D., Richard Dunham, John Spritzler, Sc.D., Evgenia Aga, M.Sc., Michael Proschan, Ph.D., Kathleen A. Medvik, B.S., M.T. (A.S.C.P.), Cathy Battaglia, M.P.H., C.C.R.P., Alan Landay, Ph.D., Savita G. Pahwa, M.D., Margaret A. Fischl, M.D., David M. Asmuth, M.D., Allan R. Tenorio, M.D., John Altman, Ph.D., Lawrence Fox, M.D., Ph.D., Susan Moir, Angelina Malaspina, Michel Morre, Renaud Buffet, M.D., Guido Silvestri, M.D., Michael M. Lederman, M.D.

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection

Blood

2009

113

25

6304-14

PMC2710926

 

Patricia Price, Ph.D., Ian James

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease

AIDS

2009

23

9

1173-6

 

Mark J. Abzug, M.D., Meredith Warshaw, M.A., Howard Max Rosenblatt, M.D., Myron Levin, M.D., Sharon Appelbaum Nachman, M.D., Stephen Ira Pelton, M.D., William Borkowsky, M.D., Terence Fenton, Ed.D.

Immunogenicity and Immunologic Memory Following Hepatitis B Virus Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Journal of Infectious Diseases

2009

200

6

935-46

19663708

PMC2814776

P1024, P1061s

Christina M. Marra, M.D., Yu Zhao, David B. Clifford, M.D., Scott L. Letendre, M.D., Scott Evans, Ph.D., Kate Henry, Ronald J. Ellis, M.D.,Ph.D., Benigno Rodriguez, M.D., Robert W. Coombs, M.D., Ph.D., Giovanni Schifitto, M.D., Justin C. McArthur, M.B.B.S., M.P.H., Kevin R. Robertson, Ph.D.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

AIDS

2009

23

11

1359-66

19424052

PMC2706549

 

Anne Butler, M.S., Paige L. Williams, Ph.D., Lois C. Howland, M.S., M.P.H., D.Ph., Deborah S. Storm, R.N.,Ph.D, Nancy Hutton, M.D., George Seage, III, Sc.D., M.P.H.

Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.

Pediatrics

2009

123

3

935-43

19255023

PMC2697844

ACTG 219C, DACS 624i

Kunjal Patel, D.Sc., M.P.H., Sue X. Ming, Patricia Williams, Kevin R. Robertson, Ph.D., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H.

Impact of highly active antiretroviral therapy and CNS-penetrating antiretroviral Pregimens on the incidence of HIV-encephalopathy among perinatally-infected children and adolescents

AIDS

2009

23

14

1893-1901

19644348

PMC2821205

ACTG 219C

Patricia Sirois, Ph.D., Grace Montepiedra, Ph.D., Suad Kapetanovic, M.D., Paige L. Williams, Ph.D., Deborah Pearson, Ph.D., Kathleen Malee, Ph.D., Patricia A. Garvie, Ph.D., Betsy Kammerer, Ph.D., Sharon L. Nichols, Ph.D., Molly Nozyce, Ph.D., Mark Mintz, M.D., Wendy G Mitchell, M.D., James M. Oleske, M.D.

Impact of medications prescribed for treatment of attention deficit-hyperactivity disorder on physical growth in children and adolescents with HIV.

Journal Of Developmental and Behavioral Pediatrics

2009

30

5

403-12

19827220

PMC2836888

ACTG 219C, DACS 620I

Sara J. Conry, Kimberly A. Milkovich, Nicole L. Yonkers, Benigno Rodriguez, M.D., Helene B. Bernstein, Robert Asaad, M.D., Frederick P. Heinzel, Magdalena Tary-Lehmann, Michael M. Lederman, M.D., Donald D. Anthony, M.D., Ph.D.

Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function

Journal of Virology

2009

83

21

11175-87

PMC2772797

 

Paige L. Williams, Ph.D., Julia (Wei) Wu, M.S., Susan Ellen Cohn, M.D., M.P.H., Susan L. Koletar, M.D., J. Allen McCutchan, M.D., M.Sc., Robert L. Murphy, M.D., Judith Silverstein Currier, M.D., M.Sc.

Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution

HIV Medicine

2009

10

5

290-301

PMC2778216

 

Norah Shire, M.P.H., Marepalli B. Rao, Ph.D., Paul Succop, Ph.D., C. Ralph Buncher, Sc.D., Janet Andersen, Sc.D., Adeel A. Butt, M.D., M.S., Raymond T. Chung, M.D., Kenneth E. Sherman, M.D., Ph.D.

Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection

Clinical Gastroenterology and Hepatology

2009

7

4

471-80

 

 

In utero HIV infection is associated with an increased risk of nevirapine resistance in Ugandan infants who were exposed to perinatal single dose nevirapine

AIDS Research and Human Retroviruses

2009

25

7

673-7

19552593

PMC2752753

 

Roger Paredes, Manish Sagar, M.D., Vincent C. Marconi, Rebecca Hoh, R.D., Jeffrey N. Martin, Neil Parkin, Christos J. Petropoulos, Ph.D., Steven G. Deeks, M.D., Daniel R. Kuritzkes, M.D.

In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine

Journal of Virology

2009

83

4

2038-43

PMC2643770

 

Sharon Appelbaum Nachman, M.D., Miriam Chernoff, Ph.D., Philimon Gona, Ph.D., Russell B. Van Dyke, M.D., Wayne M. Dankner, M.D., George Seage, III, Sc.D., M.P.H., James M. Oleske, M.D., Paige L. Williams, Ph.D.

Incidence of non-infectious complications in perinatally HIV-infected children and adolescents in the HAART era.

Archives of Pediatrics and Adolescent Medicine

2009

163

2

164-71

19188649

PMC2730663

ACTG 219C

Warren A. Andiman, M.D., Miriam Chernoff, Ph.D., Charles Debeaux Mitchell, M.D., Murli Purswani, M.D., James M. Oleske, M.D., Paige L. Williams, Ph.D., Hans ML Spiegel, M.D., Ph.D., Philimon Gona, Ph.D., George Seage, III, Sc.D., M.P.H.

Incidence of persistent renal dysfunction in HIV-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.

Pediatric Infectious Disease Journal

2009

28

7

619-625

19561425

PMC3192653

ACTG 219C, DACS 617i

Gregory K. Robbins, M.D., M.P.H., John Spritzler, Sc.D., Ellen Chan, M.Sc., David M. Asmuth, M.D., Rajesh Gandhi, M.D., Benigno Rodriguez, M.D., Gail Skowron, M.D., Paul Skolnik, M.D., Robert Shafer, M.D., Richard B. Pollard, M.D.

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group Protocol 384

Clinical Infectious Diseases

2009

48

3

350-61

19123865

PMC2676920

 

David W. Ouyang, M.D., David E. Shapiro, Ph.D., Ming Lu, Susan Brogly, Ph.D., Anne French, Rob Leighty, Ph.D., Betsy Thompson, Ruth E. Tuomala, M.D., Ronald C. Hershow, M.D.

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

AIDS

2009

23

18

2473-7

19617813

PMC2783653

DACS 622, P1025

Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Susan Brogly, Ph.D., Michael T. Basar, B.S., Gwendolyn B. Scott, M.D.

Infant HIV-1 Diagnostic Testing at Clinical Sites in North America: 2002-2006

Pediatric Infectious Disease Journal

2009

28

7

 

19478686

P1025

 

Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa

Pediatrics

2009

124

1e

e137-144

19564260

PMC2764263

 

 

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention

AIDS Research and Human Retroviruses

2009

25

11

1099-106

19886836

PMC2828257

 

John A. Crump, MB ChB, DTM&H, Jakko van Ingen, Anne B. Morrissey, M.S., Martin J. Boeree, Daudi R. Mavura, Britta Swai, Nathan Thielman, M.D., M.P.H., John Alexander Bartlett, M.D., Henning Grossman, Venance P. Maro, M.D., MMED, Dick van Soolingen

Invasive disease caused by nontuberculous mycobacteria, Tanzania

Emergency Infectious Diseases

2009

15

1

53-5

PMC2660713

 

Judith A. Aberg, M.D.

Lipid management in patients who have HIV and are receiving HIV therapy (Review)

Endocrinology Metabolism Clinics of North America

2009

38

1

207-22

PMC2753589

 

David B. Clifford, M.D., Scott Evans, Ph.D., Yijun Yang, M.S., Sc.D., Edward P. Acosta, Pharm.D., Heather Ribaudo, Ph.D., Roy (Trip) Gulick, M.D., M.P.H.

Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)

HIV Clinical Trials

2009

10

6

343-55

 

David Alain Wohl, M.D., Michelle A. Kendall, M.S., Janet Andersen, Sc.D., Clyde S. Crumpacker, M.D., Stephen A. Spector, M.D., Judith Feinberg, M.D., Beverly L. Alston-Smith, M.D., Susan Owens, R.N., M.S., Suzette A. Chafey, R.N., N.P., Michael Marco, Sharon D. Maxwell-Henkel, B.S., Nell Lurain, Ph.D., Douglas Jabs, M.D., M.B.A., Constance A. Benson, M.D., Philip Keiser, M.D.

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

HIV Clinical Trials

2009

10

3

143-52

19632953

PMC2754189

 

Athe Tsibris, M.D., Roger Paredes, Amy Chadburn, Zhaohui Su, Ph.D., Timothy Henrich, M.D., Amy Krambrink, M.S., Michael Hughes, Ph.D., Judith A. Aberg, M.D., Judith Silverstein Currier, M.D., M.Sc., Karen T. Tashima, M.D., Catherine Godfrey, M.D., Wayne Greaves, M.D., Charles Flexner, M.D., Paul Skolnik, M.D., Timothy J. Wilkin, M.D., M.P.H., Roy (Trip) Gulick, M.D., M.P.H., Daniel R. Kuritzkes, M.D.

Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS clinical trials group A5211

Clinical Infectious Diseases

2009

48

5

642-9

PMC2756462

 

Kenneth D. Gadow, Ph.D., Miriam Chernoff, Ph.D., Pim Brouwers, Ph.D., Edward V. Morse, Ph.D., Jerry D. Heston, M.D., Janice Hodge, R.N., B.S., Vincenza M. Di Poalo, Nagamah Sandra Deygoo, Sharon Appelbaum Nachman, M.D.

Mental health treatment patterns in perinatally HIV-infected youth and controls

Pediatrics

2009

124

2

627-36

19596734

PMC2764487

P1055

Miriam Chernoff, Ph.D., Sharon Appelbaum Nachman, M.D., Paige L. Williams, Ph.D., Pim Brouwers, Ph.D., Jerry D. Heston, M.D., Janice Hodge, R.N., B.S., Vincenza M. Di Poalo, Nagamah Sandra Deygoo, Kenneth D. Gadow, Ph.D.

Mental health treatment patterns in perinatally HIV-infected youth and controls.

Pediatrics

2009

124

2

627-36

P1055

Richard H. Haubrich, M.D., Sharon A. Riddler, M.D., M.P.H., Greg DiRienzo, Ph.D., Lauren Komarow, M.S., William G. Powderly, M.D., Karin L. Klingman, M.D., Kevin W. Garren, Ph.D., Tania George, Pharm.D., James F. Rooney, M.D., Barbara Brizz, M.H.S.Ed., B.S.N., Hector Bolivar, M.D., Mitchell (Mitch) Goldman, M.D., David W. Haas, M.D., John W. Mellors, M.D., Diane V. Havlir, M.D.

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

AIDS

2009

23

9

1109-18

PMC2739977

 

Robert Gross, M.D., M.S.C.E., Camlin Tierney, Ph.D., Adriana Andrade, M.D., M.P.H., Christina M. Lalama, M.S., Susan L Rosenkranz, Ph.D., Susan H. Eshleman, M.D., PH.D., Timothy P. Flanigan, M.D., Jorge L. Santana, M.D., Nadim Salomon, M.D., Ronald B. Reisler, M.D., M.P.H., Ilene P. Wiggins, R.N., Evelyn Hogg, B.A., Charles Flexner, M.D., Donna Mildvan, M.D.

Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial

Archives of Internal Medicine

2009

169

13

1224-32

PMC2771688

 

L. G. Tillekeratne, Nathan Thielman, M.D., M.P.H., Rehema A. Kiwera, Helen Y. Chu, M.D., Lightness Kaale, Susan C. Morpeth, MB ChB, DTM&H, Jan Ostermann, Ph.D., Sabina Mtweve, M.D., M.H.P., John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., John A. Crump, MB ChB, DTM&H

Morbidity and mortality among a cohort of HIV-infected adults in a programme for community home-based care, in the Kilimanjaro Region of Tanzania, (2003-2005)

Annals of Tropical Medicine & Parasitology

2009

103

3

263-73

 

Grace M. Aldrovandi, MD, Jane C. Lindsey, Sc.D., Denise L. Jacobson, Amanda Zadzilka, B.S., Elizabeth Sheeran, M.S., R.D., John ( Jack ) Moye, Jr., M.D., Peggy R. Borum, Ph.D., William A. Meyer, III, Ph.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D.

Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team

AIDS

2009

23

6

661-72

19279441

PMC2680185

P1045

Julie Nelson, Ph.D., Amy M. Loftis, B.S., Wafaie Fawzi, M.D., Taha El Tahir Taha, M.B.B.S., Ph.D., M.P.H., Robert Goldenberg, M.D., Susan A. Fiscus, Ph.D.

Nevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperature

Journal of Clinical Microbiology

2009

47

4

1209-11

19225101

PMC2668311

 

Edmund Capparelli, Pharm.D., S Syed

Nitazoxanide for the Treatment of Cryptosporidium parvum in HIV-Infected Children.

Pediatric Infectious Disease Journal

2009

27

11

1041

 

 

Novel method for determination of substance P levels in unextracted human plasma by using acidification

Clinical and Vaccine Immunology

2009

16

4

594-6

19193832

PMC2668282

 

Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Cynthia L. Wilkening, M.S., Anne Sevin, Ph.D., Bruce P. Blais, B.A., Raul Louzao, M.P.A., Dana Stein, B.S., Patricia Alexandra Defechereux, Ph.D., Deborah Durand, B.A., Eric Riedel, B.S., Nancy E. Raftery, B.A., Renee Jesser, Betty Brown, M.S., M. Fran Keller, Ruth E. Dickover, Ph.D., Elizabeth (Betsy) J. McFarland, M.D., Terence Fenton, Ed.D.

Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.

Clinical and Vaccine Immunology

2009

16

8

1176-86

19515870

PMC2725535

 

Todd Hulgan, M.D., M.P.H., John P. Donahue, Laura Smeaton, M.S., Minya Pu, M.A., Hongying Wang, M.S., Michael M. Lederman, M.D., Kimberly Y. Smith, M.D., M.P.H., Hernan Valdez, M.D., Christopher D. Pilcher, M.D., David W. Haas, M.D.

Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

European Journal of Clinical Pharmacology

2009

65

11

1081-8

19779705

PMC2873632

 

Elizabeth Andrews, William (Todd) Seaman, M.D., Jennifer Y. Webster-Cyriaque, D.D.S., Ph.D.

Oropharyngeal carcinoma in non-smokers and non-drinkers: A role for HPV

Oral Oncology

2009

45

6

486-91

19027350

 

Pablo Tebas, M.D., Jiameng Zhang, Ph.D., Richard Hafner, M.D., Karen T. Tashima, M.D., Abby Helen Shevitz, M.D., M.P.H., Kevin E. Yarasheski, Ph.D., Baiba Berzins, M.P.H., Susan Owens, R.N., M.S., Jodi Lee Forand, B.S., Scott Evans, Ph.D., Robert L. Murphy, M.D.

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110

Journal of Antimicrobial Chemotherapy

2009

63

5

998-1005

PMC2721697

 

Yvonne J. Bryson, M.D., Mark Mirochnick, M.D., Alice M. Stek, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James D. Connor, M.D., Edmund Capparelli, Pharm.D., Heather D. Watts, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., Bethann Cunningham, B.S., Lynette Purdue, Pharm.D., Yetemegnu Asfaw, B.S., Margaret A. Keller, M.D., Elizabeth (Betsy) Smith, M.D.

Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant womenlamivudine in HIV-infected pregnant women.

HIV Clinical Trials

2009

9

2

115-25

18474496

ACTG 353

Wei Jiang, M.D., M.S., Michael M. Lederman, M.D., Peter W. Hunt, M.D., Scott F. Sieg, Ph.D., Kathryn Haley, Benigno Rodriguez, M.D., Alan Landay, Ph.D., Jeffrey N. Martin, Elizabeth Sinclair, Ph.D., John Spritzler, Sc.D., Ava I. Asher, Steven G. Deeks, M.D., Daniel C Douek, M.D., Ph.D., Jason M. Brenchley

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

Journal of Infectious Diseases

2009

199

8

1177¿85

PMC2728622

 

Davey M. Smith, M.D., Selene Zarate, Hai Shao, Satish K. Pillai, Scott L. Letendre, M.D., Joseph K. Wong, M.D., Douglas D. Richman, M.D., Simon D. W. Frost, D.Phil., Ronald J. Ellis, M.D.,Ph.D.

Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations

Virology

2009

385

1

204-8

PMC2794037

 

Joseph J. Eron, Jr., M.D., Jeong-Gun Park, Ph.D., Richard H. Haubrich, M.D., Francesca Aweeka, Pharm.D., Barbara Bastow, R.N., B.S.N., Gary E. Pakes, Pharm.D., Song Yu, M.S., Hulin Wu, Ph.D., Douglas D. Richman, M.D.

Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy

Antimicrobial Agents and Chemotherapy

2009

53

6

2335-41

PMC2687257

 

Kenneth H. Fife, M.D., Ph.D., Julia (Wei) Wu, M.S., Kathleen E. Squires, M.D., Heather D. Watts, M.D., Janet Andersen, Sc.D., Darron R. Brown, M.D.

Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

2009

51

3

274-282

PMC2742168

 

 

Primary HIV-1 infection among infants in sub-Saharan Africa: HPTN 024

Journal of Acquired Immune Deficiency Syndromes

2009

51

3

317-322

19367174

PMC2753468

 

Theresa Whiteside, Ph.D., P. Piazza, Nancy C. Connolly, M.D., M.P.H., Charles Rinaldo, Jr., Ph.D., Sharon A. Riddler, M.D., M.P.H.

Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection

Clinical and Vaccine Immunology

2009

16

2

233-40

PMC2643533

 

Samir K. Gupta, M.D., Lauren Komarow, M.S., Roy (Trip) Gulick, M.D., M.P.H., Richard B. Pollard, M.D., Gregory K. Robbins, M.D., M.P.H., Nora Franceschini, M.D., M.P.H., Lynda Anne Szczech, M.D., M.S.C.E., Susan L. Koletar, M.D., Robert C Kalayjian, M.D.

Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects

Journal of Infectious Diseases

2009

200

4

614-8

PMC2858634

 

Ryan J. Kerr, B.A., G. Player, Susan A. Fiscus, Ph.D., Julie Nelson, Ph.D.

Qualitative human immunodeficiency virus RNA analysis of dried blood spots for diagnosis of infections in infants

Journal of Clinical Microbiology

2009

47

1

220-2

19005148

PMC2620881

 

Athe Tsibris, M.D., Bette T. Korber, Ramy Arnaout, Carsten Russ, Chien-Chi Lo, Thomas Leitner, Brian Gaschen, James Theiler, Roger Paredes, Zhaohui Su, Ph.D., Michael Hughes, Ph.D., Roy (Trip) Gulick, M.D., M.P.H., Wayne Greaves, M.D., Eoin Coakley, M.D., Charles Flexner, M.D., Chad Nusbaum, Daniel R. Kuritzkes, M.D.

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

Public Library of Science One

2009

4

5

e5683 1-12

PMC2682648

 

Aylin Yilmaz, Magnus Gisslen, M.D., Ph.D., Serena S. Spudich, M.D., Evelyn Lee, Anura L. Jayewardene, Ph.D., Francesca Aweeka, Pharm.D., Richard W. Price, M.D.

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

Public Library of Science One

2009

4

9

e6877 1-5

PMC2731205

 

Timothy J. Wilkin, M.D., M.P.H., Timothy J. Wilkin, M.D., M.P.H., John Ernest McKinnon, M.D., Greg DiRienzo, Ph.D., Katie Mollan, M.S., Courtney V. Fletcher, Pharm.D., David M. Margolis, M.D., Barbara Bastow, R.N., B.S.N., Gary D. Thal, M.D., William Chris Woodward, D.O., Catherine Godfrey, M.D., A. Wiegand, Frank Maldarelli, Sarah Palmer, Ph.D., John Coffin, M.D., John W. Mellors, M.D., Susan Swindells, M.B.B.S.

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes

Journal of Infectious Diseases

2009

199

6

866-71

PMC2756462

 

Heather D. Watts, M.D., Stanley Cohen, R.Ph., Jane Hitti, M.D., M.P.H.

Repeat Pregnancies Among HIV-infected Women Enrolled onto a Clinical Trial: PACTG1022

Journal of Acquired Immune Deficiency Syndromes

2009

51

2

231-3

19465826

PMC2766524

P1022

Gail Skowron, M.D., John Spritzler, Sc.D., Jodi M. Weidler, Pharm.D., Gregory K. Robbins, M.D., M.P.H., Victoria A. Johnson, M.D., Ellen Chan, M.Sc., David M. Asmuth, M.D., Rajesh Gandhi, M.D., Yolanda Lie, Michael P. Bates, M.D., Richard B. Pollard, M.D.

Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects

Journal of Acquired Immune Deficiency Syndromes

2009

50

3

250-8

 

Zhaohui Su, Ph.D., J. Reeves, Amy Krambrink, M.S., Eoin Coakley, M.D., Michael Hughes, Ph.D., Cong Han, Charles Flexner, M.D., Timothy J. Wilkin, M.D., M.P.H., Paul Skolnik, M.D., Wayne Greaves, M.D., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H.

Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211

Journal of Infectious Diseases

2009

200

11

1724-28

PMC2783913

 

T. Chen, Grace M. Aldrovandi, MD

Review of HIV Antiretroviral Drug Resistance.

Pediatric Infectious Disease Journal

2009

27

8

749-52

18664987

 

Giovanni Schifitto, M.D., Constantin Yiannoutsos, Ph.D., Thomas Ernst, Ph.D., Bradford A. Navia, M.D., Avindra Nath, M.D., Ned Sacktor, M.D., Cheryl L. Anderson, Christina M. Marra, M.D., David B. Clifford, M.D.

Selegiline and oxidative stress in HIV-associated cognitive impairment

Neurology

2009

73

23

1975-81

PMC2790227

 

angela Meier, Judy Chang, Ellen Chan, M.Sc., Richard B. Pollard, M.D., Harlyn K. Sidhu, Smita Shrikant Kulkarni, Ph.D., Tom Fang Wen, Robert J. Lindsay, Liliana del Carmen Orellana, Donna Mildvan, M.D., Sue Bazner, M.S.N, N.P., C.S., A.C.R.N., Hendrick Streeck, Galit Alter, J. D. Lifson, Mary Carrington, Ph.D., Ronald J. Bosch, Ph.D., Gregory K. Robbins, M.D., M.P.H., Marcus Altfeld, M.D., Ph.D.

Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

Nature Medicine

2009

15

8

955-9

19597505

PMC2821111

 

Myron Levin, M.D., Jeffrey Anderson, M.P.H., George Seage, III, Sc.D., M.P.H., Paige L. Williams, Ph.D.

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Journal of Acquired Immune Deficiency Syndromes

2009

50

2

182-91

19131890

PMC2748317

ACTG 219C

Dominic Chow, M.D., M.P.H., Huichao Chen, Ph.D., Marshall Jay Glesby, M.D., Ph.D., Anthony J. Busti, Pharm.D., B.P.S., Scott Souza, Pharm.D., Janet Andersen, Sc.D., Sharon Kohrs, R.N., B.S.N., Julia (Wei) Wu, M.S., Susan L. Koletar, M.D.

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.

AIDS

2009

23

16

2133-41

19770624

PMC2782438

 

Todd T. Brown, M.D., Marlene Smurzynski, Ph.D., M.S.P.H., Kunling Wu, M.S., Ronald J. Bosch, Ph.D., Grace McComsey, M.D.

Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort.

Antiviral Therapy

2009

14

6

853-8

19812448

PMC2865258

 

Jennifer R. King, Pharm.D., Edward P. Acosta, Pharm.D., Ram Yogev, M.D., Andrew A. Wiznia, M.D., Bobbie L. Graham, B.S., Vincent J. Carey, Ph.D., Paula Britto, M.S.

Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients.

Pediatric Infectious Disease Journal

2009

28

2

159-161

19106779

PMC2755569

P1058

Allan R. Tenorio, M.D., John Spritzler, Sc.D., Jeff Martinson, Carolyne Gichinga, Richard B. Pollard, M.D., Michael M. Lederman, M.D., Robert C Kalayjian, M.D., Alan Landay, Ph.D.

The effect of aging on T-regulatory cell frequency in HIV infection

Clinical Immunology and Immunopathology (Now Clin Immunol)

2009

130

3

298-303

19008157

PMC2662473

 

Samir K. Gupta, M.D., Marlene Smurzynski, Ph.D., M.S.P.H., Nora Franceschini, M.D., M.P.H., Ronald J. Bosch, Ph.D., Lynda Anne Szczech, M.D., M.S.C.E., Robert C Kalayjian, M.D.

The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.

Antiviral Therapy

2009

14

4

543-9

19578239

PMC2720522

 

Caroline Shiboski, D.D.S., M.P.H., Ph.D., Lauren L. Patton, D.D.S., Jennifer Y. Webster-Cyriaque, D.D.S., Ph.D., Deborah Greenspan, B.D.S., D.Sc., Rana Traboulsi, M.D., Mahmoud A. Ghannoum, M.Sc., Ph.D., Richard J. Jurevic, D.D.S., Ph.D., joan A. Phelan, D.D.S., David Reznik, D.D.S., John S. Greenspan, B.D.S., Ph.D., F.R.C.P.

The oral HIV/AIDS research alliance: updated case definitions for oral mucosal disease endpoints

Journal of Oral Pathology and Medicine

2009

38

6

481-8

 

Kathleen Malee, Ph.D., Paige L. Williams, Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D, John J. Farley, M.D., M.P.H., Betsy Kammerer, Ph.D.

The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Journal of Pediatric Psychology

2009

34

2

165-75

18647794

PMC2722123

ACTG 219C

 

The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

2009

877

20-21

1907-1914

19493710

PMC2714254

 

Tom Delahunty, Lane R. Bushman, B.Ch., Brian Robbins, Ph.D., Courtney V. Fletcher, Pharm.D.

The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

2009

877

20-21

1907-14

19493710

PMC2714254

 

Suad Kapetanovic, M.D., Lisa Aaron, Grace Montepiedra, Ph.D., Patricia Sirois, Ph.D., James M. Oleske, M.D., Kathleen Malee, Ph.D., Deborah Pearson, Ph.D., Sharon L. Nichols, Ph.D., Patricia A. Garvie, Ph.D., John J. Farley, M.D., M.P.H., Molly Nozyce, Ph.D., Mark Mintz, M.D., Paige L. Williams, Ph.D.

The use of second generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV

AIDS Patient Care and STDs

2009

23

11

939-47

19827949

PMC2832650

ACTG 219C, DACS 642

Kristine Patterson, M.D., Susan Ellen Cohn, M.D., M.P.H., Jennifer Uyanik, Michael Hughes, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Joseph J. Eron, Jr., M.D.

Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.

Clinical Infectious Diseases

2009

49

3

473-6

19555288

PMC2712125

 

Steven G. Deeks, M.D., Stephen J. Gange, Mari M. Kitahata, M.D., M.P.H., Michael Switow Saag, M.D., Amy C. Justice, M.D.,Ph.D., Robert S. Hogg, Joseph J. Eron, Jr., M.D., John T. Brooks, M.D., Sean B. Rourke, M. John Gill, Ronald J. Bosch, Ph.D., Constance A. Benson, M.D., Ann C. Collier, M.D., Jeffrey N. Martin, Marina B. Klein, M.D., C.M., M.Sc., Lisa P. Jacobson, Benigno Rodriguez, M.D., Timothy R. Sterling, M.D., M.P.H., Gregory D. Kirk, Sonia Napravnik, M.P.H., Ph.D., Anita Rachlis, M.D., Liviana M. Calzavara, Michael Horberg, Michael J. Silverberg, Kelly A. Gebo, Margaret B. Kushel, James J. Goedert, M.D., Rosemary G. McKaig, M.P.H., Ph.D., Richard D. Moore

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

Clinical Infectious Diseases

2009

49

10

1582-90

19845473

PMC2871149

 

Thomas Valente, Ph.D., Jennifer B. Zogg, Ph.D., Jean Richardson, Ph.D., Andrea Kovacs, M.D., Eva A. Operskalski, Ph.D., M.B.A.

Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort

Journal of Acquired Immune Deficiency Syndromes

2009

52

4

514-23

19584741

PMC2783777

 

Coleen K. Cunningham, M.D., Elizabeth (Betsy) J. McFarland, M.D.

Vaccines for prevention of mother to child transmission of HIV.

Current Opinion in HIV AIDS

2009

3

2

151-154

19372958

 

Adriana Weinberg, M.D., Sharon Huang, M.S., Terence Fenton, Ed.D., Julie A. Patterson, B.S., Philimon Gona, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Wayne M. Dankner, M.D., Sharon Appelbaum Nachman, M.D.

Virologic and Immunologic Correlates with the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on HAART

Journal of Acquired Immune Deficiency Syndromes

2009

51

1

54-9

19617848

PMC2836885

P1008

Chantelle Bennetto-Hood, Ph.D., Yvonne J. Bryson, M.D., Alice M. Stek, M.D., Jennifer R. King, Pharm.D., Mark Mirochnick, M.D., Edward P. Acosta, Pharm.D.

Zidovudine, Lamivudine and Nelfinavir Concentrations in Amniotic Fluid and Maternal Serum

HIV Clinical Trials

2009

10

1

41-7

19362995

ACTG 353

Lixia Pei, Michael Hughes, Ph.D.

A statistical framework for quantile equivalence clinical trials with application to pharmacokinetic studies that bridge from HIV-infected adults to children

Biometrics

2008

64

4

1117-25

18261161

 

Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Jane C. Lindsey, Sc.D., Maureen Shannon, M.S., C.N.M., F.N.P., Ruth E. Tuomala, M.D., Susan Ellen Cohn, M.D., M.P.H., Elizabeth (Betsy) Smith, M.D., Alice M. Stek, M.D., Shelley L. Buscher, R.N., C.N.M., Amanda Cotter, M.D., Linda Bettica, B.S.N., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H

Adherence to antiretrovirals among U.S. women during and after pregnancy.

Journal of Acquired Immune Deficiency Syndromes

2008

48

4

408-17

18614923

PMC2764488

P1025

Marlene Smurzynski, Ph.D., M.S.P.H., Ann C. Collier, M.D., Susan L. Koletar, M.D., Ronald J. Bosch, Ph.D., Kunling Wu, M.S., Barbara Bastow, R.N., B.S.N., Constance A. Benson, M.D.

AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics

HIV Clinical Trials

2008

9

4

269-82

PMC2704053

 

Allison George Agwu, M.D., Jane C. Lindsey, Sc.D., Kimberly Ferguson, Haili Zhang, Stephen A. Spector, M.D., Bret J. Rudy, M.D., Steven D. Douglas, M.D., Patricia M. Flynn, M.D., M.S., Deborah Persaud, M.D.

Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy

AIDS Patient Care and STDs

2008

22

7

545-52

18479228

PMC2929158

ACTG 381

Constantin Yiannoutsos, Ph.D., Christos T. Nakas, Bradford A. Navia, M.D.

Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury

Neuroimage

2008

10

1

248-55

 

John J. Farley, M.D., M.P.H., Grace Montepiedra, Ph.D., Deborah S. Storm, R.N.,Ph.D, Patricia Sirois, Ph.D., Kathleen Malee, Ph.D., Patricia A. Garvie, Ph.D., Betsy Kammerer, Ph.D., Sylvie Naar-King, M.D., Ph.D., Sharon L. Nichols, Ph.D.

Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.

Journal Of Developmental and Behavioral Pediatrics

2008

29

5

377-84

18714204

P1042S

Lisa M. Demeter, M.D., Victor DeGruttola, Sc.D., Stephanie Lustgarten, M.S., Daniel Bettendorf, M.S., Margaret A. Fischl, M.D., Susan H. Eshleman, M.D., PH.D., William Spreen, Pharm.D., Bach-Yen Nguyen, M.D., Christine E. Koval, Joseph J. Eron, Jr., M.D., Scott M. Hammer, M.D., Kathleen E. Squires, M.D.

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

HIV Clinical Trials

2008

9

1

11-25

PMC2821073

 

Katherine Tassiopoulos, Sc.D., M.P.H., Paige L. Williams, Ph.D., George Seage, III, Sc.D., M.P.H., Marilyn Jean Crain, M.P.H., M.D., James M. Oleske, M.D., John J. Farley, M.D., M.P.H.

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Journal of Acquired Immune Deficiency Syndromes

2008

47

5

607-14

18209684

PMC3089963

ACTG 219C

Paige L. Williams, Ph.D., Russell B. Van Dyke, M.D., Michelle L. Eagle, P.A.-C., Dorothy Smith, M.S., C.P.N.P., Carol A. Vincent, C.R.N.P., M.S.N, Gregory Ciupak, B.A., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H.

Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.

American Journal Of Epidemiology

2008

167

11

1375-86

18413359

PMC2862644

ACTG 219C

Edmund Capparelli, Pharm.D., Jane Hitti, M.D., M.P.H., Alice M. Stek, M.D., ChengCheng Hu, Ph.D., Sandra K. Burchett, M.D., M.S., Brookie M. Best, Pharm.D., Elizabeth (Betsy) Smith, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Heather D. Watts, M.D., Sharon Appelbaum Nachman, M.D., Edwin M. Thorpe, Jr., M.D., Stephen A. Spector, M.D., Eleanor Jimenez, M.D., F.A.A.P., William T. Shearer, M.D., Ph.D., Marc Foca, M.D., Mark Mirochnick, M.D.

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.

HIV Medicine

2008

11

3

214-20

18366444

PMC2755564

P1022, P1026S

Andrea De Luca, M.D., Adriana Ammassari, Patrizio Pezzotti, Paola Cinque, Jacques Gasnault, Juan Berenguer, Simona Di Giambenedetto, Antonella Cingolani, Yassine Taofik, Rosa Pedale, Pilar Piralles, Dora Larussa, Subir Sinha, M.S., Roberto Cauda, Christina M. Marra, M.D., Andrea Antinori

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

AIDS

2008

22

14

1759-67

 

Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D., Greg DiRienzo, Ph.D., Lynne Peeples, M.S., William G. Powderly, M.D., Karin L. Klingman, M.D., Kevin W. Garren, Ph.D., Tania George, Pharm.D., James F. Rooney, M.D., Barbara Brizz, M.H.S.Ed., B.S.N., Umesh Gangharam Lalloo, M.D., F.R.C.P., Robert L. Murphy, M.D., Susan Swindells, M.B.B.S., Diane V. Havlir, M.D., John W. Mellors, M.D.

Class-sparing regimens for initial treatment of HIV-1 infection

New England Journal of Medicine

2008

358

20

2095-106

 

Lin Liu, Susanne May, Douglas D. Richman, M.D., Frederick M. Hecht, M.D., Martin Markowitz, M.D., Eric S Daar, M.D., Jean-Pierre Routy, M.D., Joseph B. Margolick, M.D., Ph.D., Ann C. Collier, M.D., Christopher H. Woelk, Susan J. Little, M.D., Davey M. Smith, M.D.

Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance

AIDS

2008

22

7

835-9

PMC2716722

 

Adriana Weinberg, M.D., Ruth E. Dickover, Ph.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Julie A. Patterson, B.S., Howard Gutzman, B.S., William T. Shearer, M.D., Ph.D., Rebecca S. Gelman, Ph.D., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D.

Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021.

AIDS and Public Policy Journal

2008

22

17

2267-77

18981766

PMC2748303

P1021

Ann J. Melvin, M.D., M.P.H., Minhee Kang, M.S., Ph.D., Jane Hitti, M.D., M.P.H., Elizabeth Livingston, M.D., Susan Ellen Cohn, M.D., M.P.H., Vicki Stocker, R.N., M.S., Allison Ross, M.D., Heather D. Watts, M.D., Grace McComsey, M.D.

Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy

Antiviral Therapy

2008

13

3

349-55

 

 

Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

Journal of Virology

2008

81

15

7885-7893

17507467

PMC1951291

 

Ada Cachafeiro, Gayle G. Sherman, A. Sohn, C. Beck-Sague, Susan A. Fiscus, Ph.D.

Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay.

Journal of Clinical Microbiology

2008

47

2

459-62

19073872

PMC2643698

 

 

Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C

Journal of Clinical Microbiology

2008

46

9

2945-9

18614660

PMC2546762

 

Maureen E. Lyon, Ph.D., Paige L. Williams, Ph.D., Elizabeth R. Woods, M.D., M.P.H., Nancy Hutton, M.D., Anne Butler, M.S., Erica M. S. Sibinga, M.D., Michael T. Brady, M.D., James M. Oleske, M.D.

DNR and/or hospice care, psychological health and quality of life among children/adolescents with AIDS.

Journal of Palliative Medicine

2008

11

3

459-69

18363489

PMC2782484

ACTG 219C, DACS 621I

Kersten K. Koelsch, M.D., Lin Liu, Richard H. Haubrich, M.D., Susanne May, Diane V. Havlir, M.D., Huldrych F. Gunthard, Caroline Ignacio, Paula Campos-Soto, Susan J. Little, M.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Richard T. D'Aquila, M.D., Yuji Kawano, Karen A. Young, R.N., B.S.N., Phillip Dao, Celsa A. Spina, Ph.D., Douglas D. Richman, M.D., Joseph K. Wong, M.D.

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

Journal of Infectious Diseases

2008

197

3

411-9

18248304

 

Heather Ribaudo, Ph.D., Daniel R. Kuritzkes, M.D., Christina M. Lalama, M.S., Jeffrey T. Schouten, M.D.,J.D., Bruce R. Schackman, Ph.D., Edward P. Acosta, Pharm.D., Roy (Trip) Gulick, M.D., M.P.H.

Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts

Journal of Infectious Diseases

2008

197

7

1006-10

 

Homer L. Twigg, III, M.D., Michael D. Weiden, M.D., Fred T. Valentine, M.D., Carol T Schnizlein Bick, Ph.D., Roland Bassett, M.S., Lu (Summer) Zheng, Ph.D., L. Joseph Wheat, M.D., Richard B. Day, B.S., Helen C. Rominger-Grubbs, R.N., M.S.N, F.N.P., C.C.R.C., Ronald G. Collman, M.D., Lawrence Fox, M.D., Ph.D., Barbara Brizz, M.H.S.Ed., B.S.N., Joan Dragavon, M.L.M., Robert W. Coombs, M.D., Ph.D., R. Pat Bucy, M.D., Ph.D.

Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects

Journal of Infectious Diseases

2008

197

1

109-116

 

P. Velilla, M.Tarek Shata, M.D., Ph.D., C. S. Lages, J. Ying, Carl J. Fichtenbaum, M.D., Claire Chougnet, Ph.D.

Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients

AIDS Research and Human Retroviruses

2008

24

1

52-61

 

Ying-Jun Cao, Charles Flexner, M.D., Shelia B. Dunaway, M.D., Jeong-Gun Park, Ph.D., Karin L. Klingman, M.D., Ilene P. Wiggins, R.N., Jeanne Conley, R.N., B.S.N., Christine Radebaugh, Angela D.M. Kashuba, Pharm.D., Ron T. MacFarland, Ph.D., Stephen L. Becker, M.D., Craig Hendrix, M.D., M.C.

Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers

Antimicrobial Agents and Chemotherapy

2008

52

5

1630-4

PMC2346642

 

Susan C. Morpeth, MB ChB, DTM&H, Nathan Thielman, M.D., M.P.H., Habib O. Ramadhani, M.D., John David Hamilton, M.D., Jan Ostermann, Ph.D., Peter R. Kisenge, M.D., MMED, Humphrey J. Shao, M.D., L.Barth Reller, M.D., DTM&H, Dafrosa K. Itemba, B.A., Noel E. Sam, John Alexander Bartlett, M.D., John F. Shao, M.D., Ph.D., John A. Crump, MB ChB, DTM&H

Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania

Journal of Acquired Immune Deficiency Syndromes

2008

47

5

585-91

PMC2586846

 

Juan Carlos Salazar, M.D., M.P.H., Pedro E. Cahn, M.D., Ram Yogev, M.D., Marinella Della Negra, Ph.D., Guido Castelli-Gattinara, Claudia Fortuny, Patricia M. Flynn, M.D., M.S., Carlo Giaquinto, M.D., Ping Ruan, Ph.D., Elizabeth (Betsy) Smith, M.D., Jaromir Mikl, Hernan Valdez, M.D., Ante Jelaska, M.D.

Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents.

AIDS

2008

22

14

1789-98

18753862

PMC2758664

P1051

Francesca J. Torriani, M.D., Lauren Komarow, M.S., Robert A. Parker, Sc.D., Bruno R. Cotter, M.D., Judith Silverstein Currier, M.D., M.Sc., Michael P. Dube, M.D., Carl J. Fichtenbaum, M.D., Mariana Gerschenson, Ph.D., Carol K. Mitchell, Robert L. Murphy, M.D., Kathleen E. Squires, M.D., James H. Stein, M.D.

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s

Journal of the American College of Cardiology

2008

52

7

569-76

PMC2603599

 

Sergei L. Kosakovsky Pond, Ph.D., Art Poon, Selene Zarate, Davey M. Smith, M.D., Susan J. Little, M.D., Satish K. Pillai, Ronald J. Ellis, M.D.,Ph.D., Joseph K. Wong, M.D., Andrew Leigh-Brown, Ph.D., Douglas D. Richman, M.D., Simon D. W. Frost, D.Phil.

Estimating selection pressures on HIV-1 using phylogenetic likelihood models

Statistics In Medicine

2008

27

23

4779-89

PMC2634745

 

Joshua J. Minuto, M.D., Richard H. Haubrich, M.D.

Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection

Future HIV Therapy

2008

2

6

525-37

PMC2770189

 

Fred Richard Sattler, M.D., Natasa Rajicic, M.S., Kathleen Mulligan, Ph.D., Kevin E. Yarasheski, Ph.D., Susan L. Koletar, M.D., Andrew R. Zolopa, M.D., Beverly L. Alston-Smith, M.D., Robert Zackin, Sc.D., Bruce Bistrian, M.D., Ph.D.

Evaluation of high protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial

American Journal of Clinical Nutrition

2008

88

5

1313-21

PMC2797483

 

John G. Gerber, M.D., Doug Kitch, M.S., Carl J. Fichtenbaum, M.D., Robert Zackin, Sc.D., Stephannie Charles, B.A., Evelyn Hogg, B.A., Edward P. Acosta, Pharm.D., Elizabeth Connick, M.D., David Alain Wohl, M.D., Erna Milu Kojic, M.D., Constance A. Benson, M.D., Judith A. Aberg, M.D.

Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186

Journal of Acquired Immune Deficiency Syndromes

2008

47

4

459-66

PMC2788607

 

Keren Z. Landman, Jan Ostermann, Ph.D., John A. Crump, MB ChB, DTM&H, Anna Mgonja, Meghan K. Mayhood, Dafrosa K. Itemba, B.A., Alison C. Tribble, Evaline M. Ndosi, Helen Y. Chu, M.D., John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., Nathan Thielman, M.D., M.P.H.

Gender differences in the risk of HIV infection among persons reporting abstinence, monogamy and multiple sexual partners in Northern Tanzania

Public Library of Science One

2008

3

8

e3075, 1-6

PMC2516930

 

Koustubh M. Ranade, Ph.D., William J/ Geese, Mustafa Noor, M.D., M.Sc., Oliver P. Flint, Pablo Tebas, M.D., Kathleen Mulligan, Ph.D., William G. Powderly, M.D., Steven K. Grinspoon, M.D., Michael P. Dube, M.D.

Genetic analysis implicates resistin in HIV lipodystrophy.

AIDS

2008

22

13

1561-8

18670214

 

Jeffrey A. Anderson, M.D., Ph.D., Hongyu Jiang, Ph.D., Xiao Ding, Leslie A. Petch, Ph.D., Susan A. Fiscus, Ph.D., Richard H. Haubrich, M.D., David Katzenstein, M.D., Ronald Swanstrom, Ph.D., Roy (Trip) Gulick, M.D., M.P.H.

Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection

AIDS Research and Human Retroviruses

2008

24

5

685-94

 

Todd Hulgan, M.D., M.P.H., Pablo Tebas, M.D., Jeffrey A. Canter, M.D., M.P.H., Kathleen Mulligan, Ph.D., David W. Haas, M.D., Michael P. Dube, M.D., Steven K. Grinspoon, M.D., Gregory K. Robbins, M.D., M.P.H., Alison A. Motsinger, Asha R. Kallianpur

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy

Journal of Infectious Diseases

2008

197

6

858-66

 

David M. Butler, M.D., Davey M. Smith, M.D., Edward R. Cachay, M.D., George K. Hightower, B.A., Charles Nugent, Douglas D. Richman, M.D., Susan J. Little, M.D.

Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men

AIDS

2008

22

13

1667-71

PMC2653089

 

Edward R. Cachay, M.D., Simon D. W. Frost, D.Phil., Art Poon, David Looney, Sherry Rostami, Mary Pacold, Douglas D. Richman, M.D., Susan J. Little, M.D., Davey M. Smith, M.D.

Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels

Journal of Acquired Immune Deficiency Syndromes

2008

47

5

592-6

PMC2630881

 

Mona Rigaud, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Adriana Weinberg, M.D., Philip LaRussa, M.D., Terence Fenton, Ed.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Patrick Jean-Philippe, M.D., Bonnie Zimmer, B.S., Dorothy Smith, M.S., C.P.N.P.

Impaired immunity to recall and neoantigens in severely immunocompromised children and adolescents during the first year of effective HAART.

Journal of Infectious Diseases

2008

198

8

1123-1130

18752430

P1006

Wei Jiang, M.D., M.S., Michael M. Lederman, M.D., Richard Mohner, B.S., Benigno Rodriguez, M.D., Todd Nedrich, B.S., Clifford V. Harding, Scott F. Sieg, Ph.D.

Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection

Journal of Virology

2008

82

16

7837-45

18524824

PMC2519583

 

Daniel J. Skiest, M.D., F.A.C.P., Amy Krambrink, M.S., Zhaohui Su, Ph.D., Kevin R. Robertson, Ph.D., David M. Margolis, M.D.

Improved measures of quality of life, lipid profile and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170

Journal of Acquired Immune Deficiency Syndromes

2008

49

4

377-83

PMC2634828

 

Rana Traboulsi, M.D., Pranab K. Mukherjee, M.Sc., Ph.D., Mahmoud A. Ghannoum, M.Sc., Ph.D.

In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients

International Journal of Antimicrobial Agents

2008

31

3

272-6

18242063

 

Adriana Weinberg, M.D., John Spritzler, Sc.D., Mostafa Nokta, M.D., Ph.D., Rachel Schrier, Ph.D., Alan Landay, Ph.D., D. Brown, Richard B. Pollard, M.D.

In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits

Clinical and Vaccine Immunology

2008

15

9

1398-409

PMC2546686

 

Athe Tsibris, M.D., Manish Sagar, M.D., Roy (Trip) Gulick, M.D., M.P.H., Zhaohui Su, Ph.D., Michael Hughes, Ph.D., Wayne Greaves, M.D., Mani Subramanian, Charles Flexner, M.D., Francoise Giguel, Kay E. Leopold, Eoin Coakley, M.D., Daniel R. Kuritzkes, M.D.

In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject

Journal of Virology

2008

82

16

8210¿14

PMC2519584

 

Grace McComsey, M.D., Minhee Kang, M.S., Ph.D., Allison Ross, M.D., Dirk Lebrecht, Elizabeth Livingston, M.D., Ann J. Melvin, M.D., M.P.H., Jane Hitti, M.D., M.P.H., Susan Ellen Cohn, M.D., M.P.H., Ulrich A. Walker

Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV infected-mothers on antiretroviral therapy

HIV Clinical Trials

2008

9

2

126-36

 

Caroline J. Chantry, M.D., Michael Hughes, Ph.D., Carmelita Alvero, Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., William A. Meyer, III, Ph.D., Janice Hodge, R.N., B.S., Peggy R. Borum, Ph.D., John ( Jack ) Moye, Jr., M.D.

Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.

Pediatrics

2008

122

e

129-38

18519448

PMC2782494

P1010

James H. Stein, M.D., Lauren Komarow, M.S., Bruno R. Cotter, M.D., Judith Silverstein Currier, M.D., M.Sc., Michael P. Dube, M.D., Carl J. Fichtenbaum, M.D., Mariana Gerschenson, Ph.D., Carol K. Mitchell, Robert L. Murphy, M.D., Kathleen E. Squires, M.D., Robert A. Parker, Sc.D., Francesca J. Torriani, M.D.

Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG study A5152s

Journal of Clinical Lipidology

2008

2

6

464-71

19956354

PMC2636959

 

Kunjal Patel, D.Sc., M.P.H., Miguel A. Hernan, Paige L. Williams, Ph.D., John D. Seeger, Kenneth McIntosh, M.D., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Clinical Infectious Diseases

2008

46

4

507 - 515

18199042

ACTG 219C

Kunjal Patel, D.Sc., M.P.H., Miguel A. Hernan, Paige L. Williams, Ph.D., John D. Seeger, Kenneth McIntosh, M.D., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H.

Long-term effects of highly active antiretroviral therapy on CD4 evolution among children and adolescents infected with HIV-1: five years and counting.

Clinical Infectious Diseases

2008

46

11

1751-60

18426371

PMC3154876

ACTG 219C

Xiao-Li Huang, M.D., Z. Fan, LuAnn Borowski, M.Sc., Charles Rinaldo, Jr., Ph.D.

Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity

Journal of Leukocyte Biology

2008

83

6

1530-40

 

Pablo Tebas, M.D., W. Keith Henry, M.D., Roy Matining, M.S., Deborah Weng-Cherng, M.S., John L. Schmitz, Ph.D., Hernan Valdez, M.D., Nasreen Jahed, M.P.H., Laurie S. Myers, M.S., M.T. (A.S.C.P.), William G. Powderly, M.D., David Katzenstein, M.D.

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

Public Library of Science One

2008

3

4

1-6

PMC2292263

 

Mark Mirochnick, M.D., Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Jose Henrique Pilotto, M.D., Jorge Pinto, M.D., D.Sc., Eleanor Jimenez, M.D., F.A.A.P., Valdilea V. Santos, M.D., Ph.D., Teresa Parsons, Ph.D., Heather D. Watts, M.D., John ( Jack ) Moye, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., Margaret Camarca, M.P.H., Yvonne J. Bryson, M.D.

Nevirapine concentrations in newborns receiving an extended prophylactic regimen.

Journal of Acquired Immune Deficiency Syndromes

2008

47

3

334-7

18398973

P1043

Bridget E. McLaughlin, M.S., Nicole Baumgarth, D.V.M., Ph.D., Martin Bigos, Mario Roederer, Ph.D., Stephen C. De Rosa, John Altman, Ph.D., Douglas F. Nixon, M.D., Ph.D., Janet Ottinger, B.S., Thomas G. Evans, M.D., David M. Asmuth, M.D.

Nine-color flow cytometry for accurate measurement of t cell subsets and cytokine responses. part I: panel design by an empiric approach

Cytometry: The Journal of the Society for Analytical Cytology

2008

73

5

400-410

 

Bridget E. McLaughlin, M.S., Nicole Baumgarth, D.V.M., Ph.D., Martin Bigos, Mario Roederer, Ph.D., Stephen C. De Rosa, John Altman, Ph.D., Douglas F. Nixon, M.D., Ph.D., Janet Ottinger, B.S., J. Li, Laurel Beckett, Ph.D., B. L. Shacklett, Thomas G. Evans, M.D., David M. Asmuth, M.D.

Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.

Cytometry: The Journal of the Society for Analytical Cytology

2008

73

5

411-20

 

 

Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women

American Journal of Clinical Nutrition

2008

87

6

1639-49

18541551

PMC2474657

 

David M. Asmuth, M.D., Kristina Abel, Michael D. George, S. Dandekar, Richard B. Pollard, M.D., Chris Miller

Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques

Journal of Medical Primatology

2008

37

1

26-30

PMC2674790

 

Susan J. Little, M.D., Simon D. W. Frost, D.Phil., Joseph K. Wong, M.D., Davey M. Smith, M.D., Sergei L. Kosakovsky Pond, Ph.D., Caroline Ignacio, Neil Parkin, Christos J. Petropoulos, Ph.D., Douglas D. Richman, M.D.

Persistence of transmitted drug resistance among subjects with primary HIV infection

Journal of Virology

2008

82

11

5510-18

PMC2395184

 

Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Brookie M. Best, Pharm.D., Alice M. Stek, M.D., ChengCheng Hu, Ph.D., Edmund Capparelli, Pharm.D., Diane Holland, M.Phil., Sandra K. Burchett, M.D., M.S., Elizabeth (Betsy) Smith, M.D., William T. Shearer, M.D., Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Irma L. Febo Rodriguez, M.D., Mark Mirochnick, M.D.

Pharmacokinetics and safety of the new 625 mg nelfinavir tablet formulation during pregnancy and postpartum.

HIV Medicine

2008

9

10

875-82

18795962

PMC2732353

P1026S

Brian Robbins, Ph.D., Edmund Capparelli, Pharm.D., Ellen Gould Chadwick, M.D., Ram Yogev, M.D., Leslie Serchuck, M.D., Carol J. Worrell, M.D., Carmelita Alvero, Terence Fenton, Ed.D., Barbara E. Heckman, B.S., Stephen Ira Pelton, M.D., Grace M. Aldrovandi, MD, William Borkowsky, M.D., John H. Rodman, Pharm.D., Peter Havens, M.D.

Pharmacokinetics of high-dose lopinavir/ritonavir with and without saquinavir or non-nucleoside reverse transcriptase inhibitors in HIV infected pediatric and adolescent patients previously treated with protease inhibitors ¿ study PACTG P1038.

Antimicrobial Agents and Chemotherapy

2008

52

9

3276-83

18625762

PMC2533475

P1038

Ellen Gould Chadwick, M.D., Edmund Capparelli, Pharm.D., Ram Yogev, M.D., Jorge Pinto, M.D., D.Sc., Brian Robbins, Ph.D., John H. Rodman, Pharm.D., Jie (Ellen) Chen, M.S., Paul Palumbo, M.D., Leslie Serchuck, M.D., Elizabeth (Betsy) Smith, M.D., Michael Hughes, Ph.D.

Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.

AIDS

2008

22

2

249 - 255

18097227

P1030

William Borkowsky, M.D., Ram Yogev, M.D., Petronella Muresan, M.S., Elizabeth (Betsy) J. McFarland, M.D., Lisa M. Frenkel, M.D., Terence Fenton, Ed.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Paul Harding, M.S., Nina Ellis, B.S., Barbara E. Heckman, B.S., Lawrence Fox, M.D., Ph.D.

Planned multiple exposures to autologous virus in HIV-1 infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.

AIDS Research and Human Retroviruses

2008

24

3

401-11

18327977

P1015

Daniel R. Kuritzkes, M.D., Christina M. Lalama, M.S., Heather Ribaudo, Ph.D., Michelle Marcial, William A. Meyer, III, Ph.D., Cecilia M. Shikuma, M.D., Victoria A. Johnson, M.D., Susan A. Fiscus, Ph.D., Richard T. D'Aquila, M.D., Bruce R. Schackman, Ph.D., Edward P. Acosta, Pharm.D., Roy (Trip) Gulick, M.D., M.P.H.

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-nanve HIV-1-infected subjects

Journal of Infectious Diseases

2008

197

6

867-70

 

Susan Ellen Cohn, M.D., M.P.H., Triin Umbleja, M.Sc., Joseph Mrus, M.D., M.Sc., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Janet Andersen, Sc.D., Margaret A. Chesney, Ph.D.

Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084

AIDS Patient Care and STDs

2008

22

1

29-40

18442305

 

Ann C. Collier, M.D., Camlin Tierney, Ph.D., Gerald F. Downey, M.Sc., Susan H. Eshleman, M.D., PH.D., Angela D.M. Kashuba, Pharm.D., Karin L. Klingman, M.D., Emanuel N. Vergis, M.D., M.P.H., Gary E. Pakes, Pharm.D., James F. Rooney, M.D., Alex R. Rinehart, Ph.D., John W. Mellors, M.D.

Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV

HIV Clinical Trials

2008

9

2

91-102

 

Robert H. Paul, Ph.D., Thomas Ernst, Ph.D., Adam M. Brickman, Ph.D., Constantin Yiannoutsos, Ph.D., David Tate, Ph.D., Ronald A. Cohen, Ph.D., ABPP, ABCN, Bradford A. Navia, M.D.

Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV

Journal of the International Neuropsychological Society

2008

14

5

725-33

 

 

Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in Sub-Saharan Africa.

Pediatric Infectious Disease Journal

2008

27

3

251-6

18277935

PMC2730543

 

Scott F. Sieg, Ph.D., Douglas A. Bazdar, Michael M. Lederman, M.D.

S-phase entry leads to cell death in circulating T cells from HIV-infected persons

Journal of Leukocyte Biology

2008

83

 

1-6

 

Thomas C. Greenough, M.D., Coleen K. Cunningham, M.D., Petronella Muresan, M.S., Margaret McManus, B.S., Deborah Persaud, M.D., Terence Fenton, Ed.D., Piers Barker, M.D., Aditya Gaur, M.D., Dennis Panicali, Ph.D., John L. Sullivan, M.D., Katherine Luzuriaga, M.D.

Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy

Vaccine

2008

26

52

6883-93

18940219

PMC2845914

P1059

Heather D. Watts, M.D., Jeong-Gun Park, Ph.D., Susan Ellen Cohn, M.D., M.P.H., Song Yu, M.S., Jane Hitti, M.D., M.P.H., Alice M. Stek, M.D., Pamela A. Clax, D.P.M., Laila Muderspach, M.D., Juan J.L. Lertora, M.D., Ph.D.

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093

Contraception

2008

77

2

84-90

PMC2424313

 

Richard T. Davey, Jr., M.D., Peter Pertel, M.D., Alice Benson, Delanie J. Cassell, Brian Gazzard, M.A., M.D., F.R.C.P., Mark Holodniy, M.D., Jay Lalezari, M.D., Yves Levy, M.D., Ph.D., Ronald T. Mitsuyasu, M.D., Frank Palella, M.D., Richard B. Pollard, M.D., Prabhu Rajagopalan, M.D., Michael Switow Saag, M.D., Robert A. Salata, M.D., Beverly E. Sha, M.D., Shurjeel Choudhri, M.D.

Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy

Journal of Interferon and Cytokine Research

2008

28

2

89-100

 

Kevin R. Robertson, Ph.D., Kathy Kopnisky, Ph.D., James Gita Hakim, M.D., Concepta A. Merry, Ph.D., M.Sc., Noeline Nakasujja, Colin D. Hall, M.D., Moussa Traore, Ned Sacktor, M.D., David B. Clifford, M.D., Charles Newton, Annelies Van Rie, Penny Holding, Ph.D., Jacqueline Clements, B.S., M. Christine Zink, D.V.M., Ph.D., Jens Karl-Heinrich Mielke, MB ChB, MRCP, Mina Christine Hosseinipour, M.D., Umesh Gangharam Lalloo, M.D., F.R.C.P., Farida Cassim Amod, M.B., CHB, FCPath (micro), Christina M. Marra, M.D., Scott Evans, Ph.D., Jeff Liner

Second assessment of neuroAIDS in Africa

Journal of Neurovirology

2008

14

2

87-101

PMC2755561

 

Myron Levin, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Sharon Appelbaum Nachman, M.D., Julie A. Patterson, B.S., Robert Walker, M.D., George Kemble, Ph.D., Maria Allende, M.D., Micki Hultquist, Tingting Yi, Barbara Nowak, B.A., Adriana Weinberg, M.D.

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.

Vaccine

2008

26

33

4210-7

18597900

PMC2615200

P1057

Jodi Grandominico, Carl J. Fichtenbaum, M.D.

Short-term affect of HAART on blood pressure in HIV-infected individuals

HIV Clinical Trials

2008

9

1

52-60

 

Scott Evans, Ph.D., David B. Clifford, M.D., Doug Kitch, M.S.

Simplification of the research diagnosis of HIV-associated sensory neuropathy

HIV Clinical Trials

2008

9

6

434-439

PMC2684847

 

William Borkowsky, M.D., Ram Yogev, M.D., Petronella Muresan, M.S., Lisa M. Frenkel, M.D., Terence Fenton, Ed.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Paul Harding, M.S., Nina Ellis, B.S., Barbara E. Heckman, B.S.

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia

Vaccine

2008

26

24

3086-9

P1015

Robert C Kalayjian, M.D., Nora Franceschini, M.D., M.P.H., Samir K. Gupta, M.D., Lynda Anne Szczech, M.D., M.S.C.E., Ezekiel Mupere, Ronald J. Bosch, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Jeffrey M. Albert, Ph.D.

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease

AIDS

2008

22

4

481-7

18301060

 

Nancy Radcliffe Reynolds, Ph.D., Marcia A. Testa, M.P.H., Ph.D., Max Su, Sc.D., Margaret A. Chesney, Ph.D., Judith Neidig, R.N., Ph.D., Ian Frank, M.D., Scott R. Smith, Ph.D., Jeannette Ickovics, Ph.D., Gregory K. Robbins, M.D., M.P.H.

Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial

Journal of Acquired Immune Deficiency Syndromes

2008

47

1

62-8

 

Lisa M. Demeter, M.D., Lisa Mukherjee, M.S., Robin DiFrancesco, M.T., (ASCP), M.B.A., Hongyu Jiang, Ph.D., Robert DiCenzo, Pharm.D., Barbara Bastow, R.N., B.S.N., Alex R. Rinehart, Ph.D., Gene D. Morse, Pharm.D., Mary Albrecht, M.D.

The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients

HIV Clinical Trials

2008

9

1

61-72

PMC2821072

 

Brian Wells Pence, Ph.D., Jan Ostermann, Ph.D., Virender Kumar, Ph.D., Kathryn Whetten, Ph.D., M.P.H., Nathan Thielman, M.D., M.P.H., Michael J. Mugavero, M.D., M.H.S.

The influence of psychosocial characteristics and race/ethnicity on the use, duration and success of antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

2008

47

2

194-201

 

Jeffrey A. Canter, M.D., M.P.H., David W. Haas, M.D., Asha R. Kallianpur, Marylyn D. Ritchie, Ph.D., Gregory K. Robbins, M.D., M.P.H., Robert Shafer, M.D., David B. Clifford, M.D., Deborah G. Murdock, M.D., Todd Hulgan, M.D., M.P.H.

The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy

Pharmacogenomics

2008

8

1

71-7

 

Samir K. Gupta, M.D., Susan L Rosenkranz, Ph.D., Yoninah S. Cramer, M.S., Susan L. Koletar, M.D., Lynda Anne Szczech, M.D., M.S.C.E., Valerianna Amorosa, M.D., Stephen D Hall, Ph.D.

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

AIDS

2008

22

15

1919-27

PMC2675161

 

Nancy C. Connolly, M.D., M.P.H., Theresa Whiteside, Ph.D., Cara C. Wilson, M.D., Venkatswarlu Kondragunta, Charles Rinaldo, Jr., Ph.D., Sharon A. Riddler, M.D., M.P.H.

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

Clinical and Vaccine Immunology

2008

15

2

284-92

PMC2238066

 

Nicholas T. Funderburg, Ph.D., Angel A. Luciano, Wei Jiang, M.D., M.S., Benigno Rodriguez, M.D., Scott F. Sieg, Ph.D., Michael M. Lederman, M.D.

Toll-like receptor ligans induce human T cell activation and death, a model for HIV pathogenesis

Public Library of Science One

2008

3

4

1-7

PMC2271052

 

Philippa Musoke, MB ChB, A. Young, Anchilla Owor, M.D., Irene Lubega, E. Brown, Missie Allen, B.S., Francis Mmiro, Lynne M. Mofenson, M.D., F.A.A.P., Brooks Jackson, M.D., M.B.A., Mary Glenn Fowler, M.D., M.P.H., Laura A. Guay, M.D.

Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children

Journal of Acquired Immune Deficiency Syndromes

2008

49

2

171-8

18769352

PMC2721476

 

Russell B. Van Dyke, M.D., Lu Wang, Paige L. Williams, Ph.D.

Toxicities associated with dual NRTI regimens in HIV-infected children

Journal of Infectious Diseases

2008

198

11

1599-608

19000014

PMC2737265

ACTG 219C

Mark F. Cotton, MMED, Ph.D., MB ChB, Hendrik Simon Schaaf, MB ChB, Genevieve Lottering, Heinrich Cjristoff Weber, MB ChB, Joan Coetzee, C.P.N., Sharon Appelbaum Nachman, M.D.

Tuberculosis exposure in HIV-exposed infants in a high prevalence setting.

International Journal of Tuberculosis and Lung Disease

2008

12

2

225-227

18230259

P1041

John Spritzler, Sc.D., Victor DeGruttola, Sc.D., Lixia Pei

Two-sample tests of area-under-the-curve in the presence of missing data

International Journal of Biostatistics

2008

4

1

1-18

PMC2835452

 

Meghan K. Mayhood, Isaac A. Afwamba, Christopher O. Odhiambo, Epimack Ndanu, Nathan Thielman, M.D., M.P.H., Anne B. Morrissey, M.S., John F. Shao, M.D., Ph.D., Brian Wells Pence, Ph.D., John A. Crump, MB ChB, DTM&H

Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania

Journal of Clinical Microbiology

2008

46

12

3946-51

PMC2593273

 

Vincent C. Marconi, Sebastian Bonhoeffer, Ph.D., Roger Paredes, Jing Lu, M.S., Rebecca Hoh, R.D., Jeffrey N. Martin, Steven G. Deeks, M.D., Daniel R. Kuritzkes, M.D.

Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide

Journal of Acquired Immune Deficiency Syndromes

2008

48

5

572-6

PMC2709806

 

Heather Ribaudo, Ph.D., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H.

A comparison of three initial antiretroviral AIDS regimens

New England Journal of Medicine

2007

357

10

1056-7

 

Giovanni Schifitto, M.D., Jiameng Zhang, Ph.D., Scott Evans, Ph.D., Ned Sacktor, M.D., David M. Simpson, M.D., Linda L. Millar, B.S., Vivian (Lang) M. Hung, M.P.H., Eric N. Miller, Ph.D., Elizabeth (Betsy) Smith, M.D., Ronald J. Ellis, M.D.,Ph.D., Victor G. Valcour, M.D., Elyse J. Singer, M.D., Christina M. Marra, M.D., Dennis Kolson, M.D., Ph.D., James Weihe, M.D., Rory P. Remmel, Ph.D., David Katzenstein, M.D., David B. Clifford, M.D.

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment

Neurology

2007

69

13

1314-21

17652642

 

Michael M. Lederman, M.D., Veronica Miller, Ph.D., Steven G. Deeks, M.D.

A new approach for 'deep salvage' trials in advanced HIV infection

AIDS

2007

21

12

1503-6

17630543

 

Sharon A. Riddler, M.D., M.P.H., Hongyu Jiang, Ph.D., Allan R. Tenorio, M.D., Hairong Huang, Daniel R. Kuritzkes, M.D., Edward P. Acosta, Pharm.D., Alan Landay, Ph.D., Barbara Bastow, R.N., B.S.N., David W. Haas, M.D., Karen T. Tashima, M.D., Mamta Khandelwal Jain, M.D., Steven G. Deeks, M.D., John Alexander Bartlett, M.D.

A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115

Antiviral Therapy

2007

12

4

531-41

 

Scott Evans, Ph.D., David M. Simpson, M.D., Doug Kitch, M.S., Agnes King, David B. Clifford, M.D., Bruce A. Cohen, M.D., Justin C. McArthur, M.B.B.S., M.P.H.

A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain

Public Library of Science Clinical Trials

2007

2

6

e551

 

Andrea S. Foulkes, Victor DeGruttola, Sc.D.

A resampling-based approach to multiple testing with uncertainty in phase

International Journal of Biostatistics

2007

3

1

Article 2

22550644

 

Peter T. Frame, M.D., Carl J. Fichtenbaum, M.D.

A truvada hypersensitivity reaction simulating abacavir hypersensitivity

AIDS

2007

21

16

2252-3

 

Edward R. Cachay, M.D., Niousha Moini, Sergei L. Kosakovsky Pond, Ph.D., Rick L. Pesano, M.D., Ph.D., Yolanda Lie, Heidi Aiem, David M. Butler, M.D., Scott L. Letendre, M.D., W. Christopher Mathews, M.D., M.S.P.H., Davey M. Smith, M.D.

Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration

The Open AIDS Journal

2007

1

 

5-10

 

Grace McComsey, M.D., Michelle A. Kendall, M.S., Pablo Tebas, M.D., Susan Swindells, M.B.B.S., Evelyn Hogg, B.A., Beverly L. Alston-Smith, M.D., Carol Suckow, B.S.N., Geetha Gopalakrishnan, M.D., Constance A. Benson, M.D., David Alain Wohl, M.D.

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV

AIDS

2007

21

18

2473-82

 

Susan L Rosenkranz, Ph.D., Kevin E. Yarasheski, Ph.D., Michael F. Para, M.D., Richard C. Reichman, M.D., Gene D. Morse, Pharm.D.

Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis

Metabolic Syndrome and Related Disorders

2007

5

2

163-73

 

Erik George, M.D., Francine Noel, M.D., Rose May Gyrlande Bois, M.D., Rachelle Cassagnol, Louise Estavien, Patricia De Matteis Rouzier, Rose I. Verdier, M.D., Warren D. Johnson, M.D., Jean William Pape, M.D., Daniel W. Fitzgerald, M.D., Peter Farnum Wright, M.D.

Antiretroviral therapy for HIV-1-infected children in Haiti

Journal of Infectious Diseases

2007

195

 

1411-8

 

Keren Z. Landman, Nathan Thielman, M.D., M.P.H., Anna Mgonja, Humphrey J. Shao, M.D., Dafrosa K. Itemba, B.A., Evaline M. Ndosi, Alison C. Tribble, John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., John A. Crump, MB ChB, DTM&H

Antiretroviral treatment literacy among HIV voluntary testing and counseling clients in Moshi, Tanzania, 2003 to 2005

Journal of the International Association of Physicians in AIDS Care

2007

6

1

24-6

 

William Douglas King, M.D., J.D., Donna DeFreitas, M.D., Kimberly Y. Smith, M.D., M.P.H., Janet Andersen, Sc.D., Lisa Patton, B.S., Oluwatoyin Adeyemi, M.D., Jennifer A. Mitty, M.D., M.P.H., Jan Fritsche, A.P.R.N., B.C., Carrie Jeffries, R.N., M.S., M.P.H., C.R.N.P.,, Melvin Littles, A.A., Margaret A. Fischl, M.D., Gregory Pavlov, Donna Mildvan, M.D.

Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study

AIDS Patient Care and STDs

2007

21

8

551-63

 

Susan A. Fiscus, Ph.D., Andrea Kovacs, M.D., Leslie A. Petch, Ph.D., ChengCheng Hu, Ph.D., Andrew A. Wiznia, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Ram Yogev, M.D., Kenneth McIntosh, M.D., Stephen Ira Pelton, M.D., Sonia Napravnik, M.P.H., Ph.D., Kenneth Stanley, Ph.D., Sharon Appelbaum Nachman, M.D.

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

AIDS Research & Therapy (online journal)

2007

4

2

 

17280617

PMC1802955

ACTG 338

Michael Hughes, Ph.D., Paige L. Williams, Ph.D.

Challenges in using observational studies to evaluate adverse effects of treatment

New England Journal of Medicine

2007

356

17

1705-7

 

Marie Louise Newell, M.D., Sharon Huang, M.S., Simone Fiore, M.D., Claire Thorne, Ph.D., Laurent Mandelbrot, M.D., John L. Sullivan, M.D., Robert T. Maupin, Jr., M.D., Issac Delke, M.D., Heather D. Watts, M.D., Richard D. Gelber, Ph.D., Coleen K. Cunningham, M.D.

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

BioMed Central Infectious Diseases

2007

7

 

60

17584491

PMC1913528

ACTG 316

Michael J. Mugavero, M.D., M.H.S., Brian Wells Pence, Ph.D., Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Marvin Swartz, M.D., Dalene Stangl, Ph.D., Nathan Thielman, M.D., M.P.H.

Childhood abuse and initial presentation for HIV care: an opportunity for early intervention

AIDS Care

2007

19

9

1083-7

 

Carmen D. Zorrilla, M.D., Russell B. Van Dyke, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Edward P. Acosta, Pharm.D., Elizabeth (Betsy) Smith, M.D., Michael Hughes, Ph.D., Sharon Huang, M.S., Heather D. Watts, M.D., Barbara E. Heckman, B.S., Barbara E. Heckman, B.S., Eleanor Jimenez, M.D., F.A.A.P., George D. McSherry, M.D., Lynne M. Mofenson, M.D., F.A.A.P.

Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.

Antimicrobial Agents and Chemotherapy

2007

51

6

2208 - 2210

17420209

PMC1891372

ACTG 386

Stephen J. Gange, Mari M. Kitahata, M.D., M.P.H., Michael Switow Saag, M.D., D. R. Bangsberg, Ronald J. Bosch, Ph.D., John Brooks, Steven G. Deeks, M.D., Joseph J. Eron, Jr., M.D., Liviana M. Calzavara, M. John Gill, David W. Haas, M.D., Kelly A. Gebo, Michael Horberg, Robert S. Hogg, Amy C. Justice, M.D.,Ph.D., Lisa P. Jacobson, Marina B. Klein, M.D., C.M., M.Sc., Jeffrey N. Martin, Gregory D. Kirk, Benigno Rodriguez, M.D., Rosemary G. McKaig, M.P.H., Ph.D., Timothy R. Sterling, M.D., M.P.H., Sean B. Rourke, Aimee M. Freeman, Richard D. Moore

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

International Journal of Epidemiology

2007

36

2

294-301

 

B. Healy, Victor DeGruttola, Sc.D., Marcello Pagano

Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations

Biometrics

2007

63

3

742-50

 

John Alexander Bartlett, M.D., S. H. Chen, M.D., Joseph Quinn, R.N.

Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview

HIV Clinical Trials

2007

8

4

221-6

 

Scott Evans, Ph.D., Carl J. Fichtenbaum, M.D., Judith A. Aberg, M.D.

Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087

HIV Clinical Trials

2007

8

1

45-52

 

L. Zhou, Doug Kitch, M.S., Scott Evans, Ph.D., Peter Hauer, M.D., S. Raman, B.S., G. J. Ebenezer, M.B.B.S., Mariana Gerschenson, Ph.D., Christina M. Marra, M.D., Victor G. Valcour, M.D., Ramon Diaz-Arrastia, M.D., Ph.D., Karl Goodkin, M.D., Ph.D., Linda L. Millar, B.S., Sharon L. Shriver, R.Ph., M.S., David M. Asmuth, M.D., David B. Clifford, M.D., David M. Simpson, M.D., Justin C. McArthur, M.B.B.S., M.P.H.

Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy

Neurology

2007

68

24

2113-9

 

Akihiko Saitoh, M.D., Elizabeth Sarles, Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D.

CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.

AIDS

2007

21

16

2191 - 2199

18090046

ACTG 366, ACTG 377

Scott Evans, Ph.D., Li-Fang Li, Lee-Jen Wei, Ph.D.

Data monitoring in clinical trials using prediction

Drug Information Journal

2007

41

6

 

 

Richard H. Haubrich, M.D.

Defining HIV susceptibility to new antiretroviral agents- darunavir

Journal of Infectious Diseases

2007

196

8

1125-7

 

Susan Ellen Cohn, M.D., M.P.H., Jeong-Gun Park, Ph.D., Heather D. Watts, M.D., Alice M. Stek, M.D., Jane Hitti, M.D., M.P.H., Pamela A. Clax, D.P.M., Song Yu, M.S., Juan J.L. Lertora, M.D., Ph.D.

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions

Clinical Pharmacology & Therapeutics

2007

81

2

222-7

 

Junfeng Sun, Haikady N. Nagaraja, Ph.D., Nancy Radcliffe Reynolds, Ph.D.

Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study

Biometrics

2007

49

5

731-41

 

Deborah Persaud, M.D., Paul Palumbo, M.D., Carrie Ziemniak, Jie (Ellen) Chen, M.S., Stuart C. Ray, Michael Hughes, Ph.D., Peter Havens, M.D., Murli Purswani, M.D., Aditya Gaur, M.D., Ellen Gould Chadwick, M.D.

Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.

Journal of Infectious Diseases

2007

195

10

1402-1410

17436219

P1030

Akihiko Saitoh, M.D., Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Carmelita Alvero, Terence Fenton, Ed.D., Karen Hsia, Ph.D., Stephen A. Spector, M.D.

Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism.

Journal of Acquired Immune Deficiency Syndromes

2007

45

3

280 - 285

17356468

ACTG 382

Jack T. Stapleton, M.D., Kara Bennett, M.S., Ronald J. Bosch, Ph.D., Philip M. Polgreen, Susan Swindells, M.B.B.S.

Effect of antiretroviral therapy and hepatitis C co-infection on changes in lipid levels in HIV-infected patients 48 weeks after initiation of therapy

HIV Clinical Trials

2007

8

6

429-36

 

Edward P. Acosta, Pharm.D., Michelle A. Kendall, M.S., John G. Gerber, M.D., Beverly L. Alston-Smith, M.D., Susan L. Koletar, M.D., Andrew R. Zolopa, M.D., Sangeeta Agarwala, Ph.D., Michael J. Child, B.S., Richard J. Bertz, Ph.D., Lara A. Hosey, M.A., C.C.R.P., David W. Haas, M.D.

Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily

Antimicrobial Agents and Chemotherapy

2007

51

9

3104-10

 

Rahul P. Bakshi, Fayez Hamzeh, M.D., Ph.D., Ian Frank, M.D., Joseph J. Eron, Jr., M.D., Ronald J. Bosch, Ph.D., Susan L Rosenkranz, Ph.D., Yoninah S. Cramer, M.S., Michael Ussery, Ph.D., Charles Flexner, M.D.

Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients

AIDS Research and Human Retroviruses

2007

23

11

1360-5

18184078

 

Kathleen Mulligan, Ph.D., Yang Yang, Ph.D., David A. Wininger, M.D., Susan L. Koletar, M.D., Robert A. Parker, Sc.D., Beverly L. Alston-Smith, M.D., Jeffrey T. Schouten, M.D.,J.D., Roger A. Fielding, Ph.D., Michael T. Basar, B.S., Steven K. Grinspoon, M.D.

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

AIDS

2007

21

1

47-57

 

Lois C. Howland, M.S., M.P.H., D.Ph., Sybil Crawford, Ph.D., Deborah S. Storm, R.N.,Ph.D, Katherine Leung, M.P.H., Steven Gortmaker, Ph.D., James M. Oleske, M.D.

Effects of negative life events on measures of quality of life and health utilization among children and youth with HIV infection.

Journal of the Association of Nurses in AIDS Care

2007

18

1

3-11

17338981

ACTG 219C, DACS 604

Michael P. Dube, M.D., Robert A. Parker, Sc.D., Kathleen Mulligan, Ph.D., Pablo Tebas, M.D., Gregory K. Robbins, M.D., M.P.H., Ronenn Roubenoff, M.D., M.H.S., Steven K. Grinspoon, M.D.

Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384

Clinical Infectious Diseases

2007

45

1

120-6

17554712

 

Shalender Bhasin, M.D., Robert A. Parker, Sc.D., Fred Richard Sattler, M.D., Richard H. Haubrich, M.D., Beverly L. Alston-Smith, M.D., Triin Umbleja, M.Sc., Cecilia M. Shikuma, M.D.

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity

Journal of Clinical Endocrinology and Metabolism

2007

92

3

1049-57

 

Janet Andersen, Sc.D., Robert J. Fass, M.D., Charles van der Horst, M.D.

Factors associated with early study discontinuation in AACTG studies, DACS 200

Contemporary Clinical Trials

2007

28

5

583-92

 

 

Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: a randomized controlled trial

Obstetrics and Gynecology

2007

109

2

392-401

17267841

 

C. M. Behler, E. Vittinghoff, F. Lin, Raymond T. Chung, M.D., Marion G. Peters, M.D., Gregory K. Robbins, M.D., M.P.H., Paul Volberding, M.D.

Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects

Clinical Infectious Diseases

2007

44

10

1375-83

 

B. Healy, Victor DeGruttola, Sc.D.

Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses

Biostatistics

2007

8

2

438-52

 

Nicole L. Yonkers, Benigno Rodriguez, M.D., Anthony B. Post, Robert Asaad, M.D., Linda Jones, R.N., Michael M. Lederman, M.D., Paul V. Lehmann, Donald D. Anthony, M.D., Ph.D.

HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells

Journal of Infectious Diseases

2007

194

3

391-400

 

Charles Flexner, M.D.

HIV drug development: the next 25 years

Nature Reviews Drug Discovery

2007

6

12

959-66

 

J. Allen McCutchan, M.D., M.Sc., Julia (Wei) Wu, M.S., Kevin R. Robertson, Ph.D., Susan L. Koletar, M.D., Ronald J. Ellis, M.D.,Ph.D., Susan Ellen Cohn, M.D., M.P.H., Michael Taylor, Steven Woods, Robert K. Heaton, Ph.D., Judith Silverstein Currier, M.D., M.Sc., Paige L. Williams, Ph.D.

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

AIDS

2007

21

9

1109-17

 

Nicholas T. Funderburg, Ph.D., Michael M. Lederman, M.D., Zhimin Feng, Michael G. Drage, Julie Jadlowsky, Clifford V. Harding, Scott F. Sieg, Ph.D.

Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2

Proceedings of the National Academy of Sciences of the United States of America

2007

104

47

18631-5

 

Akihiko Saitoh, M.D., Terence Fenton, Ed.D., Carmelita Alvero, Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D.

Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.

Antimicrobial Agents and Chemotherapy

2007

51

12

4236 - 4242

17893156

PMC2167993

ACTG 382

Angel A. Luciano, Michael M. Lederman, M.D., Alice Valentin-Torres, Douglas A. Bazdar, Scott F. Sieg, Ph.D.

Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease.

Journal of Immunology

2007

179

6

3543-9

17785788

 

Smita A. Kshirsagar, Terrence F. Blaschke, M.D., Lewis Sheiner, M.D., Mizue Krygowski, B.A., Edward P. Acosta, Pharm.D., Davide Verotta, Ph.D.

Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria

Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics)

2007

34

1

35-55

 

Susan Brogly, Ph.D., Nathalie Ylitalo, M.D., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., James M. Oleske, M.D., Russell B. Van Dyke, M.D., Marilyn Jean Crain, M.P.H., M.D., Mark J. Abzug, M.D., Michael T. Brady, M.D., Patrick Jean-Philippe, M.D., Michael Hughes, Ph.D., George Seage, III, Sc.D., M.P.H.

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

AIDS

2007

21

8

929-938

17457086

ACTG 219C

Kim Keil, M.A., Jill S. Hochreiter, MT, (ASCP), Robin DiFrancesco, M.T., (ASCP), M.B.A., Barry Zingman, M.D., Richard C. Reichman, M.D., Margaret A. Fischl, M.D., Barbara Gripshover, M.D., Gene D. Morse, Pharm.D.

Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application

Therapeutic Drug Monitoring

2007

29

1

103-9

 

Roy (Trip) Gulick, M.D., M.P.H., Christina M. Lalama, M.S., Heather Ribaudo, Ph.D., Cecilia M. Shikuma, M.D., Bruce R. Schackman, Ph.D., Jeffrey T. Schouten, M.D.,J.D., Kathleen E. Squires, M.D., Susan L. Koletar, M.D., Christopher D. Pilcher, M.D., Richard C. Reichman, M.D., Karin L. Klingman, M.D., Daniel R. Kuritzkes, M.D.

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression

AIDS

2007

21

7

813-23

 

Daniel J. Skiest, M.D., F.A.C.P., Zhaohui Su, Ph.D., Diane V. Havlir, M.D., Kevin R. Robertson, Ph.D., Robert W. Coombs, M.D., Ph.D., Pat Cain, R.N., Tianna Petersen, M.S., Amy Krambrink, M.S., Nasreen Jahed, M.P.H., Deborah McMahon, M.D., David M. Margolis, M.D.

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS clinical trials group 5170

Journal of Infectious Diseases

2007

195

10

1426-36

 

Jeff D. Moore, Edward P. Acosta, Pharm.D., Victoria A. Johnson, M.D., Roland Bassett, M.S., Joseph J. Eron, Jr., M.D., Margaret A. Fischl, M.D., Mary C. Long, Ph.D., Daniel R. Kuritzkes, M.D., Jean-Pierre Sommadossi, Pharm.D., Ph.D.

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy

Antiviral Therapy

2007

12

6

981-6

 

Patricia M. Flynn, M.D., M.S., John H. Rodman, Pharm.D., Jane C. Lindsey, Sc.D., Brian Robbins, Ph.D., Edmund Capparelli, Pharm.D., Katherine M. Knapp, M.D., Jose F. Rodriguez, Ph.D., James McNamara, M.D., Leslie Serchuck, M.D., Barbara E. Heckman, B.S., Jaime Martinez, M.D.

Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.

Antimicrobial Agents and Chemotherapy

2007

51

10

3516-3522

17664328

PMC2043291

P1012

Elizabeth Livingston, M.D., Susan Ellen Cohn, M.D., M.P.H., Yang Yang, Ph.D., Heather D. Watts, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Theodore Benjamin Jones, M.D., F.A.C.O.G., Laura M. Smith, M.P.H., Triin Umbleja, M.Sc., Grace McComsey, M.D.

Lipids and lactate in human immunodeficiency virus-1-infected pregnancies with or without protease inhibitor-based therapy

Obstetrics and Gynecology

2007

110

2: Part 1

391-7

 

Michael P. Dube, M.D., Lauren Komarow, M.S., Kathleen Mulligan, Ph.D., Steven K. Grinspoon, M.D., Robert A. Parker, Sc.D., Gregory K. Robbins, M.D., M.P.H., Ronenn Roubenoff, M.D., M.H.S., Pablo Tebas, M.D.

Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384

Journal of Acquired Immune Deficiency Syndromes

2007

45

5

508-14

 

Patricia M. Flynn, M.D., M.S., Bret J. Rudy, M.D., Jane C. Lindsey, Sc.D., Steven D. Douglas, M.D., Janet L. Lathey, Ph.D., Stephen A. Spector, M.D., Jaime Martinez, M.D., Margarita Silio, M.D., Elizabeth (Betsy) Smith, M.D., Janice Hodge, R.N., B.S., Michael Hughes, Ph.D.

Long-term observation of adolescents initiating HAART therapy: three-year follow-up.

AIDS Research and Human Retroviruses

2007

23

10

1208 - 1214

17961106

ACTG 381

Davey M. Smith, M.D., Joseph K. Wong, M.D., George K. Hightower, B.A., Caroline Ignacio, Simon D. W. Frost, D.Phil., Douglas D. Richman, M.D., Susan J. Little, M.D.

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission

Journal of Infectious Diseases

2007

196

3

356-60

 

Ross E. McKinney, Jr., M.D., John H. Rodman, Pharm.D., ChengCheng Hu, Ph.D., Paula Britto, M.S., Michael Hughes, Ph.D., Elizabeth (Betsy) Smith, M.D., Leslie Serchuck, M.D., Alberto A. Ortiz, M.S., Patricia M. Flynn, M.D., M.S., Ram Yogev, M.D., Stephen A. Spector, M.D., Linda Draper (Marillo), B.A., Melissa Scites, B.S., R.N., C.C.R.C., Ruth E. Dickover, Ph.D., Adriana Weinberg, M.D., Coleen K. Cunningham, M.D., Elaine J. Abrams, M.D., M. Robert Blum, Ph.D., Gregory E. Chittick, B.S., Laurie Reynolds, Mobeen H. Rathore, M.D.

Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.

Pediatrics

2007

120

2

e416-e423

17646352

P1021

Giovanni Schifitto, M.D., Bradford A. Navia, M.D., Constantin Yiannoutsos, Ph.D., Christina M. Marra, M.D., Linda Chang, M.D., Thomas Ernst, Ph.D., Jeffrey G. Jarvik, M.D., M.P.H., Eric N. Miller, Ph.D., Elyse J. Singer, M.D., Ronald J. Ellis, M.D.,Ph.D., Dennis Kolson, M.D., Ph.D., David M. Simpson, M.D., Avindra Nath, M.D., Joseph R. Berger, M.D., Sharon L. Shriver, R.Ph., M.S., Linda L. Millar, B.S., Dodi Colquhoun, M.Sc., Robert Lenkinski, Ph.D., R.Gilberto Gonzalez, M.D., Ph.D., Stuart A. Lipton, M.D., Ph.D.

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study

AIDS

2007

21

14

1877-86

 

Brian Wells Pence, Ph.D., Susan Reif, Ph.D., M.S.W, Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Dalene Stangl, Ph.D., Marvin Swartz, M.D., Nathan Thielman, M.D., M.P.H., Michael J. Mugavero, M.D., M.H.S.

Minorities, the poor and survivors of abuse: HIV-infected patients in the US deep south

Journal of the Southern Medical Association

2007

100

11

1114-22

 

J. William Critchfield, Donna Lemongello, Digna H. Walker, Juan C. Garcia, David M. Asmuth, M.D., Richard B. Pollard, M.D., B. L. Shacklett

Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection

Virology

2007

81

11

5460-5471

 

Nimalie D. Stone, Shelia B. Dunaway, M.D., Charles Flexner, M.D., Camlin Tierney, Ph.D., Gary B. Calandra, Ph.D., M.D., F.A.C.P., Stephen L. Becker, M.D., Ying-Jun Cao, Ilene P. Wiggins, R.N., Jeanne Conley, R.N., B.S.N., Ron T. MacFarland, Ph.D., Jeong-Gun Park, Ph.D., Christina M. Lalama, M.S., Sally Snyder, B.S., Beatrice A. Kallungal, B.S., Karin L. Klingman, M.D., Craig Hendrix, M.D., M.C.

Multiple dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects

Antimicrobial Agents and Chemotherapy

2007

51

7

2351-8

 

Lois C. Howland, M.S., M.P.H., D.Ph., Deborah S. Storm, R.N.,Ph.D, Sybil Crawford, Ph.D., Yunsheng Ma, Ph.D., Steven Gortmaker, Ph.D., James M. Oleske, M.D.

Negative life events: risk to health-related quality of life in children and youth with HIV infection.

Journal of the Association of Nurses in AIDS Care

2007

18

1

3 - 11

17338981

ACTG 219C, DACS 604

Jane C. Lindsey, Sc.D., Kathleen Malee, Ph.D., Pim Brouwers, Ph.D., Michael Hughes, Ph.D.

Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease-inhibitor-based highly active antiretroviral therapy.

Pediatrics

2007

119

3

e681 - e693

17296781

ACTG 219C

Richard H. Haubrich, M.D., Hongyu Jiang, Ph.D., Ronald Swanstrom, Ph.D., Michael P. Bates, M.D., David Katzenstein, M.D., Leslie A. Petch, Ph.D., Courtney V. Fletcher, Pharm.D., Susan A. Fiscus, Ph.D., Roy (Trip) Gulick, M.D., M.P.H.

Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359

HIV Clinical Trials

2007

8

2

63-7

 

Courtney V. Fletcher, Pharm.D., Jaime G. Deville, M.D., Pearl Samson, M.S., John ( Jack ) Moye, Jr., M.D., Joseph A. Church, M.D., Hans ML Spiegel, M.D., Ph.D., Paul Palumbo, M.D., Terence Fenton, Ed.D., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., William T. Shearer, M.D., Ph.D.

Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.

Journal of Allergy and Clinical Immunology

2007

119

3

747 - 750

17336619

PMC1910693

ACTG 351

Joan X. Hu, Ph.D., Stephen W. Lagakos, Ph.D.

Nonparametric estimation of the mean function of a stochastic process with missing observations

Lifetime Data Analysis

2007

13

1

51-73

 

Nancy Radcliffe Reynolds, Ph.D., Junfeng Sun, Haikady N. Nagaraja, Ph.D., Allen L. Gifford, M.D., Albert W. Wu, M.D., M.P.H., Margaret A. Chesney, Ph.D.

Optimizing measurement of self-reported adherence with the ACTG adherence questionnaire: a cross-protocol analysis

Journal of Acquired Immune Deficiency Syndromes

2007

46

4

402-9

 

Susan Brogly, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, David E. Shapiro, Ph.D., Alice M. Stek, M.D., Ruth E. Tuomala, M.D.

Participation of HIV-infected pregnant women in research in the United States.

AIDS Research and Human Retroviruses

2007

23

1

51 - 53

17263632

P1025

 

Persistence of K103N-containing HIV-1 variants after single dose nevirapine for prevention of HIV-1 mother-to-child transmission

Journal of Infectious Diseases

2007

195

5

711-5

17262714

 

Mark J. Abzug, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Sharon Appelbaum Nachman, M.D., Myron Levin, M.D., Howard Max Rosenblatt, M.D., Stephen Ira Pelton, M.D., William Borkowsky, M.D.

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

Pediatrics

2007

120

5

e1190 - e1202

17938165

P1024

Francesca Aweeka, Pharm.D., Minhee Kang, M.S., Ph.D., Ji Young Yu, M.P.H., Patricia S. Lizak, B.S., Beverly L. Alston-Smith, M.D., Raymond T. Chung, M.D.

Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team

HIV Medicine

2007

8

5

288-94

 

Qing Ma, Ph.D., Alan Forrest, Ph.D., Susan L Rosenkranz, Ph.D., Michael F. Para, M.D., Kevin E. Yarasheski, Ph.D., Richard C. Reichman, M.D., Gene D. Morse, Pharm.D.

Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers

Biopharmaceutics & Drug Disposition

2007

29

2

91-101

 

Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Terence Fenton, Ed.D., Carmelita Alvero, Christine Powell, M.A., Lynne M. Mofenson, M.D., F.A.A.P., Stephen A. Spector, M.D.

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial.

Clinical Pharmacology & Therapeutics

2007

83

2

300-6

17609682

PMC2848440

ACTG 382

Jashvant D. Unadkat, Ph.D., Diane W. Wara, M.D., Michael Hughes, Ph.D., Anita A. Mathias, Ph.D., Diane Holland, M.Phil., Mary E. Paul, M.D., James D. Connor, M.D., Sharon Huang, M.S., Bach-Yen Nguyen, M.D., Heather D. Watts, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Paul Deutsch, M.D., Ph.D., Kathleen A. Kaiser, A.A.S., Ruth E. Tuomala, M.D.

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Antimicrobial Agents and Chemotherapy

2007

51

2

783 - 786

17158945

PMC1797783

ACTG 358

Mark Mirochnick, M.D., John H. Rodman, Pharm.D., Brian Robbins, Ph.D., Arnold Fridland, Ph.D., Jorge Gandia, M.D., Jane Hitti, M.D., M.P.H., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Mobeen H. Rathore, M.D., Adolfo Gonzalez-Garcia, M.D., Mae P. Cababasay, M.S., Pearl Samson, M.S., Lynne M. Mofenson, M.D., F.A.A.P., Yvonne J. Bryson, M.D., Alejandro Dorenbaum, M.D.

Pharmacokinetics of oral zidovudine administered during labor: a preliminary study.

HIV Medicine

2007

8

7

451-456

17760737

ACTG 324

Roy (Trip) Gulick, M.D., M.P.H., Zhaohui Su, Ph.D., Charles Flexner, M.D., Michael Hughes, Ph.D., Paul Skolnik, M.D., Timothy J. Wilkin, M.D., M.P.H., Robert Gross, M.D., M.S.C.E., Amy Krambrink, M.S., Eoin Coakley, M.D., Wayne Greaves, M.D., Andrew R. Zolopa, M.D., Richard C. Reichman, M.D., Catherine Godfrey, M.D., Martin S. Hirsch, M.D., Daniel R. Kuritzkes, M.D.

Phase 2 study of the safety and efficacy of Vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment-experienced patients: AIDS clinical trials group 5211

Journal of Infectious Diseases

2007

196

2

304-12

 

Savita G. Pahwa, M.D., Petronella Muresan, M.S., John W. Sleasman, M.D., Terence Fenton, Ed.D., John ( Jack ) Moye, Jr., M.D., Audra Deveikis, M.D., Diane W. Wara, M.D., Russell B. Van Dyke, M.D.

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

Journal of Allergy and Clinical Immunology

2007

119

6

1538 - 1541

17418382

ACTG 402

Adriana H. Tremoulet, Edmund Capparelli, Pharm.D., Pratima K. Patel, Edward P. Acosta, Pharm.D., Katherine Luzuriaga, M.D., Yvonne J. Bryson, M.D., Diane W. Wara, M.D., Diane Holland, M.Phil., Mark Mirochnick, M.D.

Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.

Antimicrobial Agents and Chemotherapy

2007

51

12

4297 - 7302

17893155

PMC2168008

DACS 609

Bruce R. Schackman, Ph.D., Callie A. Scott, B.A., Paul Edward Sax, M.D., Elena Losina, Timothy J. Wilkin, M.D., M.P.H., John Ernest McKinnon, M.D., Susan Swindells, M.B.B.S., Milton C. Weinstein, Kenneth A. Freedberg, M.D., M.Sc.

Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial

Clinical Infectious Diseases

2007

45

8

1062-70

 

Susan C. Morpeth, MB ChB, DTM&H, John A. Crump, MB ChB, DTM&H, Humphrey J. Shao, M.D., Habib O. Ramadhani, M.D., Peter R. Kisenge, M.D., MMED, Cindy A. Moylan, Susanna Naggie, L. Brett Caram, Keren Z. Landman, Noel E. Sam, Dafrosa K. Itemba, B.A., John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., Nathan Thielman, M.D., M.P.H.

Predicting CD4 lymphocyte count <200 cells/mm3 in an HIV type 1-infected African population

AIDS Research and Human Retroviruses

2007

23

10

1230-6

 

Michael J. Mugavero, M.D., M.H.S., Brian Wells Pence, Ph.D., Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Marvin Swartz, M.D., Dalene Stangl, Ph.D., Nathan Thielman, M.D., M.P.H.

Predictors of AIDS-related morbidity and mortality in a southern U.S. cohort

AIDS Patient Care and STDs

2007

21

9

681-90

17919095

 

Habib O. Ramadhani, M.D., Nathan Thielman, M.D., M.P.H., Keren Z. Landman, Evaline M. Ndosi, Feng Gao, Jennifer L. Kirchherr, Rekha Shah, Humphrey J. Shao, M.D., Susan C. Morpeth, MB ChB, DTM&H, Jonathan D. McNeill, John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., John A. Crump, MB ChB, DTM&H

Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania

Clinical Infectious Diseases

2007

45

11

1492-8

 

 

Predictors of stillbirth in sub-saharan Africa

Obstetrics and Gynecology

2007

110

5

989-97

17978109

 

Judith Silverstein Currier, M.D., M.Sc., Michelle A. Kendall, M.S., W. Keith Henry, M.D., Beverly L. Alston-Smith, M.D., Francesca J. Torriani, M.D., Pablo Tebas, M.D., Yanjie Li, Howard N. Hodis, M.D.

Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults

AIDS

2007

21

9

1137-45

 

Jane Hitti, M.D., M.P.H., Janet Andersen, Sc.D., Grace McComsey, M.D., Tun Liu, M.S., Ann J. Melvin, M.D., M.P.H., Laura M. Smith, M.P.H., Alice M. Stek, M.D., Judith A. Aberg, M.D., Andrew D. Hull, M.D., Beverly L. Alston-Smith, M.D., Heather D. Watts, M.D., Elizabeth Livingston, M.D.

Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS clinical trials group 5084

American Journal of Obstetrics and Gynecology

2007

196

4

331.e1-7

 

Robert H. Paul, Ph.D., Constantin Yiannoutsos, Ph.D., Eric N. Miller, Ph.D., Linda Chang, M.D., Christina M. Marra, M.D., Giovanni Schifitto, M.D., Thomas Ernst, Ph.D., Elyse J. Singer, M.D., Todd Richards, Jeffrey G. Jarvik, M.D., M.P.H., Richard W. Price, M.D., Dieter J. Meyerhoff, Dennis Kolson, M.D., Ph.D., Ronald J. Ellis, M.D.,Ph.D., G. Gonzalez, Robert Lenkinski, Ph.D., Ronald A. Cohen, Ph.D., ABPP, ABCN, Bradford A. Navia, M.D.

Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity

Journal of Neuropsychiatry and Clinical Neurosciences

2007

19

3

283-92

 

 

Quality assurance program for peripheral blood mononuclear cell cryopreservation

Clinical and Vaccine Immunology

2007

14

9

1242-1244

PMC2043300

 

Bruce R. Schackman, Ph.D., Heather Ribaudo, Ph.D., Amy Krambrink, M.S., Valery Hughes, F.N.P., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H.

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095

Journal of Acquired Immune Deficiency Syndromes

2007

46

5

547-54

18193496

 

Susan Brogly, Ph.D., Heather D. Watts, M.D., Nathalie Ylitalo, M.D., Ph.D., E. L. Franco, George Seage, III, Sc.D., M.P.H., James M. Oleske, M.D., Michelle L. Eagle, P.A.-C., Russell B. Van Dyke, M.D.

Reproductive health of adolescent girls perinatally infected with HIV.

American Journal of Public Health

2007

97

6

1047-1052

17463385

PMC1874205

ACTG 219C

Scott Evans, Ph.D., Tzu-min Yeh, Ned Sacktor, M.D., David B. Clifford, M.D., David M. Simpson, M.D., Eric N. Miller, Ph.D., Ronald J. Ellis, M.D.,Ph.D., Victor G. Valcour, M.D., Christina M. Marra, M.D., Linda L. Millar, B.S., Giovanni Schifitto, M.D.

Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090

HIV Clinical Trials

2007

8

6

437-46

 

Rui Wang, M.S., Stephen W. Lagakos, Ph.D., J. H. Ware, Deborah L. Hunter, J. Drazen

Statistics in medicine--reporting of subgroup analyses in clinical trials

New England Journal of Medicine

2007

357

21

2189-94

 

Pablo Tebas, M.D., Jiameng Zhang, Ph.D., Kevin E. Yarasheski, Ph.D., Scott Evans, Ph.D., Margaret A. Fischl, M.D., Abby Helen Shevitz, M.D., M.P.H., Judith Feinberg, M.D., Ann C. Collier, M.D., Cecilia M. Shikuma, M.D., Barbara Brizz, M.H.S.Ed., B.S.N., Fred Richard Sattler, M.D.

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels. Results of a prospective randomized trial (AIDS clinical trial group 5125s)

Journal of Acquired Immune Deficiency Syndromes

2007

45

2

193-200

 

Roger Paredes, Vincent C. Marconi, Thomas B. Campbell, M.D., Daniel R. Kuritzkes, M.D.

Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations

Journal of Virological Methods

2007

146

1-2

136-46

 

Joseph J. Eron, Jr., M.D., Ronald J. Bosch, Ph.D., Daniel Bettendorf, M.S., Michael P. Bates, M.D., Leslie A. Petch, Ph.D., Susan A. Fiscus, Ph.D., Ian Frank, M.D.

The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine

Journal of Acquired Immune Deficiency Syndromes

2007

45

2

249-51

 

Kevin R. Robertson, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Thomas D. Parsons, Ph.D., Kunling Wu, M.S., Ronald J. Bosch, Ph.D., Julia (Wei) Wu, M.S., Justin C. McArthur, M.B.B.S., M.P.H., Ann C. Collier, M.D., Scott Evans, Ph.D., Ronald J. Ellis, M.D.,Ph.D.

The prevalence and incidence of neurocognitive impairment in the HAART era

AIDS

2007

21

14

1915-21

 

Minhee Kang, M.S., Ph.D., Raymond T. Chung, M.D.

The role of early viral decline in the treatment of hepatitis C in HIV-1 coinfected persons [Letter to the Editor]

Journal of Acquired Immune Deficiency Syndromes

2007

46

3

371-3

 

David M. Margolis, M.D., Lisa Mukherjee, M.S., Courtney V. Fletcher, Pharm.D., Evelyn Hogg, B.A., Debra M. Ogata-Arakaki, R.N., Tianna Petersen, M.S., Dave H. Rusin, M.T. (A.S.C.P.), Ana I. Martinez, R.Ph., John W. Mellors, M.D.

The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection

AIDS

2007

21

15

2025-32

 

Ronald T. Mitsuyasu, M.D., Rebecca S. Gelman, Ph.D., Richard B. Pollard, M.D., Deborah Weng-Cherng, M.S., Alan Landay, Ph.D., John L. Fahey, M.D., Richard C. Reichman, M.D., Alejo Erice, M.D., R. Pat Bucy, M.D., Ph.D., J. Michael Kilby, M.D., Michael M. Lederman, M.D., Carol S. Dukes-Hamilton, M.D., Juan J.L. Lertora, M.D., Ph.D., Becky Stephenson, M.D., Pablo Tebas, M.D., Anne-Marie Duliege, M.D., M.S., Richard B. Pollard, M.D.

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328

Archives of Internal Medicine

2007

167

6

597-605

17389292

 

Wei Jiang, M.D., M.S., Michael M. Lederman, M.D., Clifford V. Harding, Benigno Rodriguez, M.D., Richard Mohner, B.S., Scott F. Sieg, Ph.D.

TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function

European Journal of Immunology

2007

37

8

2205-13

 

Jason T. Blackard, Ph.D., Minhee Kang, M.S., Ph.D., Benjamin St. Clair, Wenyu Lin, Yoshitaka Kamegaya, Kenneth E. Sherman, M.D., Ph.D., Margaret James Koziel, M.D., Marion G. Peters, M.D., Janet Andersen, Sc.D., Raymond T. Chung, M.D.

Viral factors associated with cytokine expression during HCV/HIV co-infection

Journal of Interferon and Cytokine Research

2007

24

7

263-9

 

Margaret James Koziel, M.D., Marion G. Peters, M.D.

Viral hepatitis in HIV infection

New England Journal of Medicine

2007

356

14

47-56

 

Zixin Hu, Ph.D., Hiroyu Hatano, M.D., M.H.S., Scott Hammond, Danielle Smith, B.S., Mary Wild, R.N., Soumi Gupta, Ph.D., Jeannette M. Whitcomb, Robert C Kalayjian, M.D., Barbara Gripshover, M.D., Daniel R. Kuritzkes, M.D.

Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase

Journal of Acquired Immune Deficiency Syndromes

2007

45

5

494-500

17496561

 

Paul Palumbo, M.D., Hulin Wu, Ph.D., Ellen Gould Chadwick, M.D., Ping Ruan, Ph.D., Katherine Luzuriaga, M.D., John H. Rodman, Pharm.D., Ram Yogev, M.D.

Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.

Journal of Infectious Diseases

2007

196

1

23-29

17538879

ACTG 345

Scott Evans, Ph.D.

When and how can endpoints be changed after initiation of a randomized clinical trial?

Public Library of Science Clinical Trials

2007

2

4

e18

 

Yangxin Huang, Ph.D., Hulin Wu, Ph.D.

A Bayesian approach for estimating antiviral efficacy in HIV dynamic models

Journal of Applied Statistics

2006

33

2

155-74

 

Molly Nozyce, Ph.D., Sophia S. Lee, M.S., Sophia S. Lee, M.S., Sharon Appelbaum Nachman, M.D., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Smith, R.N., Ram Yogev, M.D., Kenneth McIntosh, M.D., Kenneth Stanley, Ph.D., Stephen Ira Pelton, M.D.

A behavioral and cognitive profile of clinically stable HIV-infected children.

Pediatrics

2006

117

3

763-770

ACTG 338

E. Richard Stiehm, M.D., Richard B. Johnston, Jr.

A history of pediatric immunology.

Pediatric Research

2006

57

3

458-467

ACTG 076

 

A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission

AIDS

2006

20

9

1313-21

16816561

 

Giovanni Schifitto, M.D., Constantin Yiannoutsos, Ph.D., David M. Simpson, M.D., Christina M. Marra, M.D., Elyse J. Singer, M.D., Dennis Kolson, M.D., Ph.D., Avindra Nath, M.D., Joseph R. Berger, M.D., Bradford A. Navia, M.D.

A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy

Journal of Neurovirology

2006

12

4

328-31

16966223

 

Constance A. Benson, M.D., Florin Vaida, Ph.D., Diane V. Havlir, M.D., Gerald F. Downey, M.Sc., Michael M. Lederman, M.D., Roy (Trip) Gulick, M.D., M.P.H., Marshall Jay Glesby, M.D., Ph.D., Michael Wantman, Christian J. Bixby, B.S., Alex R. Rinehart, Ph.D., Sally Snyder, B.S., Rui Wang, M.S., Sheran Patel, D.O., John W. Mellors, M.D.

A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086

Journal of Infectious Diseases

2006

194

9

1309-18

 

J. Michael Kilby, M.D., R. Pat Bucy, M.D., Ph.D., Donna Mildvan, M.D., Margaret A. Fischl, M.D., Jorge L. Santana, M.D., Jeffrey L. Lennox, M.D., Christopher D. Pilcher, M.D., Andrew R. Zolopa, M.D., Jody Lawrence, M.D., Richard B. Pollard, M.D., Rafaelle El-Habib, Ph.D., David Sahner, M.D., Lawrence Fox, M.D., Ph.D., Evgenia Aga, M.Sc., Ronald J. Bosch, Ph.D., Ronald T. Mitsuyasu, M.D.

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

Journal of Infectious Diseases

2006

194

12

1672-6

17109338

 

Pachamuthu (Bala) Balakrishnan, Ph.D., Suniti (Daralak) Solomon, M.D., J. Mohanakrishnan, Anitha J. Cecelia, M.Sc., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., K. G. Murugavel, B. Venkatakrishnan, S. S. Solomon, S. M. Crowe, Aylur Kailasam Ganesh, A.C.A., B. Com., S. P. Thyagarajan, Timothy P. Flanigan, M.D., Kenneth H. Mayer, M.D.

A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

2006

43

1

23-6

 

L. Joseph Wheat, M.D., Patricia A. Connolly, M.S., Melinda L. Smedema, Michelle M. Durkin, Edward Brizendine, Paul Mann, Reena Patel, Paul McNicholas, Mitchell (Mitch) Goldman, M.D.

Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole

Journal of Antimicrobial Chemotherapy

2006

57

6

1235-9

16627592

 

Myron Levin, M.D., Anne A. Gershon, M.D., Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Barbara Nowak, B.A.

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.

Journal of Infectious Diseases

2006

194

2

247 - 255

16779732

ACTG 265

Adriana Weinberg, M.D., Philimon Gona, Ph.D., Sharon Appelbaum Nachman, M.D., Patricia Alexandra Defechereux, Ph.D., Ram Yogev, M.D., Walter T. Hughes, M.D., Diane W. Wara, M.D., Carol Elgie, B.S., Marlene A. Cooper, M.S., Wayne M. Dankner, M.D.

Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008

Journal of Infectious Diseases

2006

193

2

302-311

P1008

 

Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission

AIDS

2006

20

2

217-22

16511414

 

Nancy Radcliffe Reynolds, Ph.D., Judith Neidig, R.N., Ph.D., Albert W. Wu, M.D., M.P.H., Allen L. Gifford, M.D., William C. Holmes, M.D., M.S.C.E.

Balancing disfigurement and fear of disease progression: Patient perceptions of HIV body fat redistribution

AIDS Care

2006

18

7

663-73

16971273

 

Michael M. Lederman, M.D., Adam Penn-Nicholson, B.A., Michael Cho, Ph.D., Donald Mosier, Ph.D., M.D.

Biology of CCR5 and its role in HIV infection and treatment

The Journal of the American Medical Association

2006

296

7

815-26

16905787

 

Elias (Lou) K. Halvas, Ph.D., Grace M. Aldrovandi, MD, Peter Balfe, Ph.D., Ingrid A. Beck, M.S., Valerie F. Boltz, John Coffin, M.D., Lisa M. Frenkel, M.D., J. Darren Hazelwood, B.A., Victoria A. Johnson, M.D., Mary Kearney, Andrea Kovacs, M.D., Daniel R. Kuritzkes, M.D., Karin J. Metzner, Dwight V. Nissley, Marek J Nowicki, Ph.D., Sarah Palmer, Ph.D., Ranier Ziermann, Richard Y. Zhao, Cheryl L. Jennings, B.S., James W. Bremer, Ph.D., Donald J. Brambilla, Ph.D., John W. Mellors, M.D.

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency

Journal of Clinical Microbiology

2006

44

7

2612-4

 

Ronald J. Bosch, Ph.D., Rui Wang, M.S., Florin Vaida, Ph.D., Michael M. Lederman, M.D., Mary Albrecht, M.D.

Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment

Journal of Acquired Immune Deficiency Syndromes

2006

43

4

433-5

 

Andrew A. Wiznia, M.D., Kenneth Stanley, Ph.D., Paul Krogstad, M.D., George M. Johnson, M.D., Sophia S. Lee, M.S., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D., Brooks Jackson, M.D., M.B.A., Hermann A. Mendez, M.D., Rosaura M. Aguayo, M.D., Arry Dieudonne, M.D., Andrea Kovacs, M.D., Mahrukh Bamji, M.D., Elaine J. Abrams, M.D., Sohail R. Rana, M.D., John L. Sever, M.D., Ph.D., Sharon Appelbaum Nachman, M.D.

Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clin

AIDS Research and Human Retroviruses

2006

16

12

1113-1121

ACTG 377

 

Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.

Journal of Acquired Immune Deficiency Syndromes

2006

42

4

518-521

16810119

 

 

Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi

Sexually Transmitted Diseases

2006

33

10

604-9

16601659

PMC2743105

 

David Alain Wohl, M.D., Grace McComsey, M.D., Pablo Tebas, M.D., Todd T. Brown, M.D., Marshall Jay Glesby, M.D., Ph.D., Dominic N. Reeds, M.D., Cecilia M. Shikuma, M.D., Kathleen Mulligan, Ph.D., Michael P. Dube, M.D., David A. Wininger, M.D., Jeannie S. Huang, M.D., M.P.H., Manuel Revuelta, M.D., Judith Silverstein Currier, M.D., M.Sc., Susan Swindells, M.B.B.S., Carl J. Fichtenbaum, M.D., Michael T. Basar, B.S., Marisa T. Tungsiripat, M.D., William A. Meyer, III, Ph.D., James Weihe, M.D., Christine Wanke, M.D.

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy

Clinical Infectious Diseases

2006

43

5

645-53

 

Michael M. Lederman, M.D., Laura Smeaton, M.S., Kimberly Y. Smith, M.D., M.P.H., Benigno Rodriguez, M.D., Minya Pu, M.A., Hongying Wang, M.S., Anne Sevin, Ph.D., Pablo Tebas, M.D., Scott F. Sieg, Ph.D., Kathleen A. Medvik, B.S., M.T. (A.S.C.P.), David M. Margolis, M.D., Richard B. Pollard, M.D., Hildegund Ertl, Hernan Valdez, M.D.

Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138

Journal of Infectious Diseases

2006

194

12

1677-85

 

joke Snoeck, Rami Kantor, M.D., Robert Shafer, M.D., Kristel Van Laethem, Koen Deforche, Ana Patricia Carvalho, Brian Wynhoven, Marcelo A. Soares, Patricia Cane, John Clarke, Candice Pillay, Sunee Sirivichayakul, Koyo Ariyoshi, Africa Holgiun, Hagit Rudich, Rosangela Rodrigues, Maria Belen Bouzas, Francoise Brun-Vezinet, Caroline Reid, Pedro E. Cahn, M.D., Luis Fernando Brigido, Zehava Grossman, Vincent Soriano, Wataru Sugiura, Praphan Phanuphak, M.D., Ph.D., Lynn Morris, Jonathan Weber, Deenan Pillay, Amilcar Tanuri, Richard Harrigan, Ricardo Camacho, Jonathan M. Schapiro, David Katzenstein, M.D., Anne-Mieke Vandamme

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent

Antimicrobial Agents and Chemotherapy

2006

50

2

694-701

 

Rajesh Gandhi, M.D., John Spritzler, Sc.D., Ellen Chan, M.Sc., David M. Asmuth, M.D., Benigno Rodriguez, M.D., Thomas C. Merigan, Jr., M.D., Martin S. Hirsch, M.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Richard B. Pollard, M.D.

Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384

Journal of Acquired Immune Deficiency Syndromes

2006

42

4

426-34

 

Jason T. Blackard, Ph.D., Minhee Kang, M.S., Ph.D., Kenneth E. Sherman, M.D., Ph.D., Margaret James Koziel, M.D.

Effects of HCV treatment on cytokine expression during HCV/HIV coinfection

Journal of Interferon and Cytokine Research

2006

26

11

834-8

 

Yangxin Huang, Ph.D., Dongxiang Liu, Hulin Wu, Ph.D.

Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system

Biometrics

2006

62

2

413-23

 

Yumi Mitsuya, Mark A. Winters, M.S., W. Jeffrey Fessel, M.D., Soo-Yon Rhee, Sally Slome, M.S., Michael Horberg, Leo Hurley, Jason Flamm, M.D., Daniel Klein, M.D., Robert Shafer, M.D.

HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml

Journal of Acquired Immune Deficiency Syndromes

2006

43

1

56-59

 

Soo-Yon Rhee, Rami Kantor, M.D., David Katzenstein, M.D., Ricardo Camacho, Lynn Morris, Sunee Sirivichayakul, Luis Fernando Brigido, Jonathan M. Schapiro, Robert Shafer, M.D.

HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

AIDS

2006

20

5

643-51

 

Elizabeth (Betsy) J. McFarland, M.D., Daniel Johnson, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Georgia D. Tomaras, Ph.D., James McNamara, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Steven D. Douglas, M.D., Jaime G. Deville, M.D., Marc Gurwith, M.D., Sanjay Gurunathan, M.D., John S. Lambert, M.D.

HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.

AIDS

2006

20

11

1481 - 1489

ACTG 326

 

HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.

American Journal of Obstetrics and Gynecology

2006

195

4

1065-74

16875654

 

David W. Haas, M.D.

Human genetic variability and HIV treatment response

Current HIV/AIDS Reports

2006

3

2

53-8

 

Michael M. Lederman, M.D.

Immune success and immune failure in HIV infection: implications for therapeutic intervention

Journal of Acquired Immune Deficiency Syndromes

2006

42

Suppl 1

S8-9

 

Mark J. Abzug, M.D., Stephen Ira Pelton, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Myron Levin, M.D., Sharon Appelbaum Nachman, M.D., William Borkowsky, M.D., Howard Max Rosenblatt, M.D., John F. Marcinak, M.D., Arry Dieudonne, M.D., Elaine J. Abrams, M.D., Indu Pathak

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Pediatric Infectious Disease Journal

2006

25

10

920 - 929

17006288

P1024

Kumud K. Singh, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Stephen A. Spector, M.D.

Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S.

AIDS

2006

20

3

475-478

ACTG 152, ACTG 300

Brookie M. Best, Pharm.D., Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D., Alice M. Stek, M.D., Sandra K. Burchett, M.D., M.S., Diane Holland, M.Phil., Jennifer S. Read, M.D., M.P.H., M.S., Elizabeth Smith, M.D., Cheng Cheng Hu, Ph.D., Stephen A. Spector, M.D., James D. Connor, M.D.

Impact of pregnancy on abacavir pharmacokinetics.

AIDS

2006

20

4

553-560

P1026S

Susan Brogly, Ph.D., Paige L. Williams, Ph.D., George Seage, III, Sc.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Russell B. Van Dyke, M.D., James M. Oleske, M.D.

In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.

Journal of Acquired Immune Deficiency Syndromes

2006

41

4

535-536

ACTG 219C

Philimon Gona, Ph.D., Russell B. Van Dyke, M.D., Paige L. Williams, Ph.D., Wayne M. Dankner, M.D., Miriam Chernoff, Ph.D., Sharon Appelbaum Nachman, M.D., George Seage, III, Sc.D., M.P.H.

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

The Journal of the American Medical Association

2006

296

3

292 - 300

16849662

ACTG 219C

Benigno Rodriguez, M.D., Michael M. Lederman, M.D., Wei Jiang, M.D., M.S., Douglas A. Bazdar, Kristen Garate, Clifford V. Harding, Scott F. Sieg, Ph.D.

Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection

AIDS

2006

20

10

1379-89

 

Tracey King, Lane R. Bushman, B.Ch., Jennifer J. Kiser, Pharm.D., Peter Anderson, Pharm.D., M. Graham Ray, R.N., M.S.N., Tom Delahunty, Courtney V. Fletcher, Pharm.D.

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

2006

843

2006

147-56

 

M. Atif Siddique, Kelly E. Hartman, B.A., M.A.T., Elvira Dragileva, Marla Silman, M.S., Tebeb Gebretsadik, Ayumi Shintani, Laurence Peiperl, M.D., Fred T. Valentine, M.D., Spyros A. Kalams, M.D.

Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy

Journal of Infectious Diseases

2006

194

5

661-5

 

Jason M. Brenchley, David A. Price, Timothy Schacker, M.D., Tedi E. Asher, Guido Silvestri, M.D., Srinivas Rao, Zachary Kazzaz, Ethan Bornstein, Olivier Lambotte, Daniel Altmann, Bruce R. Blazar, Benigno Rodriguez, M.D., Lucileia Teixeira, Alan Landay, Ph.D., Jeffrey N. Martin, Frederick M. Hecht, M.D., Louis J. Picker, M.D., Michael M. Lederman, M.D., Steven G. Deeks, M.D., Daniel C Douek, M.D., Ph.D.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Nature Medicine

2006

12

12

1365-71

 

Alison A. Motsinger, Marylyn D. Ritchie, Ph.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Gene D. Morse, Pharm.D., Line Labbe, Ph.D., Grant R Wilkinson, Ph.D., D.Sc., David B. Clifford, M.D., Richard T. D'Aquila, M.D., Victoria A. Johnson, M.D., Richard B. Pollard, M.D., Thomas C. Merigan, Jr., M.D., Martin S. Hirsch, M.D., John P. Donahue, Richard B. Kim, M.D., David W. Haas, M.D.

Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study

Pharmacogenetics and Genomics

2006

16

11

837-45

 

Yumi Mitsuya, Mark A. Winters, M.S., W. Jeffrey Fessel, M.D., Soo-Yon Rhee, Leo Hurley, Michael Horberg, Celia A. Schiffer, Andrew R. Zolopa, M.D., Robert Shafer, M.D.

N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure

AIDS Research and Human Retroviruses

2006

22

12

1300-5

 

Michelle S. Cespedes, M.D., Judith A. Aberg, M.D.

Neuropsychiatric complications of antiretroviral therapy

Drug Safety

2006

29

10

865-74

 

Michelle Marcial, Jing Lu, M.S., Steven G. Deeks, M.D., Ranier Ziermann, Daniel R. Kuritzkes, M.D.

Performance of human immunodeficiency virus type 1 gp41 assays for detecting enfuvirtide (T-20) resistance mutations

Journal of Clinical Microbiology

2006

44

9

3384-7

 

Heather Ribaudo, Ph.D., David W. Haas, M.D., Camlin Tierney, Ph.D., Richard B. Kim, M.D., Grant R Wilkinson, Ph.D., D.Sc., Roy (Trip) Gulick, M.D., M.P.H., David B. Clifford, M.D., Catia Marzolini, Courtney V. Fletcher, Pharm.D., Karen T. Tashima, M.D., Daniel R. Kuritzkes, M.D., Edward P. Acosta, Pharm.D.

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study

Clinical Infectious Diseases

2006

42

3

401-7

 

Qing Yao, Ph.D.

Play the Winner for Phase II/III Clinical Trials.

Statistics In Medicine

2006

15

21-22

2413-2423

ACTG 076

Paige L. Williams, Ph.D., Deborah S. Storm, R.N.,Ph.D, Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Betsy Kammerer, Ph.D., Patricia Sirois, Ph.D., John J. Farley, M.D., M.P.H., Kathleen Malee, Ph.D.

Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.

Pediatrics

2006

118

6

e1745 - e1757

17101712

ACTG 219C, DACS 607

Grace M. Lee, Steven Gortmaker, Ph.D., Kenneth McIntosh, M.D., Michael Hughes, Ph.D., James M. Oleske, M.D.

Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment.

Pediatrics

2006

117

2

273-283

ACTG 219C

 

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

American Journal of Obstetrics and Gynecology

2006

42

5

610-3

16773030

 

Alice M. Stek, M.D., Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D., Brookie M. Best, Pharm.D., ChengCheng Hu, Ph.D., Sandra K. Burchett, M.D., M.S., Carol Elgie, B.S., Diane Holland, M.Phil., Elizabeth (Betsy) Smith, M.D., Ruth E. Tuomala, M.D., Amanda Cotter, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H

Reduced lopinavir exposure during pregnancy.

AIDS

2006

20

15

1931 - 1939

16988514

P1026S

Nathalie Ylitalo, M.D., Ph.D., Susan Brogly, Ph.D., Michael Hughes, Ph.D., Sharon Appelbaum Nachman, M.D., Wayne M. Dankner, M.D., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Archives of Pediatrics and Adolescent Medicine

2006

160

8

778 - 787

16894075

ACTG 219C

Karen Messer, Florin Vaida, Ph.D., Christine M. Hogan, M.D.

Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217

Contemporary Clinical Trials

2006

27

6

506-17

16962381

 

 

Sensitivity of the ViroSeqTM HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D

2006

8

4

430-2

16931582

PMC1867617

 

Kunjal Patel, D.Sc., M.P.H., Geoffrey A. Weinberg, M.D., Kate Buchacz, Ph.D., Kenneth McIntosh, M.D., Wayne M. Dankner, M.D., George Seage, III, Sc.D., M.P.H.

Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings.

Journal of Acquired Immune Deficiency Syndromes

2006

43

5

611 - 617

17003691

ACTG 219C

William T. Shearer, M.D., Ph.D., Jaime G. Deville, M.D., Pearl Samson, M.S., John ( Jack ) Moye, Jr., M.D., Courtney V. Fletcher, Pharm.D., Joseph A. Church, M.D., Hans ML Spiegel, M.D., Ph.D., Paul Palumbo, M.D., Terence Fenton, Ed.D., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., William C. Olson, Ph.D.

Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)

Journal of Allergy and Clinical Immunology

2006

118

2

518 - 521

16890780

ACTG 351

George Seage, III, Sc.D., M.P.H., Kate Buchacz, Ph.D., Geoffrey A. Weinberg, M.D., Kunjal Patel, D.Sc., M.P.H., Kenneth McIntosh, M.D., Wayne M. Dankner, M.D.

The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection.

Journal of Acquired Immune Deficiency Syndromes

2006

43

5

603 - 610

17003692

ACTG 219C

Akihiko Saitoh, K. K. Singh, Christine Powell, M.A., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D.

An MDRI-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children.

AIDS

2005

19

4

371-80

ACTG 382

Glenn Lopate, Alan Pestronk, M.D., Scott Evans, Ph.D., Lingling Li, David B. Clifford, M.D.

Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy

Neurology

2005

64

9

1632-4

 

W. Nicholas Haining, Donna S. Neuberg, Heather L. Keczkemethy, John W. Evans, Stephen Rivoli, Rebecca S. Gelman, Ph.D., Howard Max Rosenblatt, M.D., William T. Shearer, M.D., Ph.D., Javier Guenaga, Daniel C Douek, M.D., Ph.D., L. Silverman, Stephen E. Sallan, Eva C. Guinan, Lee M. Nadler

Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.

Blood

2005

106

5

1749-54

P1009

Patrice Severe, M.D., Paul Denis Leger, M.D., Macarthur Charles, M.D., Ph.D., Francine Noel, M.D., Jerry Eugene Joseph Bonhomme, M.D., Rose May Gyrlande Bois, M.D., Erik George, M.D., Stefan Kenel-Pierre, B.S., Peter Farnum Wright, M.D., Roy (Trip) Gulick, M.D., M.P.H., Warren D. Johnson, M.D., Jean William Pape, M.D., Daniel W. Fitzgerald, M.D.

Antiretroviral therapy in a thousand patients with AIDS in Haiti

New England Journal of Medicine

2005

353

22

2325-34

 

Susan Brogly, Ph.D., Paige L. Williams, Ph.D., George Seage, III, Sc.D., M.P.H., James M. Oleske, M.D., Russell B. Van Dyke, M.D., Kenneth McIntosh, M.D.

Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.

The Journal of the American Medical Association

2005

293

18

2213-2220

15886376

ACTG 219C

John S. Lambert, M.D., John ( Jack ) Moye, Jr., M.D., Susan Plaeger, Ph.D., E. Richard Stiehm, M.D., James Bethel, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Bonnie J. Mathieson, Ph.D., Jonathan Kagan, Ph.D., Howard Max Rosenblatt, M.D., Helene M.A. Paxton, M.S., M.T., Hildie Suter, B.S., Alan Landay, Ph.D.

Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.

Clinical and Diagnostic Laboratory Immunology

2005

12

5

622-631

ACTG 185

Esther J. Lee, Rami Kantor, M.D., Lynn Zijenah, Wayne Sheldon, Lynda Emel, Patrick Mateta, Elizabeth R. Johnston, Jennifer Wells, Avinash K. Shetty, Hoosen M. Coovadia, M.D., M.B.B.S., Yvonne (Bonnie) A. Maldonado, M.D., M.P.H., Samuel Adeniyi-Jones, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Christopher H. Contag, Mary Bassett, David Katzenstein, M.D.

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine

Journal of Infectious Diseases

2005

192

7

1260-4

 

Luis J. Montaner, D.Phil., James Alasdair McIntyre, M.D., Charles van der Horst, M.D., Ian M. Sanne, M.D., FCP (medicine), DTM&H

Change in US research policies and directives are needed to remove barriers on HIV-1 operational research programs in developing countries: A case report of two NIH clinical trials in South Africa

Harvard Health Policy Review

2005

6

1

114-123

 

Ronald J. Ellis, M.D.,Ph.D., Scott Evans, Ph.D., David B. Clifford, M.D., Lauren Moo, M.D., Justin C. McArthur, M.B.B.S., M.P.H., Ann C. Collier, M.D., Constance A. Benson, M.D., Ronald J. Bosch, Ph.D., David M. Simpson, M.D., Constantin Yiannoutsos, Ph.D., Yijun Yang, M.S., Sc.D., Kevin R. Robertson, Ph.D.

Clinical validation of the NeuroScreen

Journal of Neurovirology

2005

11

6

203-11

 

Walter T. Hughes, M.D., Wayne M. Dankner, M.D., Ram Yogev, M.D., Sharon Huang, M.S., Mary E. Paul, M.D., Midnela Acevedo Flores, Mark W. Kline, M.D., Lee-Jen Wei, Ph.D.

Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.

Clinical Infectious Diseases

2005

40

1

136-45

ACTG 254

Jie Zhang, M.S., Soo-Yon Rhee, Jonathan Taylor, Ph.D., Robert Shafer, M.D.

Comparison of the precision and sensitivity of the antivirogram and PhenoSense HIV drug susceptibility assays

Journal of Acquired Immune Deficiency Syndromes

2005

38

4

439-44

 

Eric S Daar, M.D., Douglas D. Richman, M.D.

Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance

AIDS Research and Human Retroviruses

2005

21

5

343-57

 

Linda M. Catanzaro, Gene D. Morse, Pharm.D.

Data from clinical trials

Journal of Acquired Immune Deficiency Syndromes

2005

38

Suppl 1

S26-S29

 

Robert Shafer, M.D., Jonathan M. Schapiro

Drug resistance and antiretroviral drug development

Journal of Antimicrobial Chemotherapy

2005

55

6

817-20

 

Thomas W. Yoo, Sharyne Donfield, Ph.D., Alice Lail, Henry S. Lynn, Eric S Daar, M.D.

Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease

Journal of Infectious Diseases

2005

191

1

4-10

 

Jennifer R. King, Pharm.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., Janice Hodge, R.N., B.S., Grace M. Aldrovandi, MD, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Andrew A. Wiznia, M.D., Bharat Damle, Ph.D., Edward P. Acosta, Pharm.D.

Efficacy, Tolerability and Pharmacokinetics of Two Nelfinavir-Based Regimens in Human Immunodeficiency Virus-Infected Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol 403

Pediatric Infectious Disease Journal

2005

24

10

880-885

ACTG 403

R.Allen White, David M. Asmuth, M.D., Ying Lu, Nan Wang, Xiao-Dong Li, Ph.D., isa Reece, Richard B. Pollard, M.D., Mostafa Nokta, M.D., Ph.D., James F. Leary, Nicholas H.A. Terry

Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry

Cytometry: The Journal of the Society for Analytical Cytology

2005

66

1

32-40

 

Chan Zeng, Samatha MaWhinney, Sc.D., Anna E. Baron, Elizabeth (Betsy) J. McFarland, M.D.

Evaluating ELISPOT summary measures with criteria for obtaining reliable estimates.

Journal of Immunological Methods

2005

297

1-2

97-108

ACTG 299

Rupinderjeet J. Kaur, V. Klichko, David M. Margolis, M.D.

Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy

AIDS Research and Human Retroviruses

2005

21

2

116-24

 

Susan Schuval, M.D., Jane C. Lindsey, Sc.D., Ph.D., Jack T. Stapleton, M.D., Russell B. Van Dyke, M.D., Paul Palumbo, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James M. Oleske, M.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Andrea Kovacs, M.D., Wayne M. Dankner, M.D., Elizabeth Smith, M.D., Barbara Nowak, B.A., Gregory Ciupak, B.A., Nancy Webb, M.S., Michelle L. Eagle, P.A.-C., Dorothy Smith, M.S., C.P.N.P., Dorothy Smith, M.S., C.P.N.P., Roslyn M. Hennessy, P.A.-C., M.S., Melissa G. Kerkau, B.S., Donna Klinzman, B.A., Georg Hess, Dietmar Zdunek, Myron Levin, M.D.

GB Virus C Infection in Children with Perinatal HIV-1 Infection

Pediatric Infectious Disease Journal

2005

24

5

417 - 422

15876940

ACTG 219C

Matthew C. Strain, Scott L. Letendre, M.D., Satish K. Pillai, T. Russell, Caroline Ignacio, Huldrych F. Gunthard, Benjamin Good, Davey M. Smith, M.D., Steven M. Wolinsky, M.D., Manohar Furtado, Ph.D., J. Marquie-Beck, J. Durelle, Irene H. Grant, M.D., Douglas D. Richman, M.D., T. Marcotte, J. Allen McCutchan, M.D., M.Sc., Ronald J. Ellis, M.D.,Ph.D., Joseph K. Wong, M.D.

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy

Journal of Virology

2005

79

3

1772-88

 

Kumud K. Singh, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Stephen A. Spector, M.D.

Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.

Journal of Infectious Diseases

2005

191

11

1971-80

ACTG 152, ACTG 300

Sharon Appelbaum Nachman, M.D., Jane C. Lindsey, Sc.D., John ( Jack ) Moye, Jr., M.D., Kenneth Stanley, Ph.D., George M. Johnson, M.D., Paul Krogstad, M.D., Andrew A. Wiznia, M.D.

Growth of HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Pediatric Infectious Disease Journal

2005

24

4

352-357

ACTG 377

Samir K. Gupta, M.D., Joseph A. Eustace, M.B., M.H.S., Jonathan A. Winston, M.D., Ivy I. Boydstun, M.D., Tejinder S. Ahuja, M.B.B.S., Rudolph Rodriguez, M.D., Karen T. Tashima, M.D., Michelle E. Roland, M.D., Nora Franceschini, M.D., M.P.H., Frank Palella, M.D., Jeffrey L. Lennox, M.D., Paul E. Klotman, M.D., Sharon Appelbaum Nachman, M.D., Stephen D Hall, Ph.D., Lynda Anne Szczech, M.D., M.S.C.E.

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Clinical Infectious Diseases

2005

40

11

1559-85

 

Pachamuthu (Bala) Balakrishnan, Ph.D., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Rami Kantor, M.D., Suniti (Daralak) Solomon, M.D., Kenneth H. Mayer, M.D., David Katzenstein, M.D., Bharat Ramratnam, M.D.

HIV type 1 genotypic variation in an antiretroviral treatement-naive population in Southern India

AIDS Research and Human Retroviruses

2005

21

4

301-5

 

Eric S Daar, M.D., Karen L. Kesler, Terri Wrin, Christos J. Petropoulos, Ph.D., Michael P. Bates, M.D., Alice Lail, Nicholas S. Hellmann, M.D., Edward Gomperts, M.D., Sharyne Donfield, Ph.D.

HIV-1 pol replication capacity predicts disease progression

AIDS

2005

19

9

871-7

 

Cecilia M. Shikuma, M.D., Victor G. Valcour, M.D., Silvia Ratto-Kim, Andrew Williams, Scott Souza, Pharm.D., Mariana Gerschenson, Ph.D., Larry Day, M.D., Jerome H. Kim, M.D., M.C., Bruce Shiramizu, M.D.

HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?

Clinical Infectious Diseases

2005

40

12

1846-8

 

Andrea Kovacs, M.D., Grace Montepiedra, Ph.D., Vincent J. Carey, Ph.D., Savita G. Pahwa, M.D., Adriana Weinberg, M.D., Lisa M. Frenkel, M.D., Edmund Capparelli, Pharm.D., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Kenneth McIntosh, M.D., Sandra K. Burchett, M.D., M.S.

Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.

Journal of Infectious Diseases

2005

192

2

296-302

ACTG 366

Bret J. Rudy, M.D., Jane C. Lindsey, Sc.D., Patricia M. Flynn, M.D., M.S., Ronald J. Bosch, Ph.D., Craig M. Wilson, M.D., Michael Hughes, Ph.D., Steven D. Douglas, M.D.

Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.

AIDS Research and Human Retroviruses

2005

22

3

213-221

ACTG 381

Howard Max Rosenblatt, M.D., Kenneth Stanley, Ph.D., Lin-Ye Song, Ph.D., George M. Johnson, M.D., Andrew A. Wiznia, M.D., Paul Krogstad, M.D., Sharon Appelbaum Nachman, M.D., Andrew A. Wiznia, M.D., Paul Krogstad, M.D., Sharon Appelbaum Nachman, M.D.

Immunological Response to Highly Active Antiretroviral Therapy in Children with Clinically Stable HIV-1 Infection.

Journal of Infectious Diseases

2005

192

3

445-55

ACTG 377

Mark Sharkey, Karine Triques, Daniel R. Kuritzkes, M.D., Mario Stevenson, Ph.D.

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA

Journal of Virology

2005

79

8

5203-10

 

Sudha S. Shankar, M.D., Michael P. Dube, M.D., J. Christopher Gorski, Ph.D., James E. Klaunig, Ph.D., M.D., Helmut O. Steinberg, M.D.

Indinavir impairs endothelial function in healthy HIV-negative men

American Heart Journal

2005

150

5

933

 

H. Kest, Susan Brogly, Ph.D., George D. McSherry, M.D., Barry Dashefsky, M.D., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H.

Malignancy in perinatally human immunodeficiency virus-infected children in the United States.

Pediatric Infectious Disease Journal

2005

24

3

237-242

ACTG 219C

David B. Clifford, M.D., Yijun Yang, M.S., Sc.D., Scott Evans, Ph.D.

Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection

Journal of Neurovirology

2005

11

Suppl 3

67-71

 

Rita J. Jeremy, Ph.D., Soyeon Kim, Ph.D., Molly Nozyce, Ph.D., Sharon Appelbaum Nachman, M.D., Kenneth McIntosh, M.D., Stephen Ira Pelton, M.D., Ram Yogev, M.D., Andrew A. Wiznia, M.D., George M. Johnson, M.D., Paul Krogstad, M.D., Kenneth Stanley, Ph.D.

Neuropsychological Functioning and Viral Load in Stable Antiretroviral Therapy-Experienced HIV-Infected Children.

Pediatrics

2005

115

2

380-387

ACTG 338, ACTG 377

Tim Roy Cressey, B.Sc., Ph.D., Gonzague A. Jourdain, M.D., Marc Lallemant, M.D., Suparat Kunkeaw, B.Sc., Brooks Jackson, M.D., M.B.A., Edmund Capparelli, Pharm.D., Philippa Musoke, MB ChB, Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D., Mark Mirochnick, M.D.

Persistence of Nevirapine Exposure During the Postpartum Period After Intrapartum Single Dose Nevirapine In Addition to Zidovudine Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV-1.

Journal of Acquired Immune Deficiency Syndromes

2005

38

3

283-288

ACTG 250

S. A. McGhee, B. Kaska, Myron Liebhaber, E. Richard Stiehm, M.D.

Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin.

Pediatric Infectious Disease Journal

2005

24

3

272-274

ACTG 185

Andrea Kovacs, M.D., Mary K. Cowles, Ph.D., Paula Britto, M.S., Edmund Capparelli, Pharm.D., Mary Glenn Fowler, M.D., M.P.H., Rita J. Jeremy, Ph.D., John ( Jack ) Moye, Jr., M.D., Kenneth McIntosh, M.D., Mobeen H. Rathore, M.D., Jane Pitt, M.D., Robert Husson, M.D.

Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to ZDV during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.

Pediatric Infectious Disease Journal

2005

24

6

503-509

ACTG 239

John J. Farley, M.D., M.P.H., Philimon Gona, Ph.D., Marilyn Jean Crain, M.P.H., M.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., James M. Oleske, M.D., George Seage, Sc.D., M.P.H., Jane C. Lindsey, Sc.D., Ph.D.

Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years) in PACTG 219C.

Journal of Acquired Immune Deficiency Syndromes

2005

38

4

480-487

ACTG 219C

Deborah S. Storm, R.N.,Ph.D, Mary D. Boland, R.N., M.S.N, D.P.H., Steven Gortmaker, Ph.D., Yan He, M.S., Joan H. Skurnick, Lois C. Howland, M.S., M.P.H., D.Ph., James M. Oleske, M.D.

Protease inhibitor combination therapy, severity of illness, and quality of life in children with perinatally acquired HIV-1 infection

Pediatrics

2005

115

2

e173-e182

ACTG 219C

Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Snigdha Vallabhaneni, B.A., Timothy P. Flanigan, M.D., Pachamuthu (Bala) Balakrishnan, Ph.D., Anitha J. Cecelia, M.Sc., Charles Carpenter, M.D., Suniti (Daralak) Solomon, M.D., Kenneth H. Mayer, M.D.

Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients

AIDS

2005

19

6

625-7

 

Ellen Gould Chadwick, M.D., John H. Rodman, Pharm.D., Paula Britto, M.S., Christine Powell, M.A., Paul Palumbo, M.D., Katherine Luzuriaga, M.D., Michael Hughes, Ph.D., Elaine J. Abrams, M.D., Patricia M. Flynn, M.D., M.S., William Borkowsky, M.D., Ram Yogev, M.D.

Ritonavir-Based Highly Active Antiretroviral Therapy In HIV-1 Infected Infants <24 Months of Age.

Pediatric Infectious Disease Journal

2005

24

9

793 - 800

ACTG 345

Scott F. Sieg, Ph.D., Benigno Rodriguez, M.D., Robert Asaad, M.D., Wei Jiang, M.D., M.S., Douglas A. Bazdar, Michael M. Lederman, M.D.

S phase lymphocytes in HIV disease have a central memory phenotype and rarely have evidence for recent T cell receptor engagement

Journal of Infectious Diseases

2005

192

 

67-70

 

Daniel Johnson, M.D., Elizabeth (Betsy) J. McFarland, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., James McNamara, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Elizabeth Hawkins, Pamela Bouquin, B.A., Scharla Estep, M.S., R.Ph., Georgia D. Tomaras, Ph.D., Carol A. Vincent, C.R.N.P., M.S.N, Mobeen H. Rathore, M.D., Ann J. Melvin, M.D., M.P.H., Sanjay Gurunathan, M.D., John S. Lambert, M.D.

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.

Journal of Infectious Diseases

2005

192

12

2129-2133

ACTG 326

Mark Mirochnick, M.D., Alice M. Stek, M.D., Midnela Acevedo, M.D., M.T., Margaret A. Keller, M.D., Diane Holland, M.Phil., Edmund Capparelli, Pharm.D., James D. Connor, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Yvonne J. Bryson, M.D.

Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life

Journal of Acquired Immune Deficiency Syndromes

2005

39

2

189-194

ACTG 353

Lynn Zijenah, Ocean Tabaiwa, B.Sc., Simbarashe Rusakaniko, Ph.D., Kusum J. Nathoo, M.D., Margaret Nhembe, R.N., Petronella Matibe, R.N., David Katzenstein, M.D.

Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years

Journal of Acquired Immune Deficiency Syndromes

2005

39

4

391-4

 

Hulin Wu, Ph.D.

Statistical methods for HIV dynamic studies in AIDS clinical trials

Statistical Methods In Medical Research

2005

14

2

171-92

 

Stephen Ira Pelton, M.D., Kenneth Stanley, Ph.D., Ram Yogev, M.D., Courtney V. Fletcher, Pharm.D., Kenneth McIntosh, M.D., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D.

Switch from Ritonavir to Indinavir Combination Therapy for HIV-Infected Children.

Clinical Infectious Diseases

2005

40

8

1181-1187

ACTG 338

Howard Max Rosenblatt, M.D., Lin-Ye Song, Ph.D., Sharon Appelbaum Nachman, M.D., Kenneth Stanley, Ph.D., Paul Krogstad, M.D., George M. Johnson, M.D., Andrew A. Wiznia, M.D.

Tetanus immunity after diptheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection.

Journal of Allergy and Clinical Immunology

2005

116

3

698-703

ACTG 377

Sharon Appelbaum Nachman, M.D., Philimon Gona, Ph.D., Wayne M. Dankner, M.D., Adriana Weinberg, M.D., Ram Yogev, M.D., Anne A. Gershon, M.D., Mobeen H. Rathore, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Sharon Huang, M.S., Carol Elgie, B.S., Kimberly Hudgens, MSHCA, M.B.A., Walter T. Hughes, M.D.

The rate of serious bacterial infection among HIV-infected children with immune reconstitution who have discontinued Opportunistic Infection prophylaxis.

Pediatrics

2005

115

4

e488-e494

P1008

Valentina Stosor, Frank Palella, M.D., Baiba Berzins, M.P.H., Michelle Till, M.D., Angel Leake, Joan S. Chmiel, Robert L. Murphy, M.D.

Transient viremia in HIV-infected patients and use of plasma preparation tubes

Clinical Infectious Diseases

2005

14

 

1671-4

 

Katherine Ruiz Luzuriaga, M.D., Margaret McManus, B.S., Lynne M. Mofenson, M.D., F.A.A.P., Paula Britto, M.S., Bobbie Graham, B.S., John L. Sullivan, M.D.

A trial of three antiretroviral regimens in HIV-1 Infected Children

New England Journal of Medicine

2004

350

24

2471-80

ACTG 356

Philip M. Polgreen, S. L. Fultz, Amy C. Justice, M.D.,Ph.D., Joyce Wagner, D. J. Diekema, Linda Rabeneck, M.D., M.P.H., Sharon Weissman, M.D., Jack T. Stapleton, M.D.

Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people

HIV Medicine

2004

5

3

144-50

 

Anish P. Mahajan, M.D., M.P.H., Joseph W. Hogan, Sc.D., Brad Snyder, M.S., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Kalindi Mehta, M.D., Suniti (Daralak) Solomon, M.D., Charles Carpenter, M.D., Kenneth H. Mayer, M.D., Timothy P. Flanigan, M.D.

Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

2004

36

1

567-75

 

Michael L. Lim, Pharm.D., Sherene S. Min, Joseph J. Eron, Jr., M.D., Richard J. Bertz, Ph.D., Marjorie Robinson, Pharm.D., Andrea Gaedigk, Ph.D., Angela D.M. Kashuba, Pharm.D.

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

Journal of Acquired Immune Deficiency Syndromes

2004

36

5

1034-40

 

Jennifer A. Mitty, M.D., M.P.H., Timothy P. Flanigan, M.D.

Community-based interventions for marginalized populations

Clinical Infectious Diseases

2004

38

Suppl 5

S373-5

 

W. Keith Henry, M.D., Richard Brundage, Pharm.D., Ph.D., Dennis Weller, Omobosola Akinsete, M.D., Anita Shet

Comparison of generic zidovudine + lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets

Journal of Acquired Immune Deficiency Syndromes

2004

35

5

537

 

Manuel Revuelta, M.D.

Cumulative insults to mitochondrial function may promote the emergence of 'syndrome X' and diabetes mellitus in HIV/HCV co-infected patients

Mitochondrion

2004

4

2-3

175-84

 

Ulrich A. Walker, J. Bauerle, M. Laguno, J. Murillas, Stefan Mauss, M.D., G. Schmutz, B. Setzer, R. Miquel, Jose M. Gatell Artigas, M.D., Ph.D., J. Mallolas

Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine

Hepatology

2004

39

2

311-7

 

Jeff Dubuisson, B.S., Jennifer R. King, Pharm.D., Jeffrey S.A. Stringer, M.D., Michele L. Turner, B.S., Chantelle Bennetto-Hood, Ph.D., Edward P. Acosta, Pharm.D.

Detection of nevirapine in plasma using thin-layer chromatography

Journal of Acquired Immune Deficiency Syndromes

2004

35

2

155-7

 

Linda M. Catanzaro, J. C. Slish, Robert DiCenzo, Pharm.D., Gene D. Morse, Pharm.D.

Drug interactions with antiretrovirals

Current HIV/AIDS Reports

2004

1

2

89-96

 

Uma Malhotra, M.D., Ronald J. Bosch, Ph.D., Rui Wang, M.S., Ann C. Collier, M.D., Julie McElrath, M.D., Ph.D.

Effect of adjunct hydroxyurea on helper T cell immunity in HIV type 1-infected patients with virological suppression

AIDS Research and Human Retroviruses

2004

20

8

807-12

 

Chantelle Bennetto-Hood, Ph.D., Jennifer R. King, Pharm.D., Michele L. Turner, B.S., Jeffrey S.A. Stringer, M.D., Edward P. Acosta, Pharm.D.

Effects of concentration and temperature on the stability of nevirapine in whole blood and serum

Clinical Chemistry

2004

50

1

209-11

 

Edward P. Acosta, Pharm.D., Ellen Gould Chadwick, M.D., Ram Yogev, M.D., Marilyn Jean Crain, M.P.H., M.D., Robert F. Pass, M.D., David W. Kimberlin, Marsha S. Sturdevant, Grace M. Aldrovandi, MD

Evaluation of Multiple Drug Salvage Therapy in HIV-1 Infected Pediatric Patients

Progress in Allergy and Clinical Immunology

2004

22

3

239-44

P1007

Daniel K. Benjamin, Jr., William C. Miller, Robin W. Ryder, M.D., M.Sc., E. Walter, Ross E. McKinney, Jr., M.D.

Growth Patterns Reflect Responses to Antiretroviral Therapy in HIV-Positive Infants: Potential in Resource-Poor Settings

AIDS Patient Care and STDs

2004

18

1

35-43

ACTG 300

Vincent J. Carey, Ph.D., Florence H. Yong, M.S., Lisa M. Frenkel, M.D., Ross E. McKinney, Jr., M.D.

Growth Velocity Assessment In Paediatric AIDS: Smoothing, Penalized Quantile Regression And The Definition Of Growth Failure.

Statistics In Medicine

2004

23

3

509-26

ACTG 144, ACTG 152, ACTG 240, ACTG 245, DACS 059

Caroline Chantry, M.D., Janet Ailene Englund, M.D., Carol J. Baker, M.D., Ross E. McKinney, Jr., M.D.

Growth, survival and viral load in symptomatic childhood human immunodefiency virus infection.

Pediatric Infectious Disease Journal

2004

22

12

1033-1039

ACTG 152

Susan Schuval, M.D., Russell B. Van Dyke, M.D., Jane C. Lindsey, Sc.D., Ph.D., Paul Palumbo, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James M. Oleske, M.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Andrea Kovacs, M.D., Wayne M. Dankner, M.D., Barbara Nowak, B.A., Roslyn M. Hennessy, P.A.-C., M.S., Gregory Ciupak, B.A., Elizabeth Smith, M.D., Melissa G. Kerkau, B.S., Myron Levin, M.D.

Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.

Archives of Pediatrics and Adolescent Medicine

2004

158

10

1007-1013

ACTG 219C

Richard A. Zuckerman, William L.H. Whittington, Connie Celum, M.D., Tarquin Collis, Aldo J. Lucchetti, M.D., Jorge L. Sanchez, M.D., M.P.H., James P. Hughes, Jose L. Sanchez, Robert W. Coombs, M.D., Ph.D.

Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy

Journal of Infectious Diseases

2004

190

1

156-61

 

Donna Mildvan, M.D., Ronald J. Bosch, Ph.D., Ryung Suk Kim, B.S., John Spritzler, Sc.D., David W. Haas, M.D., Daniel R. Kuritzkes, M.D., Jonathan Kagan, Ph.D., Mostafa Nokta, M.D., Ph.D., Victor DeGruttola, Sc.D., Melanie Moreno, M.A., Alan Landay, Ph.D.

Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response

Journal of Infectious Diseases

2004

189

10

1811-20

 

Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Sreekanth K. Chaguturu, Kenneth H. Mayer, M.D., Suniti (Daralak) Solomon, M.D., Tokugha Yepthomi, M.B.B.S., Pachamuthu (Bala) Balakrishnan, Ph.D., Timothy P. Flanigan, M.D.

Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India

Journal of Acquired Immune Deficiency Syndromes

2004

37

5

1574-6

 

Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Terrence Fenton, Ed.D., Stephen A. Spector, M.D., Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D.

Intrapatient Variability of Efavirenz Concentrations as a Predictor of Virologic Response to Antiretroviral Therapy

Antimicrobial Agents and Chemotherapy

2004

48

3

979-984

ACTG 382

Joseph A. Church, M.D., Michael Hughes, Ph.D., Paul Palumbo, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Patricia Mastrodonato DeLora, Elizabeth (Betsy) Smith, M.D., Andrew A. Wiznia, M.D., Elizabeth Hawkins, Prakash Sista, Ph.D., Coleen K. Cunningham, M.D.

Long-Term Tolerability and Safety of Enfuvirtide for HIV-1 Infected Children.

Pediatric Infectious Disease Journal

2004

23

8

713-8

P1005

Akihiko Saitoh, Christine Powell, M.A., Terrence Fenton, Ed.D., Steven Douglas, M.D., Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D.

Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in children

Journal of Infectious Diseases

2004

 

189

1216-20

ACTG 382

Hitti, Jane MD, Lisa M. Frenkel, M.D., Stek, Alice M. MD, Sharon Huang, M.S., Nachman, Sharon A. MD, Lee-Jen, Wei PhD, Baker, David MD, Stevens, Laura M. BS, Gonzalez-Garcia, Adolfo MD, Watts, Heather D. MD, Provisor, Arthur MD, McNamara, James MD, Thorpe, Edwin M. MD, Paul, Mary E. MD, Foca, Marc MD, Gandia, Jorge MD, Huang, Sharon MS, Lee-Jen Wei, Ph.D., Laura M. Smith, M.P.H., Heather D. Watts, M.D., James McNamara, M.D.

Maternal Toxicity with Continuous Nevirapine in Pregnancy: Results from PACTG 1022.

Journal of Acquired Immune Deficiency Syndromes

2004

36

3

772-776

P1022

Janet Ailene Englund, M.D., Claire Raskino, M.S., Cindy L. Vavro, Carol J. Baker, M.D., Paul Palumbo, M.D., Lisa L. Ross, Ross E. McKinney, Jr., M.D., Ross E. McKinney, Jr., M.D., Robin C. Colgrove, Divna Nikolic-Djokic, M.D., Robin C. Colgrove

Mutations Linked to Drug Resistance, HIV Biological Phenotype, and their Association with Disease Progression in HIV-Infected Children Receiving Nucleoside Reverse Transcriptase Inhibitors.

Pediatric Infectious Disease Journal

2004

23

1

15-22

ACTG 152

Susan H. Eshleman, M.D., PH.D., John Hackett, Jr., Priscilla Swanson, Shawn P. Cunningham, B.S., M.T., Sushil G. Devare, Catherine Brennan, Birgit Drews, Leopold Zekeng, Lazare Kaptue

Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains

Journal of Clinical Microbiology

2004

42

6

2711-7

 

Nancy Wade, M.D., M.P.H., Jashvant D. Unadkat, Ph.D., Sharon Huang, M.S., David E. Shapiro, Ph.D., Anita Mathias, Salih Yasin, M.D., Gregory Ciupak, B.A., Salih Yasin, M.D., Gregory Ciupak, B.A., Heather D. Watts, M.D., Heather D. Watts, M.D., Issac Delke, M.D., Mobeen H. Rathore, M.D., Jane Hitti, M.D., M.P.H., Lisa M. Frenkel, M.D., Renee Samelson, M.D., Elizabeth Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Sandra K. Burchett, M.D., M.S.

Pharmacokinetics and Safety of d4T in Combination with 3TC in HIV-infected Pregnant Women and Their Infants: Pediatric AIDS Clinical Trials Group Protocol 332.

Journal of Infectious Diseases

2004

190

12

2167-74

ACTG 332

Nancy Wade, M.D., M.P.H., Jashvant D. Unadkat, Ph.D., Sharon Huang, M.S., David E. Shapiro, Ph.D., Anita A. Mathias, Ph.D., Salih Yasin, M.D., Gregory Ciupak, B.A., Heather D. Watts, M.D., Issac Delke, M.D., Mobeen H. Rathore, M.D., Jane Hitti, M.D., M.P.H., Renee Samelson, M.D., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Sandra K. Burchett, M.D., M.S.

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332

Journal of Infectious Diseases

2004

190

12

2167-74

ACTG 332

Edward P. Acosta, Pharm.D., Arlene D. Bardeguez, M.D., F.A.C.O.G., M.P.H., Carmen D. Zorrilla, M.D., Russell B. Van Dyke, M.D., Michael Hughes, Ph.D., Sharon Huang, M.S., Alice M. Stek, M.D., Jane Pitt, M.D., Heather Watts, M.D., Elizabeth Smith, M.D., Eleanor Jimenez, M.D., F.A.A.P., Lynne M. Mofenson, M.D., F.A.A.P.

Pharmacokinetics of Saquinavir Plus Low-Dose Ritonavir in HIV-Infected Pregnant Women.

Antimicrobial Agents and Chemotherapy

2004

48

2

430-436

ACTG 386

Kumud K. Singh, Charlene F. Barroga, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Claire Raskino, M.S., Ross E. McKinney, Jr., M.D., Stephen A. Spector, M.D.

Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the U.S.

AIDS

2004

35

3

309-313

ACTG 152, ACTG 300

Denise Gaughan, M.P.H., Michael Hughes, Ph.D., James M. Oleske, M.D., Kay Malee, Ph.D., Carol Gore, Sharon Appelbaum Nachman, M.D.

Psychiatric hospitalizations among children and youths with HIV infection

Pediatrics

2004

113

6

e44-e551

15173535

ACTG 219C

Hulin Wu, Ph.D., Janet L. Lathey, Ph.D., Ping Ruan, Ph.D., Steven D. Douglas, M.D., Stephen A. Spector, M.D., Jane C. Lindsey, Sc.D., Michael Hughes, Ph.D., Bret J. Rudy, M.D., Patricia M. Flynn, M.D., M.S.

Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy (HAART) in adolescents (age 12-22 years) infected through high-risk behavior.

Journal of Infectious Diseases

2004

189

4

593-601

ACTG 381

Jennifer R. King, Pharm.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., Janice Hodge, R.N., B.S., Grace M. Aldrovandi, MD, Bharat Damle, Ph.D., Elizabeth (Betsy) Smith, M.D., Andrew A. Wiznia, M.D., Edward P. Acosta, Pharm.D.

Single Dose Pharmacokinetic of Enteric-Coated Didanosine in HIV-Infected Children

Antiviral Therapy

2004

7

4

267-70

ACTG 403

Coleen K. Cunningham, M.D., Rajalaksh Balasubramanian, Sc.D., Issac Delke, M.D., Robert T. Maupin, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., Alejandro Dorenbaum, M.D., John L. Sullivan, M.D., Adolfo Gonzalez-Garcia, M.D., Edwin M. Thorpe, Jr., M.D., Richard D. Gelber, Ph.D.

The impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the U.S. in Pediatric AIDS Clinical Trials Group Protocol

Journal of Acquired Immune Deficiency Syndromes

2004

36

3

800-807

ACTG 316

Patricia M. Flynn, M.D., Bret J. Rudy, M.D., Steven Douglas, M.D., Janet L. Lathey, Ph.D., Stephen A. Spector, M.D., Margarita Silio, M.D., Marvin Eric Belzer, M.D., Lawrence S. Friedman, M.D., Lawrence D'Angelo, M.D., M.P.H., Audrey S. Rogers, Ph.D., M.P.H., James McNamara, M.D., Janice Hodge, R.N., B.S., Michael Hughes, Ph.D., Jane C. Lindsey, Sc.D.

Virologic and immunologic outcomes after 24 weeks in HIV-1 infected adolescents on highly active antiretroviral therapy.

Journal of Infectious Diseases

2004

190

2

271-9

ACTG 381

Patricia Lani Lee, Ph.D., Constantin Yiannoutsos, Ph.D., Thomas Ernst, Ph.D., Linda Chang, M.D., Christina M. Marra, M.D., Jeffrey G. Jarvik, M.D., M.P.H., Todd Richards, Edmund Kwok, Dennis Kolson, M.D., Ph.D., David M. Simpson, M.D., Cheuk Tang, Giovanni Schifitto, M.D., Leena Ketonen, Dieter J. Meyerhoff, Robert Lenkinski, Ph.D., Bradford A. Navia, M.D., R.Gilberto Gonzalez, M.D., Ph.D.

A multi-center H MRS study of the AIDS dementia complex: validation and preliminary analysis

Journal of Magnetic Resonance Imaging

2003

17

6

625-33

 

Robert M. Grant, M.D., Daniel R. Kuritzkes, M.D., Victoria A. Johnson, M.D., John W. Mellors, M.D., John L. Sullivan, M.D., Ronald Swanstrom, Ph.D., Richard T. D'Aquila, M.D., Mark Van Gorder, Mark Holodniy, M.D., Robert M. Lloyd, Jr., Caroline Reid, Gillian F. Morgan, Dean L. Winslow, M.D.

Accuracy of the TRUGENE HIV-1 genotyping kit

Journal of Clinical Microbiology

2003

41

4

1586-93

 

Christina M. Marra, M.D., D. Lockhart, M.S., J. R. Zunt, M.D., Margot Perrin, R.N., B.S.N., Robert W. Coombs, M.D., Ph.D., Ann C. Collier, M.D.

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

Neurology

2003

60

8

1388-90

 

Kate Buchacz, M.P.H., Ph.D., A. D. Rogol, Jane C. Lindsey, Sc.D., Ph.D., Craig M. Wilson, M.D., Michael Hughes, Ph.D., George Seage, Sc.D., M.P.H., James M. Oleske, M.D., Audrey S. Rogers, Ph.D., M.P.H.

Delayed onset of pubertal development in children and adolescents with perinatally acquired human immunodeficiency virus (HIV) infection.

Journal of Infectious Diseases

2003

33

1

56-65

12792356

ACTG 219

Winston Cavert, M.D., Henry H. Balfour, Jr., M.D.

Detection of antiretroviral resistance in HIV-1

Clinics in Laboratory Medicine

2003

23

4

915-28

 

Joseph I. Harwell, M.D., Timothy P. Flanigan, M.D., Jennifer A. Mitty, M.D., M.P.H., Angela Caliendo, M.D., Ph.D., Jessica Ingersoll, M.S., Molly Stenzel, M.D., Charles Carpenter, M.D., Susan Cu-Uvin, M.D.

Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence

AIDS

2003

17

13

1990-3

 

Grace McComsey, M.D., Heather Southwell, M.S., R.D., Barbara Gripshover, M.D., Robert A. Salata, M.D., Hernan Valdez, M.D.

Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy

Journal of Acquired Immune Deficiency Syndromes

2003

33

5

605-7

 

Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., David E. Shapiro, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Robert W. Coombs, M.D., Ph.D., Lisa M. Frenkel, M.D., Mary Glenn Fowler, M.D., M.P.H., Sharon Huang, M.S., Rhoda S. Sperling, M.D., Bethann Cunningham, B.S., Jorge Gandia, M.D., Robert T. Maupin, Jr., M.D., Carmen D. Zorrilla, M.D., Theodore Benjamin Jones, M.D., F.A.C.O.G., Mary Jo O'Sullivan, M.D.

Effect of cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival.

Journal of Acquired Immune Deficiency Syndromes

2003

32

2

170-181

ACTG 288

Sharon Lynn Walmsley, M.D., W. Keith Henry, M.D., Christine Katlama, Mark Nelson, M.D., Antonella Castagna, Jacques Reynes, Ph.D., Bonaventura Clotet, M.D., Ph.D., James Hui, Miklos P. Salgo, M.D., Ph.D., Ralph A. DeMasi, Ph.D., John Delehanty, Ph.D.

Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide

Journal of Infectious Diseases

2003

188

12

1827-33

 

Jay Lalezari, M.D., W. Keith Henry, M.D., Mary O'Hearn, M.D., Julio S.G. Montaner, M.D., Peter J. Piliero, M.D., Benoit Trottier, M.D., Sharon Lynn Walmsley, M.D., Calvin J. Cohen, M.D., M.Sc., Daniel R. Kuritzkes, M.D., Joseph J. Eron, Jr., M.D., Jain Chung, Ph.D., Ralph A. DeMasi, Ph.D., Lucille Donatacci, M.S., Claude Drobnes, M.D., John Delehanty, Ph.D., Miklos P. Salgo, M.D., Ph.D.

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

New England Journal of Medicine

2003

384

22

2175-85

 

Richard A. Zuckerman, William L.H. Whittington, Connie Celum, M.D., Tarquin Collis, Aldo J. Lucchetti, M.D., Jorge L. Sanchez, M.D., M.P.H., James P. Hughes, Robert W. Coombs, M.D., Ph.D.

Factors associated with oropharyngeal human immunodeficiency virus shedding

Journal of Infectious Diseases

2003

188

1

142-5

 

Jack T. Stapleton, M.D.

GB virus type C/hepatitis G virus

Seminars in Liver Disease

2003

23

2

137-48

 

Philip M. Polgreen, Jinhua Xiang, Qing Chang, Jack T. Stapleton, M.D.

GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals

Microbes and Infection

2003

5

13

1255-61

 

Mario Cozzolino, Marcos Vidal, Maria Vittoria Arcidiacono, Pablo Tebas, M.D., Kevin E. Yarasheski, Ph.D., Adriana S. Dusso

HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D

AIDS

2003

17

4

513-20

 

C. Soh, James M. Oleske, M.D., Michael T. Brady, M.D., Stephen A. Spector, M.D., William Borkowsky, M.D., Sandra K. Burchett, M.D., M.S., M. Foca, Edward Handelsman, M.D., Eleanor Jimenez, M.D., F.A.A.P., Wayne Mathew Dankner, M.D., Michael Hughes, Ph.D.

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.

Lancet

2003

362

9401

2045-2051

ACTG 219, ACTG 219C

William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Rebecca S. Gelman, Ph.D., Rebecca Oyomopito, M.S., Susan Plaeger, Ph.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Bobbie L. Graham, B.S., Stephen A. Spector, M.D.

Lymphocyte subsets in healthy children from birth through 18 years of age: the PACTG 1009 Study.

Journal of Allergy and Clinical Immunology

2003

112

 

973-80

P1009

Susan Reif, Ph.D., M.S.W, Scott R. Smith, Ph.D., Carol E. Golin

Medication adherence practices of HIV/AIDS case managers: a statewide survey in North Carolina

AIDS Patient Care and STDs

2003

17

9

471-81

 

M. Ancukiewicz, Dianne M. Finkelstein, Ph.D., David A. Schoenfeld, Ph.D.

Modelling the relationship between continuous covariates and clinical events using isotonic regression

Statistics In Medicine

2003

22

20

3151-9

 

Leslie Carstensen Floren, Pharm.D., Andrew A. Wiznia, M.D., Sandra Hayashi, Pharm.D., Anura L. Jayewardene, Ph.D., Kenneth Stanley, Ph.D., George M. Johnson, M.D., Sharon Appelbaum Nachman, M.D., Paul Krogstad, M.D., Francesca Aweeka, Pharm.D.

Nelfinavir Pharmacokinetics in Stable Human Immunodeficiency Virus-Positive Children: Pediatric AIDS Clinical Trials Group Protocol 377

Pediatrics

2003

112

3

e220-e227

ACTG 377

William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Stephen A. Spector, M.D., E. Richard Stiehm, M.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Bobbie L. Graham, B.S., Rebecca Oyomopito, M.S., Rebecca S. Gelman, Ph.D.

Normal Distribution of Peripheral Blood Mononuclear Cell (PBMC) Subsets from Birth to 18 years: The NIH NIAID DAIDS Pediatric AIDS Clinical Trials group P-1009 Protocol.

Journal of Allergy and Clinical Immunology

2003

 

111

s271

P1009

Edmund Capparelli, Pharm.D., Mark Mirochnick, M.D., Wayne M. Dankner, M.D., Wayne Mathew Dankner, M.D., Suzette Blanchard, M.S., Ph.D., Suzette Blanchard, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Lynne M. Mofenson, M.D., F.A.A.P., George D. McSherry, M.D., George D. McSherry, M.D., Hannah Gay, M.D., Gregory Ciupak, B.A., Gregory Ciupak, B.A., Hannah Gay, M.D., Gregory Ciupak, B.A., Elizabeth (Betsy) Smith, M.D., Elizabeth Smith, M.D., James D. Connor, M.D., Barbara A. Smith, James D. Connor, M.D., Mark Mirochnick, M.D.

Pharmacokinetics and Tolerance of Zidovudine in Preterm Infants

Journal of Pediatrics

2003

142

(1)

47-52

ACTG 331

Stuart E. Starr, M.D., Elizabeth J. McFarland, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Jane Pitt, M.D., Steven Douglas, M.D., Audra Deveikis, M.D., Myron Levin, M.D., Mobeen H. Rathore, M.D.

Phase I/II Trial of Intravenous Recombinant Interleukin-2 in Human Immunodeficiency Virus-infected Children

AIDS

2003

17

 

2181-2189

ACTG 299

Edmund Capparelli, Pharm.D., Janet Ailene Englund, M.D., James D. Connor, M.D., Stephen A. Spector, M.D., Ross E. McKinney, Jr., M.D., Paul Palumbo, M.D., Paul Palumbo, M.D., Carol J. Baker, M.D., Carol J. Baker, M.D.

Population Pharmacokinetics and Pharmacodynamics of Zidovudine in HIV-infected Infants and Children.

Journal of Clinical Pharmacology

2003

43

2

133-140

ACTG 152

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Suzette Blanchard, M.S., Ph.D., Coleen Cunningham, M.D., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., John L. Sullivan, M.D.

Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.

Journal of Acquired Immune Deficiency Syndromes

2003

33

2

153-6

ACTG 250, ACTG 316

Sharon Appelbaum Nachman, M.D., James King, M.D., Elaine J. Abrams, M.D., David Margolis, M.D., Ann Petru, M.D., William T. Shearer, M.D., Ph.D., Elizabeth Smith, M.D., John ( Jack ) Moye, Jr., M.D., Suzette Blanchard, M.S., Ph.D., Elizabeth Hawkins, Pamela Bouquin, B.A., Peter Eugene Vink, M.D., Mindy Benson, R.N., P.N.P., Scharla Estep, M.S., R.Ph., F. Maloniski

Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants with HIV Type-1 Infection

Pediatrics

2003

112

1 Pt. 1

66-73

ACTG 292

David Dunn, Ross E. McKinney, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., John ( Jack ) Moye, Jr., M.D., Paul Palumbo, M.D., William T. Shearer, M.D., Ph.D.

Short-term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent viral load, and age.

Lancet

2003

362

9396

1605-11

ACTG 152, ACTG 300

William R. Robinson, III, M.D., Mindy B. Luck, M.D., Michelle A. Kendall, M.S., Terri Darragh, M.D.

The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: A substudy of a randomized, phase III chemoprevention trial

American Journal of Obstetrics and Gynecology

2003

188

4

896-900

 

Nancy Radcliffe Reynolds, Ph.D.

The problem of antiretroviral adherence: a self-regulatory model for intervention

AIDS Care

2003

15

1

117-124

 

Judith A. Aberg, M.D., Richard W. Price, M.D., Dorie M. Heeren, Barry Bredt, M.A.

A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy

Journal of Infectious Diseases

2002

185

8

1179-82

 

Jeannette Ickovics, Ph.D., C.S. Meade

Adherence to HAART among patients with HIV: breakthroughs and barriers

AIDS Care

2002

14

3

309-18

 

William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Stephen A. Spector, M.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Barney S. Graham, M.D., Ph.D., Rebecca Oyomopito, M.S., Rebecca S. Gelman, Ph.D.

Age-related expression of naive (CD45RA/62L) and activation (HLADR/CD38) surface markers on CD4+ T-cells in normal children (birth to 18 years)

Journal of Allergy and Clinical Immunology

2002

109

1

S199

P1009

Susan H. Eshleman, M.D., PH.D., Paul Krogstad, M.D., Brooks Jackson, M.D., M.B.A., YouGan Wang, Sabina Lee, Lee-Jen Wei, Ph.D., Coleen K. Cunningham, M.D., Michael Wantman, Andrew A. Wiznia, M.D., George M. Johnson, M.D., Sharon Appelbaum Nachman, M.D., Paul Palumbo, M.D.

Analysis of HIV-1 Drug Resistance in Children Receiving Nucleoside Analog Reverse Transcriptase Inhibitors Plus Nevirapine, Nelfinavir or Ritonavir.

Journal of Infectious Diseases

2002

 

184

1732-1708

ACTG 377

Ruth E. Tuomala, M.D., David E. Shapiro, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Yvonne J. Bryson, M.D., Mary Culnane, C.R.N.P., M.S., Michael Hughes, Ph.D., Mary Jo O'Sullivan, M.D., Gwendolyn B. Scott, M.D., Alice M. Stek, M.D., Diane W. Wara, M.D., Marc Bulterys, M.D., Ph.D.

Antiretroviral Therapy During Pregnancy and the Risk Of Preterm Delivery: Preterm Delivery Meta-Analysis

New England Journal of Medicine

2002

24

346

1863-70

ACTG 367

Peter Anderson, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Thomas N Kakuda, Pharm.D., Courtney V. Fletcher, Pharm.D.

CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid

Clinical Pharmacology & Therapeutics

2002

71

4

280-5

 

John L. Schmitz, Ph.D., Thomas Denny, B.S., M.Sc., Ambrosia Garcia-Louzao, M.S., Janet L. Lathey, Ph.D.

Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays

Clinical and Diagnostic Laboratory Immunology

2002

9

3

525-9

 

Courtney V. Fletcher, Pharm.D., Peter Anderson, Pharm.D., Thomas N Kakuda, Pharm.D., Timothy Schacker, M.D., W. Keith Henry, M.D., Cynthia R. Gross, Richard Brundage, Pharm.D., Ph.D.

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection

AIDS

2002

16

4

551-60

 

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Diane Holland, M.Phil., Bethann Cunningham-Schrader, B.A., M.S., Coleen K. Cunningham, M.D., Coleen Cunningham, M.D., Bethann Cunningham-Schrader, B.A., M.S., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., James D. Connor, M.D., John L. Sullivan, M.D.

Concentrations of protease inhibitors in cord blood after in utero exposure.

Pediatric Infectious Disease Journal

2002

21

9

835-8

ACTG 316, ACTG 316A, ACTG 316B

Coleen Cunningham, M.D., Marie-Laure Chaix, Claire Rekacewicz, M.D., Paula Britto, M.S., Christine Rouzioux, Ph.D., Richard D. Gelber, Ph.D., Alejandro Dorenbaum, M.D., Jean-Francois Delfraissy, M.D., B. Brazin, Lynne M. Mofenson, M.D., F.A.A.P., John L. Sullivan, M.D., John P. Sullivan, M.D.

Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316.

Journal of Infectious Diseases

2002

186

2

181-8

ACTG 316, ACTG 316A, ACTG 316B

Mohammed M. Hossain, Jason J. Coull, George Drusano, M.D., David M. Margolis, M.D.

Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir

Antiviral Research

2002

55

1

41-52

 

Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D., Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Steven D. Douglas, M.D., Patricia M. Flynn, M.D., M.S., Mark W. Kline, M.D., Patricia M. Flynn, M.D., M.S.

Efavirenz liquid Formulation in human immunodeficiency virus-infected children.

Pediatric Infectious Disease Journal

2002

21

7

659-63

ACTG 382

Sharon Appelbaum Nachman, M.D., Kenneth McIntosh, M.D., Stephen Ira Pelton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Jane C. Lindsey, Sc.D., Ph.D., Andrew A. Wiznia, M.D., Sophia S. Lee, M.S., Kenneth Stanley, Ph.D.

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretriviral therapy.

Archives of Pediatrics and Adolescent Medicine

2002

6

5

497-503

ACTG 338

Z. A. Scott, Ellen Gould Chadwick, M.D., Lynn Gibson, Margaret McManus, B.S., Ram Yogev, M.D., Paul Palumbo, M.D., John L. Sullivan, M.D., Paula Britto, M.S., Hannah Gay, M.D., Katherine Luzuriaga, M.D.

Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.

Journal of Immunology

2002

167

12

7134-40

ACTG 345, ACTG 356

Steven A. Miles, M.D., Marcia A. Testa, M.P.H., Ph.D., Jie Huang, M.S., Michael Wade, M.S., Judith Carden, R.N., David Scadden, M.D.

Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma

Journal of Interferon and Cytokine Research

2002

22

11

1143-8

 

Sharon Appelbaum Nachman, M.D., Jane C. Lindsey, Sc.D., Ph.D., Stephen Ira Pelton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Ram Yogev, M.D.

Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy

Archives of Pediatrics and Adolescent Medicine

2002

156

5

497-503

ACTG 338

Jian-Feng Lu, Ph.D., Terrence F. Blaschke, M.D., Charles Flexner, M.D., Susan L Rosenkranz, Ph.D., Lewis Sheiner, M.D.

Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration

Drug Metabolism and Disposition

2002

30

12

1455-61

 

A. P. Fitzgerald, Victor DeGruttola, Sc.D., Florin Vaida, Ph.D.

Modelling HIV viral rebound using non-linear mixed effects models

Statistics In Medicine

2002

21

14

2093-108

 

Paul Krogstad, M.D., Susan H. Eshleman, M.D., PH.D., Y. Z. Geng, Brooks Jackson, M.D., M.B.A., Michael Wantman, Bette T. Korber, Andrew A. Wiznia, M.D., George M. Johnson, M.D., Sharon Appelbaum Nachman, M.D., Paul Palumbo, M.D.

Mother to Child transmission in the United States of subtypes D and A/G human Immunodeficiency virus type 1.

AIDS Research and Human Retroviruses

2002

18

6

413-417

ACTG 377

Mark Mirochnick, M.D., Suzanne Siminski, M.S., M.B.A., Terence Fenton, Ed.D., M. Lugo, John L. Sullivan, M.D.

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.

Journal of Infectious Diseases

2002

2

186

181-8

ACTG 250, ACTG 316

Paul Krogstad, M.D., Sophia S. Lee, M.S., George M. Johnson, M.D., Kenneth Stanley, Ph.D., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D., Brooks Jackson, M.D., M.B.A., Rosaura M. Aguayo, M.D., Arry Dieudonne, M.D., Margaret Khoury, M.D., Hermann A. Mendez, M.D., Sharon Appelbaum Nachman, M.D., Andrew A. Wiznia, M.D.

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.

Clinical Infectious Diseases

2002

34

7

991-1001

ACTG 377

Denise Gaughan, M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Michael Hughes, Ph.D., George Seage, III, Sc.D., M.P.H., Gregory Ciupak, B.A., James M. Oleske, M.D.

Osteonecrosis of the hip ( Legg-Calve-Perthes disease [LCPD]) in Human Immunodeficiency Virus-infected children.

Pediatrics

2002

109

5

e74-4

ACTG 219, ACTG 219C

John L. Sullivan, M.D., Katherine Ruiz Luzuriaga, M.D.

Pediatric HIV-1 infection: Advances and Remaining Challenges.

AIDS Clinical Review

2002

 

4

22-7

ACTG 180, ACTG 316, ACTG 345, ACTG 356

A. Saitoh, Karen Hsia, Ph.D., Terence Fenton, Ed.D., Christine Powell, M.A., Cindy Christopherson, Courtney V. Fletcher, Pharm.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D.

Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged supression of plasma HIV-1 RNA in children.

Journal of Infectious Diseases

2002

185

10

1409-16

ACTG 382

A. Saitoh, Terence Fenton, Ed.D., Karen Hsia, Ph.D., Christine Powell, M.A., Cindy Christopherson, Courtney V. Fletcher, Pharm.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D.

Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.

Journal of Infectious Diseases

2002

185

10

1409-16

ACTG 382

Courtney V. Fletcher, Pharm.D., Ram Yogev, M.D., Sharon Appelbaum Nachman, M.D., Andrew A. Wiznia, M.D., Stephen Ira Pelton, M.D., Kenneth McIntosh, M.D., Kenneth Stanley, Ph.D.

Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children

Pharmacotherapy

2002

24

4

453-9

ACTG 338

Keith D. Chirgwin, M.D., Richard Hafner, M.D., Catherine Leport, M.D., Jack S. Remington, M.D., Janet Andersen, Sc.D., Elizabeth M. Bosler, M.P.H., Clemente Roque, M.D., Natasa Rajicic, M.S., Vincent J. McAuliffe, M.D., Philippe Morlat, M.D., Dushyantha T. Jayaweera, M.D., Jean-Louis Vilde, Benjamin J. Luft, M.D.

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche

Clinical Infectious Diseases

2002

34

9

1243-50

11941551

 

Ingrid A. Beck, M.S., Madhumita S. Mahalanabis, G. Pepper, A. Wright, Scott Hamilton, R.N., E. Langston, Lisa M. Frenkel, M.D.

Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors

Journal of Clinical Microbiology

2002

40

4

1413-9

11923366

PMC140364

 

Russell B. Van Dyke, M.D., Sophia S. Lee, M.S., George M. Johnson, M.D., Andrew A. Wiznia, M.D., Kathleen Mohan, A.R.N.P., M.N., Kenneth Stanley, Ph.D., Edward V. Morse, Ph.D., Paul Krogstad, M.D., Sharon Appelbaum Nachman, M.D.

Reported Adherence as a Determinant of response to Highly Active Antiretroviral Therapy in Children Who Have Human Immunodeficiency Virus Infection.

Pediatrics

2002

109

4

7

ACTG 377

Joseph A. Church, M.D., Coleen Cunningham, M.D., Michael Hughes, Ph.D., Paul Palumbo, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Patricia Mastrodonato DeLora, Elaine Margaret Smith, M.D., Andrew A. Wiznia, M.D., Lynette Purdue, Pharm.D., Elizabeth Hawkins, Prakash Sista, Ph.D.

Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.

Pediatric Infectious Disease Journal

2002

21

7

653-9

P1005

Coleen K. Cunningham, M.D., Diane W. Wara, M.D., Minhee Kang, M.S., Ph.D., Terence Fenton, Ed.D., Elizabeth Hawkins, James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Anne-Marie Duliege, M.D., M.S., Donald P. Francis, M.D., D.Sc., Donald P. Francis, M.D., D.Sc., Elizabeth (Betsy) J. McFarland, M.D., William Borkowsky, M.D.

Safety of Two Recombinant HIV-1 Envelope Vaccines in Neonates Born to HIV-1 Infected Women

Clinical Infectious Diseases

2002

32

 

801-807

ACTG 230

Adrienne Rogers, M.D., Jane C. Lindsey, Sc.D., Donna Futterman, M.D., Bonnie Zimmer, B.S., Susan Abdalian, M.D., Lawrence D'Angelo, M.D., M.P.H.

Serologic Examination of Hepatitis B Infection and Immunization in HIV-Positive Youth and Associated Risks.

AIDS

2002

14

12

651-657

ACTG 220

Ram Yogev, M.D., Sophia S. Lee, M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Kenneth Stanley, Ph.D., Stephen Ira Pelton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Susan A. Fiscus, Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Mobeen H. Rathore, M.D., Elizabeth (Betsy) Smith, M.D., Kenneth McIntosh, M.D.

Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2)

Pediatric Infectious Disease Journal

2002

2

 

119-25

ACTG 338

W. E. Naugler, Florence H. Yong, M.S., Vincent J. Carey, Ph.D., Joan Dragavon, M.L.M., Robert W. Coombs, M.D., Ph.D., Lisa M. Frenkel, M.D.

T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.

Journal of Infectious Diseases

2002

4

185

448-55

ACTG 144

Denise Gaughan, M.P.H., James M. Oleske, M.D., Michael Hughes, Ph.D., Michael T. Brady, M.D., George Seage, Sc.D., M.P.H., Wayne Mathew Dankner, M.D., Peter A. Selwyn, M.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Vincent J. Carey, Ph.D., Elizabeth Smith, M.D., Steven Gortmaker, Ph.D., George Seage, Sc.D., M.P.H., James M. Oleske, M.D., Denise Gaughan, M.P.H., Richard D. Gelber, Ph.D., Steven Gortmaker, Ph.D., Jane C. Lindsey, Sc.D., Ph.D., Rebecca Oyomopito, M.S., Carol Elgie, B.S., Janice Hodge, R.N., B.S., Barbara Nowak, B.A., Bonnie Zimmer, B.S., Yvonne J. Bryson, M.D., John W. Sleasman, M.D.

The prevalence of pain in pediatric human immunodeficiency virus/acquired immunodeficiency syndrome as reported by participants in the Pediatric Late Outcomes Study (PACTG 219)

Pediatrics

2002

109

(6)

1144-1152

ACTG 219, ACTG 219C

Alejandro Dorenbaum, M.D., Coleen Cunningham, M.D., Richard D. Gelber, Ph.D., Mary Culnane, C.R.N.P., M.S., Lynne M. Mofenson, M.D., F.A.A.P., Paula Britto, M.S., Claire Rekacewicz, M.D., Marie Louise Newell, M.D., Jean-Francois Delfraissy, M.D., Bethann Cunningham-Schrader, B.A., M.S., Mark Mirochnick, M.D., John L. Sullivan, M.D.

Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission

The Journal of the American Medical Association

2002

288

2

189-198

ACTG 316

Paul Krogstad, M.D., Susan H. Eshleman, M.D., PH.D., Jennifer Jackson, Michael Wantman, Bette T. Korber, Andrew A. Wiznia, M.D., George M. Johnson, M.D., Sharon Appelbaum Nachman, M.D., Paul Palumbo, M.D.

Vertical transmission of Subtype D and Subtype A/G Human Immunodeficiency virus in the United States.

AIDS Research and Human Retroviruses

2002

18

 

413-417

ACTG 377

Laura Smeaton, M.S., Victor DeGruttola, Sc.D., Gregory K. Robbins, M.D., M.P.H., Robert Shafer, M.D.

ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1

Controlled Clinical Trials

2001

22

2

142-59

 

Anura L. Jayewardene, Ph.D., Brian Kearney, Pharm.D., J. Stone, John G. Gambertoglio, Pharm.D., Francesca Aweeka, Pharm.D.

An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma

Journal of Pharmaceutical and Biomedical Analysis

2001

25

2

309-17

 

Terry A. Lennie, Ph.D., R.N., Judith Neidig, R.N., Ph.D., Karen F. Stein, Ph.D., R.N., Barbara A. Smith

Assessment of hunger and appetite and their relationship to food intake in persons with HIV infection

Journal of the Association of Nurses in AIDS Care

2001

12

3

66-74

 

Hernan Valdez, M.D., Tanvir K. Chowdhry, Robert Asaad, M.D., Ian Woolley, M.D., Traci L. Davis, B.S.N., R.N., Robin Davidson, Nele K. Beinker, Barbara Gripshover, M.D., Robert A. Salata, M.D., Grace McComsey, M.D., Sharon Weissman, M.D., Michael M. Lederman, M.D.

Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999

Clinical Infectious Diseases

2001

32

10

1487-93

 

L. Joseph Wheat, M.D., Gretchen Cloud, M.S., Philip C. Johnson, M.D., Patricia A. Connolly, M.S., Mitchell (Mitch) Goldman, M.D., Ann Le Monte, DeAnna E. Fuller, Thomas E Davis, Richard Hafner, M.D.

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole

Antimicrobial Agents and Chemotherapy

2001

45

8

2354-7

 

Kenneth Lichtenstein, M.D., Douglas J. Ward, M.D., A. C. Moorman, K. M. Delaney, Benjamin Young, M.D., Ph.D., Frank Palella, M.D., S. D. Holmberg

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

AIDS

2001

15

11

1389-1398

 

Dianne M. Finkelstein, Ph.D., David A. Schoenfeld, Ph.D.

Comparing treatment strategies using a synthesized clinical trial: An analysis of late versus early use of bactrim for AIDS patients

Journal of Statistical Planning and Inference

2001

96

1

179-189

 

Scott F. Sieg, Ph.D., Douglas A. Bazdar, Clifford V. Harding, Michael M. Lederman, M.D.

Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease

Journal of Virology

2001

75

20

9983-5

 

Ann Le Monte, Mitchell (Mitch) Goldman, M.D., Melinda L. Smedema, Patricia A. Connolly, M.S., David S. McKinsey, M.D., Gretchen Cloud, M.S., Carol Kauffman, M.D., L. Joseph Wheat, M.D.

DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS

Medical Mycology

2001

39

2

207-13

 

Jean Marie Arduino, Sc.D., Margaret A. Fischl, M.D., Kenneth Stanley, Ph.D., Ann C. Collier, M.D., Donna Spiegelman, Sc.D.

Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?

AIDS Research and Human Retroviruses

2001

17

12

1099-105

 

Paul Palumbo, M.D., William T. Shearer, M.D., Ph.D.

Duration of ruptured mambranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies.

AIDS

2001

15

 

357-368

ACTG 076, ACTG 185, ACTG 316

Steven Gortmaker, Ph.D., Michael Hughes, Ph.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Rebecca Oyomopito, M.S., Michael T. Brady, M.D., James M. Oleske, M.D., George M. Johnson, M.D., George Seage, III, Sc.D., M.P.H., Lin-Ye Song, Ph.D., Wayne M. Dankner, M.D., Wayne M. Dankner, M.D., James M. Oleske, M.D.

Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

New England Journal of Medicine

2001

21

345

1522-1528

11794218

ACTG 219

Hernan Valdez, M.D., Julia A. Metcalf, Barbara Gripshover, M.D., Jeffrey M. Jacobson, M.D., Ronald T. Mitsuyasu, M.D., Michael M. Lederman, M.D.

Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients

AIDS

2001

15

5

661-2

 

Woraphot Tantisiriwat, Pablo Tebas, M.D., Louis B. Polish, Ed Casabar, William G. Powderly, M.D., Carl J. Fichtenbaum, M.D.

Elevated lactate levels in hospitalized persons with HIV infection

AIDS Research and Human Retroviruses

2001

17

3

195-201

 

Nancy S. Shulman, M.D., Roderick A. Machekano, Ph.D., M.P.H., Robert Shafer, M.D., Mark A. Winters, M.S., Andrew R. Zolopa, M.D., Song-Heng Liou, M.S., Michael Hughes, Ph.D., David Katzenstein, M.D.

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy

Journal of Acquired Immune Deficiency Syndromes

2001

27

4

377-80

 

Helene Hardy, Pharm.D., Lori Esch, Pharm.D., Gene D. Morse, Pharm.D.

Glucose disorders associated with HIV and its drug therapy

Annals of Pharmacotherapy

2001

35

3

343-51

 

Robert Shafer, M.D., Kurt Hertogs, Ph.D., Andrew R. Zolopa, M.D., Ann Warford, Ph.D., Stuart Bloor, Bradley J. Betts, Thomas C. Merigan, Jr., M.D., Richard Harrigan, Brendan Larder, Ph.D.

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients

Journal of Clinical Microbiology

2001

39

4

1522-9

 

Oluwatoyin Adeyemi, M.D., Judith A. Aberg, M.D.

HIV and cardiovascular risk factors

The AIDS Reader

2001

11

5

263-8

 

Elizabeth (Betsy) J. McFarland, M.D., William Borkowsky, M.D., Terence Fenton, Ed.D., Diane W. Wara, M.D., James McNamara, M.D., Pearl Samson, M.S., Minhee Kang, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Coleen K. Cunningham, M.D., Anne-Marie Duliege, M.D., M.S., Faruk Sinangil, Stephen A. Spector, M.D., Eleanor Jimenez, M.D., F.A.A.P., Yvonne J. Bryson, M.D., Sandra K. Burchett, M.D., M.S., Lisa M. Frenkel, M.D., Ram Yogev, M.D., Francis Gigliotti, M.D., Katherine Luzuriaga, M.D., Robert Livingston, M.D.

Human Immunodeficiency Virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.

Journal of Infectious Diseases

2001

184

10

1331-1335

ACTG 230

Myron Levin, M.D., Anne A. Gershon, M.D., Adriana Weinberg, M.D., Suzette Blanchard, M.S., Ph.D., Barbara Nowak, B.A., Paul Palumbo, M.D., Christina Y. O'Brien, M.D.

Immunization of HIV-Infected Children with Varicella Vaccine

Journal of Pediatrics

2001

139

(2)

305-310

ACTG 265

Catherine Leport, M.D., J. Franck, Genevieve Chene, F. Derouin, JL Ecobichon, Sophie Pueyo, Jose Miro, Benjamin J. Luft, M.D., Philippe Morlat, M.D., H. Dumon

Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus

Clinical and Diagnostic Laboratory Immunology

2001

8

3

579-84

 

Kate Buchacz, M.P.H., Ph.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Jane C. Lindsey, Sc.D., Ph.D., Michael Hughes, Ph.D., George Seage, Sc.D., M.P.H., Wayne Mathew Dankner, M.D., James M. Oleske, M.D., John ( Jack ) Moye, Jr., M.D.

Impact of protease inhibitors (PI) containing combination antiretroviral therapies on height and weight growth in HIV-infected children.

Pediatrics

2001

108

4

1-7

11581480

ACTG 219

Z. A. Scott, Ellen Gould Chadwick, M.D., Lynn Gibson, Margaret McManus, B.S., Ram Yogev, M.D., Paul Palumbo, M.D., John L. Sullivan, M.D., Paula Britto, M.S., Hannah Gay, M.D., Katherine Luzuriaga, M.D.

Infrequent Detection of Hiv-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Celll Responses in Young HIV-1-Infected Infants.

Journal of Immunology

2001

167

12

7134-7140

ACTG 345

Elizabeth Livingston, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Jorge Gandia, M.D., Mary Jo O'Sullivan, M.D., Sharon Huang, M.S., Ross E. McKinney, Jr., M.D., W. N.P. Herbert, Pamela A. Clax, D.P.M., Yi Wang, Ph.D., Sheran Patel, D.O., Ruth E. Dickover, Ph.D., Jashvant D. Unadkat, Ph.D.

Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection

American Journal of Obstetrics and Gynecology

2001

 

 

 

ACTG 249

A. Rotnitzky, D. Scharfstein, T. L. Su, J. Robins

Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring

Biometrics

2001

57

1

103-13

 

Jason Simdon, Dan Watters, Stephen D. Bartlett, R.Ph., M.S.P.H., Elizabeth Connick, M.D.

Ototoxicity associated with use of nucleoside analog reverse transcriptase inhibitors: a report of 3 possible cases and review of the literature

Clinical Infectious Diseases

2001

32

11

1623-7

 

Bettina Haidich, M.Sc., John P.A. Ioannidis, M.D.

Patterns of patient enrollment in randomized controlled trials

Journal of Clinical Epidemiology

2001

54

9

877-83

 

Coleen Cunningham, M.D., Bonnie J. Ank, Dorothy E. Lewis, Ph.D., W. Lu, Michael Wantman, J. Dileanis, Brooks Jackson, M.D., M.B.A., Paul Palumbo, M.D., Paul Krogstad, M.D., Susan H. Eshleman, M.D., PH.D.

Performance of the applied Biosystems ViroSeqTM HIV-1 Genotyping System for Analysis of HIV-1 in Peditric Plasma Sample.

Journal of Clinical Microbiology

2001

39

 

1254-7

ACTG 377

Edmund Capparelli, Pharm.D., John L. Sullivan, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Elaine Margaret Smith, M.D., Bobbie L. Graham, B.S., Bobbie L. Graham, B.S., Paula Britto, M.S., Mark I. Becker, Pharm.D., Diane Holland, M.Phil., James D. Connor, M.D., Katherine Luzuriaga, M.D.

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.

Pediatric Infectious Disease Journal

2001

20

8

746-51

ACTG 356

Edward P. Acosta, Pharm.D., Carmen D. Zorrilla, M.D., Russell B. Van Dyke, M.D., Arlene D. Bardeguez, M.D., F.A.C.O.G., M.P.H., Elizabeth Smith, M.D., Michael Hughes, Ph.D., Sheila Huang, Pharm.D., Jane Pitt, M.D., Heather Watts, M.D., Lynne M. Mofenson, M.D., F.A.A.P.

Pharmacokinetics of Saquinavir-SCG in HIV-Infected Pregnant Women

HIV Clinical Trials

2001

6

2

460-465

ACTG 386

David M. Simpson, M.D., David Katzenstein, M.D., Bettina Haidich, M.Sc., David Millington, Constantin Yiannoutsos, Ph.D., Giovanni Schifitto, M.D., Justin C. McArthur, M.B.B.S., M.P.H.

Plasma carnitine in HIV-associated neuropathy

AIDS

2001

15

16

2207-8

 

Mark Mirochnick, M.D., Ellen Rae Cooper, M.P.H., M.D., Edmund Capparelli, Pharm.D., Kenneth McIntosh, M.D., Jane C. Lindsey, Sc.D., Ph.D., Jing Xu, M.S., David P. Jacobus, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Vincent R. Bonagura, M.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., Stephen A. Spector, M.D.

Population pharmacokinetics of dapson in children with human immunodeficiency virus infection.

Clinical Pharmacology & Therapeutics

2001

1

70

24-32

ACTG 179

Mark Mirochnick, M.D., Ellen Rae Cooper, M.P.H., M.D., Edmund Capparelli, Pharm.D., Kenneth McIntosh, M.D., Jane C. Lindsey, Sc.D., Jing Xu, M.S., David P. Jacobus, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Vincent R. Bonagura, M.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., John L. Sullivan, M.D., Stephen A. Spector, M.D.

Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.

Clinical Pharmacology & Therapeutics

2001

70

1

24-32

ACTG 179

Jing Lu, M.S., Jean-Michel Gries, Davide Verotta, Ph.D., Lewis Sheiner, M.D.

Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.

Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics)

2001

28

4

343-62

 

John L. Sullivan, M.D., Katherine Luzuriaga, M.D.

The changing face of Pediatric HIV-1 infection.

New England Journal of Medicine

2001

344

21

1568-1569

ACTG 180, ACTG 316, ACTG 345, ACTG 356

Robert W. Coombs, M.D., Ph.D., David Wright, Ph.D., Patricia Reichelderfer, Ph.D., David Burns, M.D., M.P.H., Jonathan Cohn, M.D., Susan Cu-Uvin, M.D., Penny Baron, M.S., Morty Cohen, B.S., R.Ph., Alan Landay, Ph.D., S. Lewis, Andrea Kovacs, M.D.

Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.

Journal of Infectious Diseases

2001

184

9

1187-91

 

Dale E. Brashers, Ph.D., Judith Neidig, R.N., Ph.D., Stephen M. Haas, Linda K. Dobbs, Ph.D., Linda W. Cardillo, M.A., Jane A. Russell, R.N.

Communication in the management of uncertainty: the case of persons living with HIV or AIDS

Communication Monographs

2000

67

1

63-84

 

Catherine Diamond, Carl E. Speck, Meei-Li Huang, Lawrence Corey, M.D., Robert W. Coombs, M.D., Ph.D., John N. Krieger

Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men

Journal of Virological Methods

2000

90

2

185-91

 

George J. Hanna, M.D., Victoria A. Johnson, M.D., Daniel R. Kuritzkes, M.D., Douglas D. Richman, M.D., Javier Martinez-Picado, Lorraine Sutton, B.A., J. Darren Hazelwood, B.A., Richard T. D'Aquila, M.D.

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase

Journal of Clinical Microbiology

2000

38

7

2715-21

 

J. Robins, Dianne M. Finkelstein, Ph.D.

Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests

Biometrics

2000

56

3

779-88

 

Wayne M. Dankner, M.D., Jane C. Lindsey, Sc.D., Myron Levin, M.D.

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.

Pediatric Infectious Disease Journal

2000

20

1

40-8

ACTG 051, ACTG 128, ACTG 138, ACTG 144, ACTG 152, ACTG 179, ACTG 190, ACTG 220, ACTG 240, ACTG 245, ACTG 254, ACTG 300, ACTG 327, DACS 087

Lena Al-Harthi, Ph.D., G. Marchetti, C. M. Steffens, J. Poulin, Rafick-Pierre Sekaly, Ph.D., Alan Landay, Ph.D.

Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA)

Journal of Immunological Methods

2000

237

1-2

187-97

 

John R. Graybill, Jack Sobel, Michael Saag, Charles Van der Horst, William Powderly, Gretchen Cloud, Laura Riser, Richard Hamill, William Dismukes

Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis

Clinical Infectious Diseases

2000

30

1

47-54

 

Judith Silverstein Currier, M.D., M.Sc., Paige L. Williams, Ph.D., Susan L. Koletar, M.D., Susan Ellen Cohn, M.D., M.P.H., Robert L. Murphy, M.D., Alison Heald, M.D., Richard Hafner, M.D., Ehab Bassily, M.Sc., Howard M. Lederman, M.D., Ph.D., Charles Knirsch, M.D., M.P.H., Constance A. Benson, M.D., Hernan Valdez, M.D., Judith A. Aberg, M.D., J. Allen McCutchan, M.D., M.Sc.

Discontinuation of mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team

Annals of Internal Medicine

2000

133

7

493-503

 

Katherine Luzuriaga, M.D., Margaret McManus, B.S., Shane Mayack, Mark Sharkey, Mario Stevenson, Ph.D., John L. Sullivan, M.D.

Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses

Journal of Virology

2000

74

15

6984-91

ACTG 356

Nancy S. Shulman, M.D., Andrew R. Zolopa, M.D., Douglas J. Passaro, Usha Murlidharan, Dennis M. Israelski, M.D., Carol L. Brosgart, M.D., Michael J. Miller, R.Ph., M.S., Sally Van Doren, Robert Shafer, M.D., David Katzenstein, M.D.

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response

Journal of Acquired Immune Deficiency Syndromes

2000

23

3

221-6

 

Robert C. Stevens, Pharm.D., John H. Rodman, Pharm.D., Florence H. Yong, M.S., Vincent J. Carey, Ph.D., Catherine Knupp, D.V.M., Lisa M. Frenkel, M.D.

Effect of Food and Pharmacokinetic Variability on Didanosine Systemic Exposure in HIV-Infected Children

AIDS Research and Human Retroviruses

2000

16

5

415-421

ACTG 144

Mark A. Winters, M.S., Kristi L. Coolley, Peng Cheng, Yvette A. Girard, Hasnah Hamdan, Ladislau C. Kovari, Thomas C. Merigan, Jr., M.D.

Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors

Journal of Virology

2000

74

22

10707-13

 

William Borkowsky, M.D., Kenneth Stanley, Ph.D., Steven D. Douglas, M.D., Sophia S. Lee, M.S., Andrew A. Wiznia, M.D., Stephen Ira Pelton, M.D., Ram Yogev, M.D., Kenneth McIntosh, M.D., Susan A. Fiscus, Ph.D., Sharon Appelbaum Nachman, M.D.

Immunologic Response To Combination Nucleoside Analogue Plus Protease Inhibitor Therapy In Stable Antiretroviral Therapy-Experienced HIV-Infected Children

Journal of Infectious Diseases

2000

182

1

96-103

ACTG 338

Premlata Shankar, Melissa Russo, Brooke Harnisch, Mark Patterson, Paul Skolnik, M.D., Judy Lieberman, M.D., Ph.D.

Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection

Blood

2000

96

9

3094-3101

 

William Borkowsky, M.D., Diane W. Wara, M.D., Terence Fenton, Ed.D., James McNamara, M.D., Minhee Kang, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) J. McFarland, M.D., Coleen K. Cunningham, M.D., Anne-Marie Duliege, M.D., M.S., Donald P. Francis, M.D., D.Sc., Yvonne J. Bryson, M.D., Sandra K. Burchett, M.D., M.S., Stephen A. Spector, M.D., Lisa M. Frenkel, M.D., Stuart E. Starr, M.D., Russell B. Van Dyke, M.D., Eleanor Jimenez, M.D., F.A.A.P.

Lymphoproliferative Responses To Recombinant HIV-1 Envelope Antigens In Neonates and Infants Receiving GP 120 Vaccines

Journal of Infectious Diseases

2000

181

3

890-6

ACTG 230

Jane C. Lindsey, Sc.D., Karen J. O'Donnell, Ph.D., Pim Brouwers, Ph.D.

Methodological Issues In Analyzing Psychological Test Scores In Pediatric Clinical Trials

Journal Of Developmental and Behavioral Pediatrics

2000

21

2

141-151

ACTG 128

Sharon Appelbaum Nachman, M.D., Kenneth Stanley, Ph.D., Ram Yogev, M.D., Stephen Ira Pelton, M.D., Andrew A. Wiznia, M.D., Sophia S. Lee, M.S., Lynne M. Mofenson, M.D., F.A.A.P., Susan A. Fiscus, Ph.D., Mobeen H. Rathore, M.D., Eleanor Jimenez, M.D., F.A.A.P., William Borkowsky, M.D., Jane Pitt, M.D., Mary Smith, R.N., Barbara Wells, B.A., Barbara Wells, B.A., Kenneth McIntosh, M.D.

Nucleoside Analogues Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Trial

The Journal of the American Medical Association

2000

283

4

492-8

ACTG 338

Kenneth McIntosh, M.D., Marc Bulterys, M.D., Ph.D., Sandra K. Burchett, M.D., M.S., Mary Culnane, C.R.N.P., M.S., Bethann Cunningham-Schrader, B.A., M.S., Ken Dominguez, M.D., Lisa M. Dunkle, M.D., Linda Draper (Marillo), B.A., Linda Draper (Marillo), B.A., Mary Glenn Fowler, M.D., M.P.H., I. Celine Hanson, M.D., E. Kpamegan, Mary Lou Lindegren, J. Louise Martin-Carpenter, M.S., James McNamara, M.D., George D. McSherry, M.D., Wendy G Mitchell, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James M. Oleske, M.D., P. H. Rhodes, David E. Shapiro, Ph.D., Elizabeth (Betsy) Smith, M.D., B. Styrt

Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts.

Journal of Acquired Immune Deficiency Syndromes

2000

25

 

261-268

ACTG 219

Charles Raines, C.R.N.P., M.S.N, Charles Flexner, M.D., Eugene Sun, M.D., Margo E. Heath-Chiozzi, M.D., Ronald Lewis, M.D., Catherine Fields, C. Deetz, Linda Apuzzo, B.S., C.C.R.C., Susan H. Eshleman, M.D., PH.D., Brooks Jackson, M.D., M.B.A., Joel E. Gallant, M.D., M.P.H.

Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks

Journal of Acquired Immune Deficiency Syndromes

2000

25

4

322-8

 

Walter T. Hughes, Jerry L. Shenep, John H. Rodman, Arnold Fridland, Rodney Willoughby, Suzette Blanchard, Lynette Purdue, Dion F. Coakley, Kenneth C Cundy, Mary Culnane, C.R.N.P., M.S., Bonnie Zimmer, B.S., Sandra K. Burchett, M.D., M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H

Single Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy

2000

44

4

1041-6

ACTG 310

Janet Holbrook, M.S., Marilyn Davis, R.N., M.S., Larry Hubbard, Barbara K. Martin, Ph.D., Gary Norman Holland, M.D., Douglas Jabs, M.D., M.B.A., Adele Gilpin, Curtis Meinert, M.D., Daniel S. Reshef

Studies of Ocular Complications of AIDS Research Group. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.

Archives of Ophthalmology

2000

118

9

1196-1204

 

E. Richard Stiehm, M.D., Courtney V. Fletcher, Pharm.D., Lynne M. Mofenson, M.D., F.A.A.P., Paul Palumbo, M.D., Minhee Kang, M.S., Ph.D., Terence Fenton, Ed.D., Christine Sapan, Ph.D., William A. Meyer, III, Ph.D., William T. Shearer, M.D., Ph.D., Elizabeth Hawkins, James McNamara, M.D., Mary Glenn Fowler, M.D., M.P.H., Pamela Bouquin, B.A., Lynette Purdue, Pharm.D., Elaine M. Sloand, M.D., George J. Nemo, Ph.D., Diane W. Wara, M.D., Yvonne J. Bryson, M.D., Stuart E. Starr, M.D., Ann Petru, M.D., Kenneth McIntosh, M.D.

Use of HIV-IVIG In HIV-1 Infected Children (PACTG 273)

Journal of Infectious Diseases

2000

181

2

548-54

ACTG 273

Carl J. Fichtenbaum, M.D., Matthew German, M.D., W. Claiborne Dunagan, Victoria J. Fraser, Gerald Medoff, M.D., Jorge Diego, William G. Powderly, M.D.

A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B

Clinical Infectious Diseases

1999

29

6

1551-6

 

Ian Marschner, Ph.D., Rebecca Betensky, Ph.D., Victor DeGruttola, Sc.D., Scott M. Hammer, M.D., Daniel R. Kuritzkes, M.D.

Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

1999

20

3

220-7

 

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Florence H. Yong, Terence Fenton, Richard C. Brundage, Douglas Manion, Nancy M. Ruiz, Merril Gersten, Mark Becker, James McNamara, Lynne M. Mofenson, Lynne M. Mofenson, M.D., F.A.A.P.

Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1

New England Journal of Medicine

1999

341

25

1874-81

ACTG 382

Mark W. Kline, M.D., Russell B. Van Dyke, M.D., Jane C. Lindsey, Sc.D., Meg Gwynne, B.A., Mary Culnane, C.R.N.P., M.S., Clemente Diaz, M.D., Ram Yogev, M.D., Ross E. McKinney, Jr., M.D., Elaine J. Abrams, M.D., Lynne M. Mofenson, M.D., F.A.A.P.

Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection

Pediatrics

1999

103

5

e62

ACTG 327

Heather D. Watts, M.D., Catherine Spino, Sc.D., Larry Zaborski, M.S., David Katzenstein, M.D., Scott M. Hammer, M.D., Constance A. Benson, M.D.

Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

1999

20

5

455-62

 

Cynthia A. Derdeyn, Ph.D., Caroline Costello, J. Michael Kilby, M.D., Greg Sfakianos, B.S., Michael Switow Saag, M.D., Richard Kaslow, M.D., R. Pat Bucy, M.D., Ph.D.

Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals

AIDS Research and Human Retroviruses

1999

15

12

1063-71

 

Luzuriaga K, Wu H, McManus M, Britto P, Borkowsky P, Burchett S, Bryan C. Cole Smith, M.Ed., Mofenson LM, Sullivan JL

Dynamics Of HIV-1 Replication In Vertically-Infected Infants

Journal of Virology

1999

73

1

362-7

ACTG 356

Shapiro DE, Sperling RS, Coombs RW

Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter)

Lancet

1999

354

9173

156

ACTG 076

E. Richard Stiehm, John S. Lambert, Lynne M. Mofenson, James Bethel, Jean Whitehouse, Robert Nugent, John Moye, Mary Glen Fowler, Bonnie Mathieson, Patricia Reichelderfer, Georg J. Nemo, James Korelitz, William A. Meyer, III, Christine V. Sapan, Eleanor Jimenez, Jorge Gandia, Gwendolyn Scott, Mary Jo O'Sullivan, Andrea Kovacs, Alice Stek, William T. Shearer, Hunter Hammill

Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185

Journal of Infectious Diseases

1999

179

3

567-75

ACTG 185

Stanley C. Deresinski, M.D., F.A.C.P.

Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection

AIDS

1999

13

6

633-43

 

Huldrych F. Gunthard, Andrew J. Leigh-Brown, Richard T. D'Aquila, Victoria A. Johnson, Daniel R. Kuritzkes, Douglas D. Richman, Joseph K. Wong

Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol

Virology

1999

259

1

154-65

 

Abhay H. Patki, Scott F. Purvis, Ph.D., Hernan Valdez, John Spritzler, Sc.D., Elizabeth Connick, Daniel R. Kuritzkes, Harold Kessler, Lawrence Fox, Marty St. Clair, Alan Landay, Michael M. Lederman, M.D.

HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication

AIDS

1999

13

10

1177-85

 

Andrew R. Zolopa, M.D., Robert Shafer, M.D., Ann Warford, Ph.D., Jose G. Montoya, M.D., Philip Hsu, B.A., David Katzenstein, M.D., Thomas C. Merigan, Jr., M.D., Brad Efron, Ph.D.

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

Annals of Internal Medicine

1999

131

11

813-21

 

Stevens RC, Frenkel LM, Rodman JH

Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children

Pharmacotherapy

1999

19

 

487

ACTG 144

Mofenson LM, Fowler MG

Interruption Of Materno-Fetal Transmission

AIDS

1999

13

Suppl

S205-14

10885777

ACTG 076, ACTG 185, ACTG 219

Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

The Journal of the American Medical Association

1999

281

2

151-157

9917118

ACTG 076, ACTG 219

I. Celine Hanson, Tracy A. Antonelli, Rhoda S. Sperling, James M. Oleske, Ellen Rae Cooper, M.P.H., M.D., Mary Culnane, Mary Glenn Fowler, Leslie A. Kalish, Sophia S. Lee, George McSherry, Lynne Mofenson, David E. Shapiro

Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

1999

20

5

463-467

ACTG 076, ACTG 219

Mary Culnane, C.R.N.P., M.S., Bethann Cunningham-Schrader, B.A., M.S., James M. Oleske, M.D., Mary Glenn Fowler, M.D., M.P.H., Sophia S. Lee, M.S., George D. McSherry, M.D., Michael T. Brady, M.D., Karen J. O'Donnell, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Steven Gortmaker, Ph.D., David E. Shapiro, Ph.D.

Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women

The Journal of the American Medical Association

1999

281

2

151-57

ACTG 219

K. Dascomb, Rebecca Adair Clark, M.D., Ph.D., Judith A. Aberg, M.D., Joseph J. Pulvirenti, M.D., Ross G. Hewitt, M.D., Patty Kissinger, Ph.D., Elizabeth Didier, Ph.D.

Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus

Journal of Clinical Microbiology

1999

37

10

3421-2

 

Leock Y. Ngo, Ram Yogev, Wayne M. Dankner, Walter T. Hughes, Sandra Burchett, Jing Xu, Brian Sadler, Jashvant D. Unadkat

Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children

Antimicrobial Agents and Chemotherapy

1999

43

6

1516-19

ACTG 254

Mirochnick M, Ellen Rae Cooper, M.P.H., M.D., McIntosh K, Xu J, Lindsey J, Jacobus D, Mofenson LM, Sullivan JL, Dankner W, Frenkel LM, Nachman S, Wara DW, Johnson D, Bonagura V, Rathore M, Coleen K. Cunningham, M.D., James McNamara, M.D.

Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children

Antimicrobial Agents and Chemotherapy

1999

43

11

2586-91

ACTG 179

Yi Wang, Elizabeth Livingston, Shivakumar Patil, Ross E. McKinney, Arlene D. Bardeguez, Jorge Gandia, Mary J. O'Sullivan, Sharon Huang, Jashvant D. Unadkat

Pharmacokinetics of Didanosine (ddI) in Antepartum and Postpartum HIV-1 Infected Pregnant Women and their Neonates

Journal of Infectious Diseases

1999

180

5

1536-41

ACTG 249

Mirochnick M, Siminski S, Fenton T, Sullivan JL

Pharmacokinetics Of Nevirapine In Infants Following In Utero Exposure

Pediatric Research

1999

45

 

168A

ACTG 250

Mark Mirochnick, Edmund Capparelli, James Connor

Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies

Clinical Pharmacology & Therapeutics

1999

66

1

16-24

DACS 066

Mark W. Kline, M.D., Suzette Blanchard, M.S., Ph.D., Courtney V. Fletcher, Pharm.D., Jerry L. Shenep, M.D., Ross E. McKinney, Jr., M.D., Richard Brundage, Pharm.D., Ph.D., Mary Culnane, C.R.N.P., M.S., Russell B. Van Dyke, M.D., Wayne M. Dankner, M.D., Andrea Kovacs, M.D., Jim McDowell, Seth Hetherington, M.D.

Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection

Pediatrics

1999

103

e47

1-5

ACTG 330

William T. Shearer, M.D., Ph.D., Mark W. Kline, M.D., Stuart L. Abramson, M.D., Ph.D., Terence Fenton, Ed.D., Stuart E. Starr, M.D., Steven D. Douglas, M.D.

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211)

Clinical and Diagnostic Laboratory Immunology

1999

6

3

311-15

ACTG 211

Burns DN, Mofenson LM

Recent Developments In Pediatric HIV-1 Infection

Lancet

1999

354

Supp II

SII1-6

ACTG 076, ACTG 185, ACTG 219

Lynne M. Mofenson, M.D., John S. Lambert, M.D., E. Richard Stiehm, M.D., James Bethel, Ph.D., William A. Meyer III, Ph.D., Jean Whitehouse, R.N., John Moye, Jr., M.D., Patricia Reichelderfer, Ph.D., D. Robert Harris, Ph.D., Mary Glenn Fowler, M.D., M.P.H., Robert Nugent, Ph.D., Bonnie J. Mathieson, Ph.D., Cynthia L. Fowler, M.D., George J. Nemo, Ph.D., Bonnie J. Mathieson, Ph.D., George J. Nemo, Ph.D.

Risk Factors For Perinatal Transmission Of Human Immunodeficiency Virus Type-1 In Women Treated With Zidovudine

New England Journal of Medicine

1999

341

6

385-93

ACTG 185

John H. Rodman, Patricia M. Flynn, Brian Robbins, Eleanor Jimenez, Arlene D. Bardeguez, Jose F. Rodriguez, Suzette Blanchard, Arnold Fridland

Systematic Pharmacokinetics and Cellular Pharmacology Of Zidovudine In HIV-1Infected Women and Newborn Infants

Journal of Infectious Diseases

1999

180

6

1844-50

ACTG 296

Donald Brambilla, Patricia S. Reichelderfer, James W. Bremer, David E. Shapiro, Ronald C. Hershow, David A. Katzenstein, Scott M. Hammer, Brooks Jackson, Ann C. Collier, Rhoda S. Sperling, Mary-Glen Fowler, Robert W. Coombs

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

AIDS

1999

13

16

2269-79

ACTG 076

GD McSherry, David E. Shapiro, Ph.D., RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling

The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1

Journal of Pediatrics

1999

134

6

717-24

ACTG 076

Kenneth McIntosh, Ellen Cooper, Jing Xu, Mark Mirochnick, Jane Lindsey, David Jacobus, Lynne Mofenson, Ram Yogev, Stephen A. Spector, John L. Sullivan, Henry Sacks, Andrea Kovacs, Sharon Nachman, John Sleasman, Vincent Bonagura, James McNamara

Toxicity and Efficacy of Daily vs. Weekly Dapsone for Prevention of Pneumocystis Carinii Pneumonia in Children with Human Immunodeficiency Virus

Pediatric Infectious Disease Journal

1999

18

5

432-9

ACTG 179

Mofenson LM, Fowler MG

Update On Prevention Of Perinatal HIV Transmission

HIV Therapy

1999

3

 

57-63

ACTG 076, ACTG 185, ACTG 219

Palumbo P, Raskino C, Fiscus S, Pahwa S, Schutzbank T, Spector S, Baker CJ, Englund JA

Virologic and Immunologic Response To Nucleoside Reverse-Transcriptase Inhibitor therapy Among HIV-Infected Infants and Children

Journal of Infectious Diseases

1999

179

3

576-83

ACTG 152

Walter T. Hughes, M.D., Alejandro Dorenbaum, M.D., Ram Yogev, M.D., B. Beauchamp, M.D., Jing Xu, M.S., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D., Lynette Purdue, Pharm.D., Russell B. Van Dyke, M.D., Martha Rogers, M.D., Brian M. Sadler, Ph.D.

A Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-infected Infants and Children

Antimicrobial Agents and Chemotherapy

1998

42

6

1315-18

ACTG 227

Donald Brambilla, Sheila Leung, Judy Lew, John Todd, Steven Herman, Mike Cronin, David E. Shapiro, James Bremer, Celine Hanson, George V. Hillyer, George D. McSherry, Rhoda S. Sperling, Robert W. Coombs, Patricia S. Reichelderfer

Absolute Copy Number and Relative Change in Determinations of Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an External Standard on Kit Comparisons.

Journal of Clinical Microbiology

1998

36

1

311-314

ACTG 076

Oleske JM

Antiretroviral Therapy and Medical Management Of Pediatric HIV Infection

Pediatrics

1998

102

4

1005-56

ACTG 076, ACTG 128, ACTG 138, ACTG 144, ACTG 152, ACTG 247, ACTG 300, ACTG 331, ACTG 338

Lawrence D'Angelo, M.D., M.P.H., Jane C. Lindsey, Sc.D., Bonnie Zimmer, B.S., Mary Culnane, C.R.N.P., M.S., Donna Futterman, M.D.

Attempting to Enhance the Enrollment of Adolescents into AIDS Clinical Trials: The Design of ACTG Protocol 220

AIDS Patient Care and STDs

1998

12

11

853-9

ACTG 220

Patricia Reichelderfer, Ph.D., Robert W. Coombs, M.D., Ph.D.

Cartesian coordinate analysis of viral burden and CD4+ T-cell count in human immunodeficiency virus type-1 infection

Antiviral Research

1998

38

3

181-94

 

Lambert J, Mofenson LM, Moye J

Correspondence (Reply): Safety and Pharmocokinetics Of Hyperimmune Anti-HIV Immunoglobulin (HIVIG) Administered To HIV-Infected Pregnant Women and Their Newborns

Journal of Infectious Diseases

1998

178

 

598-99

ACTG 185

Frank Palella, M.D., K. M. Delaney, A. C. Moorman, Mark O. Loveless, M.D., Jack Fuhrer, M.D., G. A. Satten, D. J. Aschman, S. D. Holmberg

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection

New England Journal of Medicine

1998

338

13

853-60

 

John P.A. Ioannidis, M.D.

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

The Journal of the American Medical Association

1998

279

4

281-6

 

Judith A. Aberg, M.D., David M. Yajko, Ph.D., Mark A. Jacobson, M.D.

Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy

Journal of Infectious Diseases

1998

178

5

1446-9

 

Sarah M. Gray, Ronald Brookmeyer, Ph.D.

Estimating a treatment effect from multidimensional longitudinal data

Biometrics

1998

54

3

976-88

 

G. Widmer, S. Tzipori, Carl J. Fichtenbaum, M.D., Jeff Griffiths, M.D., MPHTM

Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS

Journal of Infectious Diseases

1998

178

3

834-40

 

Claudia Goulston, M.D., W. McFarland, David Katzenstein, M.D.

Human immunodeficiency virus type 1 RNA shedding in the female genital tract

Journal of Infectious Diseases

1998

177

4

1100-3

 

Genevieve Chene, Philippe Morlat, M.D., Catherine Leport, M.D., Richard Hafner, M.D., L. Dequae, I. Charreau, Jean-Pierre Aboulker, Ph.D., Benjamin J. Luft, M.D., Jean Aubertin, Jean-Louis Vilde, Roger Salamon

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group

Controlled Clinical Trials

1998

19

3

233-48

 

Lisa M. Demeter, Richard D'Aquila, Owen Weislow, Alejo Erice, Joseph Fitzgibbon, Robert Shafer, Douglas Richman, Yuqi Zhao, Diana Huang, Douglas Mayers, Max Arens, Kim Sannerud, Suraiya Rasheed, Daniel Kuritzkes, Patricia Reichelderfer, Anthony Japour

Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA

Journal of Virological Methods

1998

75

1

93-104

 

P. S. Eastman, David E. Shapiro, Robert W. Coombs, Lisa M. Frenkel, George D. McSherry, Paula Britto, Steven A. Herman, Ph.D., Rhoda S. Sperling

Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076

Journal of Infectious Diseases

1998

177

 

557-64

ACTG 076

Mirochnick M, Fenton T, Gagnier P, Pav J, Gwynne M, Siminski S, Sperling RS, Beckerman K, Jimenez E, Yogev R, Spector SA, Sullivan JL

Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus type 1- Infected Pregnant Women and Their Neonates.

Journal of Infectious Diseases

1998

178

2

368-74

ACTG 250

Lorenz Von Seidlein, Susan Plaeger, Ph.D., Ruth E. Dickover, Ph.D., Paul Krogstad, M.D., E. Richard Stiehm, M.D., Yvonne J. Bryson, M.D.

Primary human immunodeficiency virus type 1 infection during pregnancy associated with transmission of SI/MT-2 cell tropic virus and precipitous loss of CD4 cells in mother and infant

Pediatric Infectious Disease Journal

1998

17

6

528-30

 

David J. Straus, M.D., Jenny Huang, M.S., Marcia A. Testa, M.P.H., Ph.D., Alexandra M. Levine, M.D., Lawrence D. Kaplan, M.D.

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor

Journal of Clinical Oncology

1998

16

11

3601-6

 

Mark W. Kline, MD, Russell B. Van Dyke, MD, Jane C. Lindsey, ScD, Meg Gwynne, B.A., Margaret Gwynne, BA, Mary Culnane, MS, Ross E. Mckinney, Jr., MD, Sharon Nichols, PhD, Wendy G. Mitchell, MD, Ram Yogev, MD, Nancy Hutcheon, MD

Randomized Comparative Trial of Stavudine (d4T) versus Zidovudine (ZDV, AZT) in Children with Human Immunodeficiency Virus Infection

Pediatrics

1998

101

2

214-220

ACTG 240

JS Lambert, J McNamara, SL Katz, T Fenton, MH Kang, TC VanCott, R Livingston, E Hawkins, J Moye, W Borkowsky, D Johnson, R Yogev, AM Duliege, Donald P. Francis, M.D., D.Sc., Anne A. Gershon, M.D., Diane W. Wara, M.D., Natasha L. Martin, Myron Levin, M.D., George D. McSherry, M.D., Gale Smith, Ph.D.

Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

1998

19

5

451-61

ACTG 218

Rhoda S. Sperling, M.D., David E. Shapiro, Ph.D., George D. McSherry, M.D., Paula Britto, M.S., Bethann Cunningham-Schrader, B.A., M.S., Mary Culnane, C.R.N.P., M.S., Robert W. Coombs, M.D., Ph.D., Gwendolyn B. Scott, M.D., Russell B. Van Dyke, M.D., William T. Shearer, M.D., Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Clemente Diaz, M.D., Duane Harrison, M.D., Jean-Francois Delfraissy, M.D.

Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study

AIDS

1998

12

14

1805-13

ACTG 076

Helen Kastrissios, J. R. Suarez, Scott M. Hammer, M.D., David Katzenstein, M.D., Terrence F. Blaschke, M.D.

The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker

AIDS

1998

12

17

2305-11

 

Fred M. Gordin, M.D., John P. Matts, Ph.D., Carol Miller, M.P.H., Lawrence S. Brown, Jr., M.D., MPH, Richard Hafner, M.D., Stanley L. John, M.D., Marina B. Klein, M.D., C.M., M.Sc., Anita Vaughn, M.D., C. Lynn Besch, M.D., George Perez, M.D., Susan Szabo, M.D., Wafaa M. El-Sadr, M.D., M.P.H., M.P.A.

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS

New England Journal of Medicine

1997

337

5

315-20

 

Michael Wulfsohn, M.D., D.Sc., Anastasios A. (Butch) Tsiatis, Ph.D.

A joint model for survival and longitudinal data measured with error

Biometrics

1997

53

1

330-9

 

Lee-Jen Wei, Ph.D., David Glidden, Ph.D.

An overview of statistical methods for multiple failure time data in clinical trials

Statistics In Medicine

1997

16

8

833-9

 

Robert Zackin, Sc.D., Lee-Jen Wei, Ph.D.

Analysis of repeated virological measurements based on cell dilution assays

Statistics In Medicine

1997

16

5

571-82

 

L. M. Frenkel, D. E. Shapiro, D. H. Watts, B. Murante, S. Burchett, Y. J. Bryson, M. J. O'Sullivan, C. Mitchell

Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1

Journal of Infectious Diseases

1997

175

 

971-974

ACTG 076

John S. Lambert, M.D., Raphael P. Viscidi, M.D., MaryClare Walker, Ph.D., Barbara Clayman, Marcy Winget, Marcelo Wolff, M.D., David H. Schwartz, M.D., Ph.D.

Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine The NIAID sponsored AIDS Vaccine Evaluation Group

Clinical and Diagnostic Laboratory Immunology

1997

4

3

302-8

 

Albert W. Wu, M.D., M.P.H., Ron D. Hays, Ph.D., Sue Kelly, B.A., F. Malitz, Sam Bozzette, M.D., Ph.D.

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS

Quality of Life Research

1997

6

6

531-4

 

Q. Zeng, Marie Davidian, Ph.D.

Calibration inference based on multiple runs of an immunoassay

Biometrics

1997

53

4

1304-17

 

Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, Sullivan JL

Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 Infection

New England Journal of Medicine

1997

336

19

1343-1349

ACTG 180

Kathleen Mulligan, Ph.D., Viva W. Tai, R.D., M.P.H., Morris Schambelan, M.D.

Cross-sectional and longitudinal evaluation of body composition in men with HIV infection

Journal of Acquired Immune Deficiency Syndromes

1997

15

1

43-48

 

Florence H. Yong, M.S., Jeremy M.G. Taylor, J. L. Bryant, Joan S. Chmiel, Stephen J. Gange, D. Hoover

Dependence of the hazard of AIDS on markers

AIDS

1997

11

2

217-28

 

Janet L. Lathey, Ph.D., Ian Marschner, Ph.D., William Kabat, B.S., Stephen A. Spector, M.D.

Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing

Journal of Clinical Microbiology

1997

35

3

631-5

ACTG 128

Bakshi SS, Britto P, Capparelli E, Mofenson L, Fowler MG, Rasheed S, Schoenfeld D, Zimmer B, Yogev R, Salgo M, Boone G, Pahwa SG

Evaluation of Pharmacokinetics, Safety, Tolerance and Activity of Combination Zalcitabine and Zidovudine (ZDV) in Stable, ZDV-Treated, Pediatric Patients with HIV Infection

Journal of Infectious Diseases

1997

175

 

1039-1050

ACTG 190

Albert W. Wu, M.D., M.P.H., Dennis A. Revicki, Ph.D., Denise Jacobson, F. Malitz

Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)

Quality of Life Research

1997

6

6

481-93

 

Javier Chinen, William T. Shearer

Gene Therapy for Pediatric HIV Infection

The Immunologist

1997

5

3

93-7

ACTG 076

Mofenson LM

Interaction Between Timing Of Perinatal Human Immunodeficiency Virus Infection and Design Of Preventive and Therapeutic Interventions

ACTA Paediatrica

1997

86

Suppl. 421

1-9

ACTG 076, ACTG 185

Yunzhen Cao, Paul Krogstad, Bette T. Korber, Richard A. Koup, M.D., Mark Muldoon, Catherine Macken, Jia-Li Song, Zhezhen Jin, Ph.D., Jia-Qi Zhao, Sheila Clapp, M.B.A., Irvin S.Y. Chen, David D. Ho, Arthur J. Ammann

Maternal HIV- 1 Viral Load and Vertical Transmission of Infection: The Ariel Project for the Prevention of HIV Transmission from Mother to Infant

Nature Medicine

1997

3

5

549-52

ACTG 076

William Lenderking, Ph.D., Marcia A. Testa, M.P.H., Ph.D., David Katzenstein, M.D., Scott M. Hammer, M.D.

Measuring quality of life in early HIV disease: the modular approach

Quality of Life Research

1997

6

6

515-30

 

J. M. Raboud, Julio S.G. Montaner, M.D., S. Rae, James O. Kahn, M.D., Scott M. Hammer, M.D., David Katzenstein, M.D., Andrew T. Pavia, M.D., Michael Hughes, Ph.D., Anne Cross, Ph.D., Mohan Beltangady, Ph.D., Jose M. Gatell Artigas, M.D., Ph.D., Lisa M. Dunkle, M.D., Laurie Smaldone, M.D.

Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals

Antiviral Therapy

1997

2

4

237-47

 

K. Dahl, Elizabeth Keath, Victoria J. Fraser, William G. Powderly, M.D.

Molecular epidemiology of mucosal candidiasis in HIV-positive women

AIDS Research and Human Retroviruses

1997

13

6

485-91

 

Ann J. Melvin, MD, Lisa M. Frenkel, MD

Pediatric HIV-1 Infection

Obstetrics and Gynecology Clinics of North America

1997

24

4

911- 924

ACTG 076, ACTG 152, ACTG 300

Ann J Melvin, Lisa M Frenkel

Prevention of Mother-to-Infant Transmission of HIV-1

Molecular Medicine

1997

3

6

242-5

ACTG 076

Mofenson LM

Reducing the Risk Of Perinatal HIV-1 Transmission With Zidovudine: Results and Implications Of AIDS Clinical Trials Group Protocol 076

ACTA Paediatrica

1997

86

Suppl. 421

89-96

ACTG 076

Lambert JS, Mofenson LM, Fletcher CV, Moye J, Stiehm ER, Meyer WA, Nemo GJ, Mathieson BJ, Hirsch G, Sapan CV, Cummins LM, Jimenez E, O'Neill E, Kovacs A, Stek A

Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their Newborns

Journal of Infectious Diseases

1997

175

 

283-291

ACTG 185

Sophie Pueyo, L. R. Salmi, Genevieve Chene, Catherine Leport, M.D., Philippe Morlat, M.D., L. Dequae, V. Gregoire, Richard Hafner, M.D., Jean-Louis Vilde, Benjamin J. Luft, M.D., Jean Aubertin, Roger Salamon

Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group

Journal of Acquired Immune Deficiency Syndromes

1997

14

5

459-64

 

Albert W. Wu, M.D., M.P.H., Denise Jacobson, Rick Berzon, Ph.D., Dennis A. Revicki, Ph.D., Charles van der Horst, M.D., Carl J. Fichtenbaum, M.D., Michael Switow Saag, M.D., L. Lynn, D. Hardy, Judith Feinberg, M.D.

The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS

Quality of Life Research

1997

6

1

3-10

 

M. Shinkai, Sam Bozzette, M.D., Ph.D., William G. Powderly, M.D., Peter T. Frame, M.D., Stephen A. Spector, M.D.

Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease

Journal of Infectious Diseases

1997

175

2

302-8

 

David Charles Perlman, M.D., Wafaa M. El-Sadr, M.D., M.P.H., M.P.A., Eileen T. Denning, M.P.H., John P. Matts, Ph.D., Edward Elliot Telzak, M.D., Nadim Salomon, M.D., Keith D. Chirgwin, M.D., Richard Hafner, M.D.

Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression.

Clinical Infectious Diseases

1997

25

2

242-6

 

Nancy Wade, M.D., M.P.H., Leonard Weiner, M.D., Lisa Frenkel, M.D., Mahrukh Bamji, M.D., Asha Gupta, M.D.

Vertical Transmission of HIV in New York State: A Basis for Statewide Testing of Newborns

AIDS Patient Care and STDs

1997

11

4

227-236

ACTG 076

William T. Shearer, Thomas C. Quinn, Philip LaRussa, Judy F. Lew, Lynne Mofenson, Susan Almay, Kenneth C. Rich, M.D., Edward Handelsman, M.D., Clemente Diaz, M.D., Marcello Pagano, Vincent Smeriglio, Leslie A. Kalish, M.D.

Viral Load and Disease Progression In Infants Infected With Human Immunodeficiency Virus Type 1

New England Journal of Medicine

1997

336

19

1337-1342

ACTG 076

Janet Ailene Englund, M.D.

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

New England Journal of Medicine

1997

336

24

1704-1712

ACTG 152

Scott M. Hammer, M.D., David A. Katzenstein, M.D., MIchael D. Hughes, Ph.D., Holly Gundacker, M.S., Robert T. Schooley, M.D., Richard H. Haubrich, M.D., W. Keith Henry, M.D., Michael M. Lederman, M.D., John P. Phair, M.D., Manette Niu, M.D., Martin S. Hirsch, M.D., Thomas C. Merigan, M.D.

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter

New England Journal of Medicine

1996

335

15

1081-90

ACTG 152

Hung-Mo Lin, Michael Hughes, Ph.D.

Analysis of uncontrolled treatment changes in HIV clinical trials

Statistics In Medicine

1996

15

19

2053-67

 

Wen-Zhe Ho, D. Kaufman, Li Song, Joann R. Cutilli, Steven D. Douglas, M.D.

Cystamine inhibits human immunodeficiency virus-1 replication in cord blood-derived mononuclear phagocytes and lymphocytes

Blood

1996

88

3

928-33

 

Sherry L. Orloff, R.J. Simonds, M.D., Richard W. Steketee, Michael E. St. Louis

Determinants of Perinatal HIV-1 Transmission

Clinical Obstetrics and Gynecology

1996

39

2

386-395

ACTG 076

Claudia Goulston, M.D., E. Stevens, D. Gallo, James I. Mullins, Carl V. Hanson, Ph.D., David Katzenstein, M.D.

Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle

Journal of Infectious Diseases

1996

174

4

858-61

 

Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ

Identification of Levels of Maternal HIV-1 RNA Associated with Risk of Perinatal Transmission: Effect of Maternal Zidovudine Treatment on Viral Load.

The Journal of the American Medical Association

1996

275

8

599-605

ACTG 076

Thomas Denny, B.S., M.Sc., Joan H. Skurnick, Ambrosia Garcia-Louzao, M.S., George Perez, M.D., Marian R. Passannante, Jose Mariano Colon, M.D., Alice Sheffet, Stanley H. Weiss, Donald Louria

Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission Study

Cytometry: The Journal of the Society for Analytical Cytology

1996

26

1

47-51

 

Rhoda S. Sperling, David E. Shapiro, Robert W. Coombs, John A. Todd, Steven A. Herman, George D. McSherry, Mary Jo O'Sullivan, Russell B. Van Dyke, Eleanor Jimenez, Christine Rouzioux, Patricia M. Flynn, John L. Sullivan

Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 From Mother To Infant

New England Journal of Medicine

1996

335

22

1621-9

ACTG 076

Katherine Luzuriaga, M.D., Yvonne J. Bryson, M.D., George D. McSherry, M.D., James Owen Robinson, M.D., Barbara W. Stechenberg, M.D., Gwendolyn B. Scott, M.D., Michael Lamson, Ph.D., Susannah Cort, John L. Sullivan, M.D.

Pharmacokinetics, Safety, and Activity of Nevirapine in HIV Type 1 Infected Children

Journal of Infectious Diseases

1996

174

4

713-721

ACTG 165, ACTG 180

F. Derouin, Catherine Leport, M.D., Sophie Pueyo, Philippe Morlat, M.D., B. Letrillart, Genevieve Chene, JL Ecobichon, Benjamin J. Luft, M.D., Jean Aubertin, Richard Hafner, M.D., Jean-Louis Vilde, Roger Salamon

Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group

AIDS

1996

10

13

1521-7

 

Thomas Denny, B.S., M.Sc., Dana Stein, B.S., Tammy Mui, Anthony Scolpino, Bart Holland, Ph.D.

Quantitative determination of surface antibody binding capacities of immune subsets present in peripheral blood of healthy adult donors

Cytometry: The Journal of the Society for Analytical Cytology

1996

26

4

265-74

 

Ross E. McKinney, Jr., M.D.

Randomized Study of the Tolerance and Efficacy of High Versus Low Dose Zidovudine in HIV-Infected Children with Mild to Moderate Symptoms (ACTG 128).

Journal of Infectious Diseases

1996

173

May

1097-1106

ACTG 128

Sam Bozzette, M.D., Ph.D., David Kanouse, Ph.D., Naihua Duan, Ph.D., Sandra H. Berry, M.A., Douglas D. Richman, M.D.

The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.

Antiviral Therapy

1996

1

1

21-32

 

Diane V. Havlir, MD, Douglas D. Richman, MD

Viral dynamics of HIV: implications for drug development and therapeutic strategies

Annals of Internal Medicine

1996

124

11

984-94

ACTG 076

Andrew A. Wiznia, Marilyn Crane, Genevieve Lambert, Jorge Sansary, Adell Harris, Laurie Solomon

Zidovudine Use to Reduce Perinatal HIV Type 1 Transmission in an Urban Medical Center

The Journal of the American Medical Association

1996

275

19

1504-6

ACTG 076

Lynne M. Mofenson, M.D., F.A.A.P.

A Criticial Review of Studies Evaluating the Relationship of Mode of Delivery to Perinatal Transmission of Human Immunodeficiency Virus

Pediatric Infectious Disease Journal

1995

14

3

169-177

ACTG 076

Rodney Willoughby, M.D.

Approach to the HIV-Infected Child with Diarrhea

Seminars in Pediatric Infectious Diseases

1995

6

1

17-25

ACTG 219

John C. Kappes, Ph.D., Michael Switow Saag, M.D., George M. Shaw, M.D., Ph.D., Beatrice Hahn, Ph.D., Pratibha Chopra-Sukumaran, Ph.D., S. H. Chen, M.D., Emilio Emini, Ph.D., R. D. McFarland, Lihua Yang, Ph.D., M. Piatak, J. D. Lifson

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared

Journal of Acquired Immune Deficiency Syndromes

1995

10

2

139-49

 

Lixin Cui, Sahyun Yoon, Raymond F. Schinazi, Jean-Pierre Sommadossi, Pharm.D., Ph.D.

Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-B-D-arabinofuranosyl)-5 Iodouracil in human liver cells

Journal of Clinical Investigation

1995

95

2

555-63

 

Yunzhen Cao, David D. Ho, M.D., John Todd, M.D., R. Kokka, M. Urdea, J. D. Lifson, M. Piatak, S. H. Chen, M.D., Beatrice Hahn, Ph.D., Michael Switow Saag, M.D.

Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma

AIDS Research and Human Retroviruses

1995

11

3

353-61

 

Douglas D. Richman, M.D.

Clinical significance of drug resistance in human immunodeficiency virus

Clinical Infectious Diseases

1995

21

Suppl 2

S166-9

 

Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H.

Correlation of Clinical Progression in Human Immunodeficiency Virus-Infected Children with In-vitro Zidovudine Resistance Measured by a Direct Quantitative Peripheral Blood Assay

Journal of Infectious Diseases

1995

172

August

359-364

ACTG 152

Robert Shafer, M.D., Astrid K.N. Iversen, Mark A. Winters, M.S., Elsa Aguiniga, David Katzenstein, M.D., Thomas C. Merigan, Jr., M.D.

Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy

Journal of Infectious Diseases

1995

172

1

70-8

 

William R. Robinson, III, M.D.

Effect of Successive Single-Gestation Pregnanacies on the Course of Maternal Human Immunodeficiency Virus Disease and Perinatal Transmission

Infectious Diseases in Obstetrics and Gynecology

1995

2

 

251-254

ACTG 076

Lisa M. Frenkel, M.D.

Effects of Zidovudine Use During Pregnancy on Resistance and Vertical Transmission of Human Immunodeficiency Virus Type 1

Clinical Infectious Diseases

1995

20

May

1321-1326

ACTG 076

GROUP

Enhancing Supportive Care and Promoting Quality of Life: Clinical Practice Guidelines

Pediatric AIDS and HIV Infection: Fetus to Adolescent

1995

6

4

187-203

ACTG 219

Susan A. Fiscus, Ph.D., Seth Welles, Ph.D., Sc.D., Stephen A. Spector, M.D., Janet L. Lathey, Ph.D.

Length of incubation time for human immunodeficiency virus cultures

Journal of Clinical Microbiology

1995

33

1

246-7

ACTG 076, ACTG 128

E. Walter

Maternal Acceptance of Voluntary Human Immunodeficiency Virus Antibody Testing During the Newborn Period with the Guthrie Card

Pediatric Infectious Disease Journal

1995

14

5

376-381

ACTG 076

Clemente Diaz, M.D.

Medical and Pharmacologic Management of the HIV-Infected Child

Immunology and Allergy Clinics of North America

1995

15

2

395-420

ACTG 076, ACTG 152, ACTG 190, ACTG 245

Russell B. Van Dyke, M.D.

Opportunistic Infections in HIV-Infected Children

Seminars in Pediatric Infectious Diseases

1995

6

1

10-16

ACTG 076

Michael D. Rogers, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P.

Reducing the Risk of Perinatal HIV Transmission Through Zidovudine Therapy: Treatment Recommendations and Implications

Journal of the American Medical Women's Association

1995

50

3&4

78-93

ACTG 076, ACTG 152, ACTG 185, ACTG 219, ACTG 230, ACTG 288

E. Richard Stiehm, M.D.

Summary of the Workshop on Passive Immunotherapy in the Prevention and Treatment of HIV Infection

Clinical Immunology and Immunopathology (Now Clin Immunol)

1995

75

1

84-93

ACTG 185

David L. DeMets, Ph.D., David L. DeMets, Ph.D., Thomas R. Fleming, Ph.D., Richard J. Whitley, M.D., J. F. Childress, Susan S. Ellenberg, Ph.D., Mary Foulkes, Ph.D., Kenneth H. Mayer, M.D., Judith O'Fallon, Ph.D., Richard B. Pollard, M.D., J. J. Rahal

The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials

Controlled Clinical Trials

1995

16

6

408-21

 

John S. Lambert, M.D.

The Prevention of Maternal-Fetal HIV-1 Infection Through Passive Antibody Products (HIVIG) and Active Immunization (AIDS Vaccines)

Pediatric AIDS and HIV Infection: Fetus to Adolescent

1995

6

5

300-302

ACTG 076, ACTG 185, ACTG 218

Jean Wilkins, Ph.D., S. Hamby, Ph.D., Kevin R. Robertson, Ph.D., Francoise Seillier-Moiseiwitsch, K. L. Knorr, N. Barry, Colin D. Hall, M.D.

The Profile of Mood States as a screening test for major depression in HIV+ patients

Assessment

1995

2

2

181-8

 

C. Hayner, Robert Baughman, M.D., Calvin C. Linnemann, Jr., M.D., Michael N. Dohn, M.D.

The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV

Chest

1995

107

3

735-40

 

William T. Shearer, M.D., Ph.D.

Transport of Recombinant Human CD4-Immunoglobulin G Across the Human Placenta: Pharmacokinetics and Safety in Six Mother-Infant Pairs in AIDS Clinical Trials Group Protocol 146

Clinical and Diagnostic Laboratory Immunology

1995

2

3

281-285

ACTG 146

 

U.S. Public Health Service Recommendations for Human Immunodefciency Virus Counseling and Voluntary Testing for Pregnant Women

Morbidity and Mortality Weekly Report

1995

44

RR-7

1-15

ACTG 076

Edward M. Connor, M.D.

Zidovudine for the Reduction of Perinatal Human Immnuodeficiency Virus Transmission: Pediatric AIDS Clinical Trials Group Protocol 076 - Results and Treatment Recommendations

Pediatric Infectious Disease Journal

1995

14

 

536-541

ACTG 076

Stephen A. Spector, M.D.

A Controlled Trial of Intravenous Gamma Globulin for Prevention of Serious Bacterial Infections in Children Receiving Zidovudine for Advanced Human Immunodeficiency Virus Infection

New England Journal of Medicine

1994

331

18

1181-1187

ACTG 051

Mark W. Kline, M.D.

Antiretroviral Therapy

Seminars in Pediatric Infectious Diseases

1994

5

4

277-282

ACTG 128, ACTG 138, ACTG 144, ACTG 152, ACTG 240, IMPAACT 2003B

M. Jenkins

Association Between Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibody-Dependent Cellular Cytotoxicity Antibody Titers at Birth and Vertical Transmission of HIV-1

Journal of Infectious Diseases

1994

170

August

308-312

ACTG 076

Marilyn S. Bartlett, M. Goheen, Chao-Hung Lee, Margaret M. Shaw, Michelle M. Durkin, James W. Smith

Close association of Pneumocystis carinii from infected rat lung with culture cells as shown by light and electron microscopy

Parasitology Research

1994

80

3

208-15

 

Robert Shafer, M.D., Michael J. Kozal, M.D., Mark A. Winters, M.S., Astrid K.N. Iversen, David Katzenstein, M.D., Margaret V. Ragni, M.D., William A. Meyer, III, Ph.D., Phalguni Gupta, Ph.D., Suraiya Rasheed, Ph.D., Robert W. Coombs, M.D., Ph.D., Michael Katzman, M.D., Susan A. Fiscus, Ph.D., Thomas C. Merigan, Jr., M.D.

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations

Journal of Infectious Diseases

1994

169

4

722-9

 

Victoria A. Johnson, M.D.

Combination Therapy: More Effective Control of HIV Type 1?

AIDS Research and Human Retroviruses

1994

10

8

907-912

ACTG 115

Brian Robbins, Ph.D., John H. Rodman, Pharm.D., Cheryl McDonald, M.D., Ranga V. Srinivas, Ph.D., Patricia M. Flynn, M.D., M.S., Arnold Fridland, Ph.D.

Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells

Antimicrobial Agents and Chemotherapy

1994

38

1

115-21

 

Lynne M. Mofenson, M.D., F.A.A.P.

Epidemiology and Determinants of Vertical HIV Transmission

Seminars in Pediatric Infectious Diseases

1994

5

4

252-265

ACTG 076

Pamela J. Boyer, M.D., Maryanne Dillon, B.S.N., N.P., Maryam Navaie, M.P.H., Audra Deveikis, M.D., Margaret A. Keller, M.D., S. O'Rourke, Yvonne J. Bryson, M.D.

Factors Predictive of Maternal-Fetal Transmission of HIV-1. Preliminary Analysis of Zidovudine Given During Pregnancy and/or Delivery.

The Journal of the American Medical Association

1994

271

24

1925-30

ACTG 076, ACTG 082

Ross E. McKinney, Jr., M.D., Catherine Wilfert, M.D.

Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine

Journal of Pediatrics

1994

125

5 Pt 1

728-33

ACTG 043, ACTG 152

Michael J. Kozal, M.D., Robert Shafer, M.D., Mark A. Winters, M.S., David Katzenstein, M.D., Elsa Aguiniga, J. Halpern, Thomas C. Merigan, Jr., M.D.

HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients

Journal of Acquired Immune Deficiency Syndromes

1994

7

8

832-8

 

Edward M. Connor, M.D.

Immune-Based Interventions in Perinatal Human Immunodeficiency Virus Infection

Pediatric Infectious Disease Journal

1994

13

5

440-448

ACTG 051, ACTG 076, ACTG 185

SOCA

Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus Infection

New England Journal of Medicine

1994

325

2

73-80

ACTG 051

J. Michael Kilby, M.D., Michael Switow Saag, M.D.

Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection

Infectious Agents and Disease

1994

3

6

313-23

 

A. Blank

Maternal and Pediatric AIDS in the United States: the Current Situation and Future Research Directions

ACTA Paediatrica

1994

s400

 

106-110

ACTG 152, ACTG 185

L. Dyster, Lynn Z. Abbott, Virginia Bryz-Gornia, Bernard Poiesz, M.D., Lawrence D. Papsidero

Microplate-based DNA hybridization assays for detection of human retroviral gene sequences

Journal of Clinical Microbiology

1994

32

2

547-50

 

P. Rameshwar, Thomas Denny, B.S., M.Sc., Daniel S. Stein, M.D., P. Gascon

Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta

Journal of Immunology

1994

153

6

2819-30

 

I. Najera, Douglas D. Richman, M.D., I. Olivares, Jose Rojas, M.D., M. A, Peinado, M. Perucho, R. Najera, C. Lopez-Galindez

Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates

AIDS Research and Human Retroviruses

1994

10

11

1479-88

 

Michael N. Dohn, M.D., Winkler Weinberg, M.D., Ramon A. Torres, M.D., Stephen E. Follansbee, M.D., P. Caldwell, Joseph Scott, Joseph Gathe, M.D., D. P. Haghighat, James H. Sampson, M.D., Jared M. Spotkov, M.D., Stanley C. Deresinski, M.D., F.A.C.P., Richard D. Meyer, M.D., Danny Lancaster, M.D.

Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS

Annals of Internal Medicine

1994

121

3

174-80

 

Mark A. Jacobson, M.D., Bruce Polsky, M.D., Dennis M. Causey, M.D., Roger Davis, William P. Tong, James O'Donnell, M.D., Baruch D. Kuppermann, Murk-Hein Heinemann, M.D., Judith Feinberg, M.D., Patricia S. Lizak, B.S., John G. Gambertoglio, Pharm.D., Francesca Aweeka, Pharm.D.

Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitis

Antimicrobial Agents and Chemotherapy

1994

38

5

1190-3

 

Ranga V. Srinivas, Ph.D., Brian Robbins, Ph.D., Michael Connolly, Y. Gong, N. Bischofberger, Arnold Fridland, Ph.D.

Pivaloyloxymethyl esters of acyclic nucleoside phosphonates

International Antiviral News

1994

2

4

53-55

 

Lynne M. Mofenson, M.D., F.A.A.P.

Prevention of Infections in Children with Human Immunodeficiency Virus Infection: Practical Recommendations

Journal of Clinical Immunology

1994

1

4

258-270

ACTG 051

T. Loughran, Michael P. Sherman, Frank Ruscetti, Sharon E. Frey, M.D., Tom Coyle, M.D., Richard Montagna, Barbara Jones, Gordon Starkebaum, Bernard Poiesz, M.D.

Prototypical HTLV-I/II infection is rare in LGL leukemia

Leukemia Research

1994

18

6

423-9

 

Lynne M. Mofenson, M.D., F.A.A.P.

Recommendations of the U.S. Public Health Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus

Morbidity and Mortality Weekly Report

1994

43

RR-11

1-20

7913986

ACTG 076, ACTG 219

Edward M. Connor, M.D., Rhoda S. Sperling, M.D., Richard D. Gelber, Ph.D., P. Kiselev, Gwendolyn B. Scott, M.D., Mary Jo O'Sullivan, M.D., Russell B. Van Dyke, M.D., Mohammed Bey, M.D., William T. Shearer, M.D., Ph.D., R. L. Jacobson

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment: Results of AIDS Clinical Trials Group Protocol 076

New England Journal of Medicine

1994

331

18

1173-80

ACTG 076

Howard Minkoff, M.D.

The Role of Obstetric Interventions in the Prevention of Pediatric Human Immunodeficiency Virus Infection

American Journal of Obstetrics and Gynecology

1994

171

5

1167-1175

ACTG 076, ACTG 185, ACTG 233, ACTG 234, ACTG 235

Margaret A. Fischl, M.D., Lionel Resnick, M.D., Robert W. Coombs, M.D., Ph.D., A. B. Kremer, John C. Pottage, Jr., M.D., Robert J. Fass, M.D., Kenneth H. Fife, M.D., Ph.D., William G. Powderly, M.D., Ann C. Collier, M.D., Richard L. Aspinall, Ph.D.

The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3

Journal of Acquired Immune Deficiency Syndromes

1994

7

2

139-47

 

Edward M. Connor, M.D.

Treatment of HIV Infection in Infancy

Clinics in Perinatology

1994

21

1

163-177

ACTG 051

Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G.

Women and HIV-1 Infection

AIDS

1994

8

suppl 1

S261-S273

ACTG 076, ACTG 185

A. Berger, Joseph Arezzo, Herbert H. Schaumburg, Gail Skowron, M.D., Thomas C. Merigan, Jr., M.D., Sam Bozzette, M.D., Ph.D., Douglas D. Richman, M.D., Whaijen Soo, M.D., Ph.D.

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

Neurology

1993

43

2

358-62

 

Stephen A. Spector, M.D., Thomas Weingeist, Richard B. Pollard, M.D., Douglas T. Dieterich, M.D., Tobias Samo, Constance A. Benson, M.D., David Busch, M.D., William R. Freeman, M.D., Thomas W. Montague, Henry J. Kaplan, Lois Kellerman, Michael Crager, Bernadette De Armond, William Buhles, Judith Feinberg, M.D.

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS

Journal of Infectious Diseases

1993

168

3

557-563

 

Walter T. Hughes, M.D., David P. Jacobus, M.D., Craig Canfield, John Killmar

Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist

Antimicrobial Agents and Chemotherapy

1993

37

7

1417-9

 

Craig Hendrix, M.D., M.C., Joseph B. Margolick, M.D., Ph.D., Brent Gray Petty, M.D., Richard B. Markham, M.D., Lynda Nerhood, R.N., B.S., Homayoon Farzadegan, M.D., Ph.D., Paul O. Ts'o, Paul S. Lietman, M.D.

Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers

Antimicrobial Agents and Chemotherapy

1993

37

3

429-35

 

John R. Black, M.D.

Clindamycin and primaquine treatment of pneumocystosis in AIDS

Reviews in Contemporary Pharmacotherapy

1993

3

 

302-12

 

Ronald T. Mitsuyasu, M.D.

Clinical aspects of AIDS-related Kaposi's Sarcoma

Current Opinion in Oncology

1993

5

5

835-44

 

D. Ennis, Michael Switow Saag, M.D.

Cryptococcal meningitis in AIDS

Hospital Practice (Office Edition)

1993

28

10

99-112

 

S. Srinivas, Ranga V. Srinivas, Ph.D., G. M. Anantharamaiah, R. W. Compans, J. P. Segrest

Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins

Journal of Biological Chemistry

1993

268

30

22895-9

 

F. Sabahi

Depression of Cell-Mediated Immunity in Pregnancy

Journal of Immunology

1993

150

8

Part II

 

Mark T. Ogino

Development and Significance of Zidovudine (ZDV) Resistance in Children Infected with the Human Immunodeficiency Virus

Journal of Pediatrics

1993

123

 

1-8

ACTG 051

Ross E. McKinney, Jr., M.D., J. W. Robertson

Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit

Journal of Pediatrics

1993

123

4

579-82

ACTG 003, ACTG 043, ACTG 049, ACTG 101, ACTG 103, ACTG 128

E. Walter

Enhanced p24 Antigen Detection in Sera from HIV-Infected Children

Pediatric Infectious Disease Journal

1993

12

1

94-96

ACTG 003, ACTG 043, ACTG 128, ACTG 152

Brooks Jackson, M.D., M.B.A., Jamie Drew, M.S., M.B.A., Hsiang Ju Lin, D.Sc., Pat Otto, James W. Bremer, Ph.D., F. Blaine Hollinger, M.D., Steven M. Wolinsky, M.D.

Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories

Journal of Clinical Microbiology

1993

31

12

3123-8

 

Pamela Stratton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Anne Willoughby, M.D., M.P.H.

Human immunodeficiency virus infection in pregnant women under care at AIDS clinical trials centers in the United States

Obstetrics and Gynecology

1993

79

3

364-8

 

Susan A. Fiscus, Ph.D., James D. Folds, Ph.D., Charles van der Horst, M.D.

Infectious immune complexes in HIV-1-infected patients.

Viral Immunology

1993

6

2

135-41

 

Tony Waitung Cheung, M.D., R. Matta, Eric P. Neibart, M.D., Glen Steven Hammer, M.D., Eileen Chusid, Ph.D., Henry S. Sacks, M.D., Ph.D., Susan Szabo, M.D., David Nathaniel Rose, M.D.

Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus

Journal of Infectious Diseases

1993

16

1

22-25

 

Lynne M. Mofenson, M.D., F.A.A.P.

Intravenous Immune Globulin for the Prevention of Infections in Children with Symptomatic Human Immunodeficiency Virus Infection

Pediatric Research

1993

33

Suppl 1

S80-S89

ACTG 051

Ranga V. Srinivas, Ph.D., Brian Robbins, Ph.D., Mark Connelly, Y. Gong, N. Bischofberger, Arnold Fridland, Ph.D.

Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates

Antimicrobial Agents and Chemotherapy

1993

37

10

2247-9

 

Michael Connolly, Robert Baughman, M.D., Michael N. Dohn, M.D.

Mycobacterium kansasii presenting as an endobronchial lesion

American Review of Respiratory Diseases

1993

148

5

1405-7

 

David M. Simpson, M.D., K. A. Citak, Ellen Godfrey, M.P.H., J. Godbold, D. E,. Wolfe

Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?

Neurology

1993

43

5

971-6

 

Catherine Wilfert, M.D., Marcia E. Herman-Giddens, P.A., M.P.H., Ross E. McKinney, Jr., M.D.

Pediatric acquired immunodeficiency syndrome. Barriers to recognizing the role of child sexual abuse

Archives of Pediatrics and Adolescent Medicine

1993

147

7

775-80

 

Linda L. Rosendorf, MS, Urania Dafni, Dsc, David A. Amato, PhD, Barbara Lunghofer, John G. Bartlett, M.D., John M. Leedom, MD, Diane W. Wara, MD, John A. Armstrong, Sc.D., Catherine Godfrey, M.D., Eivind Sukkestad, Georg W. Counts, MD

Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group

Controlled Clinical Trials

1993

14

6

523-7

ACTG 128

F. Boucher

Phase I Evaluation of Zidovudine Adminstered to Infants Exposed at Birth to the Human Immunodeficiency Virus

Journal of Pediatrics

1993

122

1

137-144

ACTG 049

Kevin R. Robertson, Ph.D., Jean Wilkins, Ph.D., Jean Handy, Charles van der Horst, M.D., Wendy Robertson, M.A., John G. Fryer, Donna Evans, Colin D. Hall, M.D.

Psychoimmunology and AIDS: psychological distress and herpes simplex virus in human immunodeficiency virus infected individuals

Psychology and Health

1993

8

 

317-27

 

Mary Jo O'Sullivan, M.D.

The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082)

American Journal of Obstetrics and Gynecology

1993

168

5

1510-1516

ACTG 082

D. Richardson, Song-Heng Liou, M.S., James O. Kahn, M.D.

Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.

Journal of Acquired Immune Deficiency Syndromes

1993

6

11

1212-23

 

William G. Powderly, M.D., Michael Switow Saag, M.D., Gretchen Cloud, M.S., Patrick Robinson, M.D., Richard D. Meyer, M.D., Jeffrey M. Jacobson, M.D., John Richard Graybill, M.D., Alan M. Sugar, M.D., Vincent J. McAuliffe, M.D., Stephen E. Follansbee, M.D., Carmelita U. Tuazon, M.D., John Stern, M.D., Judith Feinberg, M.D., Richard Hafner, M.D., William E. Dismukes, M.D.

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS clinical trials group and mycoses study group

New England Journal of Medicine

1992

326

12

793-8

 

D. O. Beenhouwer, J. A. Rankin, John W. Mellors, M.D.

Anti-HIV-1 activity of 3'-azido-3'-deoxythymidine (AZT) in primary mononuclear phagocytes.

Antiviral Research

1992

19

1

43-54

 

Margaret V. Ragni, M.D., B. J. Miller, R. Whalen, R. Ptachcinski R

Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men

American Journal of Hematology

1992

40

3

176-82

 

Pascal R. Meylan, James R. Munis, Douglas D. Richman, M.D., Richard S. Kornbluth

Concurrent human immunodeficiency virus and mycobacterial infection of macrophages in vitro does not reveal any reciprocal effect

Journal of Infectious Diseases

1992

165

1

80-6

 

L. Joseph Wheat, M.D., Patricia A. Connolly, M.S., Brian Williams, Kathleen Connolly, R. Blair, Marilyn S. Bartlett, Michelle M. Durkin

Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid

American Review of Respiratory Diseases

1992

145

6

1421-4

 

Mark J. Shelton, Pharm.D., Alice M. O'Donnell, Gene D. Morse, Pharm.D.

Didanosine

Annals of Pharmacotherapy

1992

26

5

660-70

 

L. Joseph Wheat, M.D., Patricia A. Connolly, M.S., R. Blair, Kathleen Connolly, Todd Garringer, Barry P. Katz, M. R. Gupta

Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis

American Journal of Medicine

1992

92

2

153-60

 

Douglas D. Richman, M.D.

Emergence of mutant HIV reverse transcriptase conferring resistance to AZT

Journal of Enzyme Inhibition and Medicinal Chemistry

1992

6

1

55-64

 

Donna Mildvan, M.D., Stella Machado, Ph.D., I. Wilets, Sidney Grossberg, M.D.

Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex

Lancet

1992

339

8791

453-6

 

C. Day, B. Schwartz, B. Li, Sidney Pestka, M.D.

Engineered disulfide bond greatly increases specific activity of recombinant murine interferon-beta

Journal of Interferon and Cytokine Research

1992

12

2

139-43

 

Karl Kieburtz, M.D., Mindell Seidlin, M.D., John S. Lambert, M.D., Raphael Dolin, M.D., Richard C. Reichman, M.D., Fred T. Valentine, M.D.

Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine

Journal of Acquired Immune Deficiency Syndromes

1992

5

1

60-4

 

H. Qavi, Michael Green, G. K. SeGall, Dorothy E. Lewis, Ph.D., F. Blaine Hollinger, M.D.

Frequency of dual infections of corneas with HIV-1 and HHV-6

Current Eye Research

1992

11

4

315-23

 

Ross G. Hewitt, M.D., Gene D. Morse, Pharm.D.

Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection

Pharmacotherapy

1992

12

6

455-61

 

L. Joseph Wheat, M.D.

Histoplasmosis - diagnosis and ,anagement

Infectious Diseases in Clinical Practice

1992

1

5

287-90

 

L. Joseph Wheat, M.D.

Histoplasmosis in Indianapolis

Clinical Infectious Diseases

1992

14

Suppl 1

S91-9

 

Antonio V. Sison, M.D.

HIV-1 Infections in Pregnancy and Perinatal Transmission of HIV-1: Current Issues

Pediatric AIDS and HIV Infection: Fetus to Adolescent

1992

3

1

 

ACTG 076, ACTG 082, ACTG 185

John L. Fahey, M.D.

Immune Abnormalities and Control of AIDS

Progress in Allergy and Clinical Immunology

1992

2

 

276-81

 

Charles S. Rabkin, M.D., M.Sc., Margaret W. Hilgartner, M.D., K. W. Hedberg, Louis M. Aledort, M.D., Angelos Hatzakis, M.D., Ph.D., S. Eichinger, M. Elaine Eyster, M.D., Gilbert C. White, II, M.D., Craig M. Kessler, M.D., Michael M. Lederman, M.D.

Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia

The Journal of the American Medical Association

1992

267

8

1090-4

 

Jamie A. De Stefano, Richard G. Sleight, George F. Babcock, R. Michael Sramkoski, Peter D. Walzer, M.D.

Isolation of Pneumocystis carinii cysts by flow cytometry

Parasitology Research

1992

78

3

179-82

 

Mark A. Jacobson, M.D.

Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet

American Journal of Medicine

1992

92

suppl 2A

26S-29S

 

Edward L. Schwartz, Anna-Barbara Brechbuhl, Patricia Kahl, Michael A. Miller, Peter A. Selwyn, M.D., M.P.H., Gerald H. Friedland, M.D.

Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection

Journal of Acquired Immune Deficiency Syndromes

1992

5

6

619-26

 

Francesca Aweeka, Pharm.D.

Pharmacokinetics of concomitantly administered foscarnet and zidovudine for the treatment of human immunodeficiency virus infection (AIDS clinical trials group protocol 053)

Antimicrobial Agents and Chemotherapy

1992

36

8

1773-78

 

Brian Stretcher, Amadeo Pesce, Ph.D., Paul Hurtubise, Ph.D., Peter T. Frame, M.D.

Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus

Therapeutic Drug Monitoring

1992

14

4

281-5

 

Walter T. Hughes, M.D.

Pneumocystis carinii infection: an update

Classics in Medicine

1992

71

 

175-77

 

L. Collart, Terrence F. Blaschke, M.D., F. Boucher, C. Prober

Potential of Population Pharmacokinetics to Reduce the Frequency of Blood Sampling Required for Estimating Kinetic Parameters in Neonates

Developmental Pharmacology and Therapeutics

1992

18

1-2

71-80

ACTG 049

N. Boyer, P. Marcellin, C. Degott, F. Degos, A. G. Saimot, S. Erlinger, J. P. Benhamou

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. ComitT des Anti-Viraux

Journal of Infectious Diseases

1992

165

4

723-6

 

T. McNearney, Zuzana Hornickova, Richard B. Markham, M.D., Anahid Birdwell, Max Arens, Ph.D., Alfred J. Saah, M.D., M.P.H., Lee Ratner, M.D., Ph.D.

Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease

Proceedings of the National Academy of Sciences of the United States of America

1992

89

21

10247-51

 

Antonio V. Sison, M.D.

Review and recent advances in human immunodeficiency virus type 1 infections in pregnancy

Postgraduate Obstetrics and Gynecology

1992

12

17

1-8

 

Douglas D. Richman, M.D.

Selection of zidovudine-resistant variants of human immunodeficiency virus by therapy

Current Topics in Microbiology and Immunology

1992

176

 

131-42

 

J. Mohle-Boetani, S. K. Akula, Mark Holodniy, M.D., David Katzenstein, M.D., Gabriel Garcia, M.D.

The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia

Western Journal of Medicine

1992

156

3

303-6

 

Lynne M. Mofenson, M.D., F.A.A.P.

The Use of Intravenous Immunoglobulin in Pediatric Human Immunodeficiency Virus Infection

Seminars in Pediatric Infectious Diseases

1992

3

3

157-166

ACTG 051

P. Witt, Greg Spear, Ph.D., M. J. Lindstrom, Harold A. Kessler, M.D., E. C. Borden, John P. Phair, M.D., Alan Landay, Ph.D.

2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals

AIDS

1991

5

3

289-93

 

Brian Stretcher, Amadeo Pesce, Ph.D., B. A. Geisler, W. H. Vine

A coupled HPLC/radioimmunoassay for analysis of zidovudine metabolites in mononuclear cells

Journal of Liquid Chromatography

1991

14

12

2261-72

 

Ross E. McKinney, Jr., M.D.

A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease

New England Journal of Medicine

1991

324

15

1018-1025

ACTG 043

Margaret A. Fischl, M.D., Raj B. Uttamchandani, Lionel Resnick, M.D., Ram Agarwal, Mary Ann Fletcher, Ph.D., Janie Reese, R.N., B.S.N., Lisa Dearmas, Jane Chidekel, Mary McCann, R.N., Mark Myers, R.N.

A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma

Journal of Acquired Immune Deficiency Syndromes

1991

4

1

1-10

 

Richard A. Koup, M.D., James Robinson, Q. V. Nguyen, Cheryl A. Pikora, M.D., Ph.D., Bruce P. Blais, B.A., A. Roskey, Dennis Panicali, Ph.D., John L. Sullivan, M.D.

Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1

AIDS

1991

5

11

1309-14

 

C. Terai, Richard S. Kornbluth, C. David Pauza, Ph.D., Douglas D. Richman, M.D., D. Carson

Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1

Journal of Clinical Investigation

1991

87

5

1710-15

 

Charles Rinaldo, Jr., Ph.D., Charles Rinaldo,